inbk-20200630

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)


☑			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period ended June 30, 2020


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period From ________ to ________.

Commission File Number 001-35750


First Internet Bancorp
(Exact Name of Registrant as Specified in Its Charter)


Indiana						20-3489991
(State or Other Jurisdiction of Incorporation or Organization)						(I.R.S. Employer Identification No.)

11201 USA Parkway Fishers, IN						46037
(Address of Principal Executive Offices)						(Zip Code)


			(317) 532-7900
			(Registrant’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbols

Name of each exchange on which registered

Common Stock, without par value

INBK

The Nasdaq Stock Market LLC

6.0% Fixed to Floating Subordinated Notes due 2026

INBKL

The Nasdaq Stock Market LLC

6.0% Fixed to Floating Subordinated Notes due 2029

INBKZ

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes þ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.


Large Accelerated Filer ¨			Accelerated Filer þ
Non-accelerated Filer ¨			Smaller Reporting Company ☑
Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No þ

As of July 31, 2020, the registrant had 9,799,047 shares of common stock issued and outstanding.

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of the federal securities laws. These statements are not historical facts, but rather statements based on the current expectations of First Internet Bancorp and its consolidated subsidiaries (“we,” “our,” “us” or the “Company”) regarding its business strategies, intended results and future performance. Forward-looking statements are generally preceded by terms such as “anticipate,” “attempt,” “believe,” “can,” “continue,” “could,” “effort,” “estimate,” “expect,” “indicate,” “intend,” “likely,” “may,” “objective,” “optimistic,” “pending,” “plan,” “position,” “potential,” “preliminary,” “remain,” “should,” “will,” “would” and other similar expressions. Forward-looking statements are not a guarantee of future performance or results, are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from the information in the forward-looking statements. The COVID-19 pandemic crisis is adversely affecting us, our customers, counterparties, employees, and third-party service providers, and the ultimate extent of the impacts on our business, financial position, results of operations, liquidity, and prospects remains uncertain. Continued deterioration in general business and economic conditions, including further increases in unemployment rates, or turbulence in domestic or global financial markets could adversely affect our revenues and the values of our assets and liabilities, reduce the availability of funding, lead to a tightening of credit, and further increase stock price volatility. In addition, changes to statutes, regulations, or regulatory policies or practices as a result of, or in response to COVID-19, could affect us in substantial and unpredictable ways. Other factors that may cause such differences include: general economic conditions, whether national or regional, and conditions in the lending markets in which we participate that may have an adverse effect on the demand for our loans and other products; our credit quality and related levels of nonperforming assets and loan losses, and the value and salability of the real estate that we own or that is the collateral for our loans; failures or breaches of or interruptions in the communication and information systems on which we rely to conduct our business that could reduce our revenues, increase our costs or lead to disruptions in our business; our plans to grow our commercial real estate, commercial and industrial, public finance, U.S. Small Business Administration and healthcare finance loan portfolios, which may carry greater risks of non-payment or other unfavorable consequences; our dependence on capital distributions from First Internet Bank of Indiana (the “Bank”); results of examinations of us by our regulators, including the possibility that our regulators may, among other things, require us to increase our allowance for loan losses or to write-down assets; changing bank regulatory conditions, policies or programs, whether arising as new legislation or regulatory initiatives, that could lead to restrictions on activities of banks generally, or the Bank in particular; more restrictive regulatory capital requirements; increased costs, including deposit insurance premiums; regulation or prohibition of certain income producing activities or changes in the secondary market for loans and other products; changes in market rates and prices that may adversely impact the value of securities, loans, deposits and other financial instruments and the interest rate sensitivity of our balance sheet; our liquidity requirements being adversely affected by changes in our assets and liabilities; the effect of legislative or regulatory developments, including changes in laws concerning taxes, banking, securities, insurance and other aspects of the financial services industry; competitive factors among financial services organizations, including product and pricing pressures and our ability to attract, develop and retain qualified banking professionals; execution of future acquisition, reorganization or disposition transactions, including without limitation, the related time and costs of implementing such transactions, integrating operations as part of these transactions and possible failures to achieve expected gains, revenue growth and/or expense savings and other anticipated benefits from such transactions; changes in applicable tax laws; the growth and profitability of noninterest or fee income being less than expected; the loss of any key members of senior management; the effect of changes in accounting policies and practices, as may be adopted by the Financial Accounting Standards Board, the Securities and Exchange Commission (the “SEC”), the Public Company Accounting Oversight Board and other regulatory agencies; and the effect of fiscal and governmental policies of the United States federal government. Additional factors that may affect our results include those discussed in this Quarterly Report on Form 10-Q, our Quarterly Report on Form 10-Q for the quarter ended March 31, 2020 and our most recent Annual Report on Form 10-K under the heading “Risk Factors” and in other reports filed with the SEC. We caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. The factors listed above could affect our financial performance and could cause our actual results for future periods to differ materially from any opinions or statements expressed with respect to future periods in any current statements.

Except as required by law, we do not undertake, and specifically disclaim any obligation, to publicly release the result of any revisions that may be made to any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

PART I

ITEM 1. FINANCIAL STATEMENTS

First Internet Bancorp

Condensed Consolidated Balance Sheets

(Amounts in thousands except share data)


	June 30, 2020		December 31, 2019
	(Unaudited)
Assets
Cash and due from banks	$	7,016	$	5,061
Interest-bearing deposits	491,603		322,300
Total cash and cash equivalents	498,619		327,361

Securities available-for-sale, at fair value (amortized cost of $590,046 and $546,640 in 2020 and 2019, respectively)	589,017		540,852
Securities held-to-maturity, at amortized cost (fair value of $69,152 and $62,560 in 2020 and 2019, respectively)	68,295		61,878
Loans held-for-sale, at fair value	38,813		56,097
Loans	2,973,674		2,963,547
Allowance for loan losses	(24,465)		(21,840)
Net loans	2,949,209		2,941,707
Accrued interest receivable	21,093		18,607
Federal Home Loan Bank of Indianapolis stock	25,650		25,650
Cash surrender value of bank-owned life insurance	37,474		37,002
Premises and equipment, net	23,939		14,630
Goodwill	4,687		4,687
Servicing asset, at fair value	2,522		2,481
Other real estate owned	2,065		2,065
Accrued income and other assets	63,217		67,066
Total assets	$	4,324,600	$	4,100,083
Liabilities and Shareholders’ Equity
Liabilities
Noninterest-bearing deposits	$	82,864	$	57,115
Interest-bearing deposits	3,297,925		3,096,848
Total deposits	3,380,789		3,153,963
Advances from Federal Home Loan Bank	514,913		514,910
Subordinated debt, net of unamortized debt issuance costs of $2,319 and $2,472 in 2020 and 2019, respectively	69,681		69,528
Accrued interest payable	1,073		3,767
Accrued expenses and other liabilities	50,433		53,002
Total liabilities	4,016,889		3,795,170
Commitments and Contingencies
Shareholders’ Equity
Preferred stock, no par value; 4,913,779 shares authorized; issued and outstanding - none	—		—
Voting common stock, no par value; 45,000,000 shares authorized; 9,799,047 and 9,741,800 shares issued and outstanding in 2020 and 2019, respectively	220,418		219,423
Nonvoting common stock, no par value; 86,221 shares authorized; issued and outstanding - none	—		—
Retained earnings	108,431		99,681
Accumulated other comprehensive loss	(21,138)		(14,191)
Total shareholders’ equity	307,711		304,913
Total liabilities and shareholders’ equity	$	4,324,600	$	4,100,083

See Notes to Condensed Consolidated Financial Statements

First Internet Bancorp

Condensed Consolidated Statements of Income – Unaudited

(Amounts in thousands except share and per share data)


	Three Months Ended						Six Months Ended
	June 30, 2020		June 30, 2019		June 30, 2020		June 30, 2019
Interest Income
Loans	$	29,730	$	30,842	$	60,138	$	60,060
Securities – taxable	3,276		3,540		6,895		6,864
Securities – non-taxable	457		668		1,029		1,352
Other earning assets	759		1,794		2,404		3,567
Total interest income	34,222		36,844		70,466		71,843
Interest Expense
Deposits	15,763		17,147		32,971		32,533
Other borrowed funds	4,033		3,592		8,051		6,961
Total interest expense	19,796		20,739		41,022		39,494
Net Interest Income	14,426		16,105		29,444		32,349
Provision for Loan Losses	2,491		1,389		3,952		2,674
Net Interest Income After Provision for Loan Losses	11,935		14,716		25,492		29,675
Noninterest Income
Service charges and fees	182		225		394		461
Loan servicing revenue	255		—		506		—
Loan servicing asset revaluation	(90)		—		(269)		—
Mortgage banking activities	3,408		2,664		7,076		4,281



Gain (loss) on sale of loans	762		(66)		2,563		(170)
(Loss) gain on sale of securities	—		(458)		41		(458)
Other	456		1,089		873		1,712
Total noninterest income	4,973		3,454		11,184		5,826
Noninterest Expense
Salaries and employee benefits	7,789		6,642		15,563		12,963
Marketing, advertising and promotion	411		466		786		935
Consulting and professional services	932		835		2,109		1,649
Data processing	339		328		714		645
Loan expenses	399		292		998		606
Premises and equipment	1,602		1,497		3,227		2,997
Deposit insurance premium	435		747		920		1,302
Other	1,337		902		2,413		1,721
Total noninterest expense	13,244		11,709		26,730		22,818
Income Before Income Taxes	3,664		6,461		9,946		12,683
Income Tax (Benefit) Provision	(268)		340		(5)		866
Net Income	$	3,932	$	6,121	$	9,951	$	11,817
Income Per Share of Common Stock
Basic	$	0.40	$	0.60	$	1.02	$	1.16
Diluted	$	0.40	$	0.60	$	1.02	$	1.16
Weighted-Average Number of Common Shares Outstanding
Basic	9,768,227		10,148,285		9,798,528		10,182,770
Diluted	9,768,227		10,148,285		9,802,427		10,186,833
Dividends Declared Per Share	$	0.06	$	0.06	$	0.12	$	0.12

See Notes to Condensed Consolidated Financial Statements

First Internet Bancorp

Condensed Consolidated Statements of Comprehensive Income – Unaudited

(Amounts in thousands)


	Three Months Ended June 30,						Six Months Ended June 30,
	2020		2019		2020		2019
Net income	$	3,932	$	6,121	$	9,951	$	11,817
Other comprehensive (loss) income
Net unrealized holding (losses) gains on securities available-for-sale recorded within other comprehensive (loss) income before income tax	(1,498)		3,667		4,801		10,577

Reclassification adjustment for gains (losses) realized	—		458		(41)		458
Net unrealized holding losses on cash flow hedging derivatives recorded within other comprehensive (loss) income before tax	(509)		(5,892)		(13,967)		(9,464)

Other comprehensive (loss) income before income tax	(2,007)		(1,767)		(9,207)		1,571
Income tax (benefit) provision	(735)		(357)		(2,260)		608
Other comprehensive (loss) income	(1,272)		(1,410)		(6,947)		963
Comprehensive income	$	2,660	$	4,711	$	3,004	$	12,780

See Notes to Condensed Consolidated Financial Statements

First Internet Bancorp

Condensed Consolidated Statements of Changes in Shareholders’ Equity - Unaudited

Six Months Ended June 30, 2020 and 2019

(Amounts in thousands except per share data)


	Voting and Nonvoting Common Stock		Retained Earnings		Accumulated Other Comprehensive Loss		Total Shareholders’ Equity
Balance, January 1, 2020	$	219,423	$	99,681	$	(14,191)	$	304,913

Net income	—		9,951		—		9,951

Other comprehensive loss	—		—		(6,947)		(6,947)
Dividends declared ($0.12 per share)	—		(1,201)		—		(1,201)

Recognition of the fair value of share-based compensation	1,073		—		—		1,073

Deferred stock rights and restricted stock units issued in lieu of cash dividends payable on outstanding deferred stock rights and restricted stock units	15		—		—		15
Common stock redeemed for the net settlement of share-based awards	(93)		—		—		(93)

Balance, June 30, 2020	$	220,418	$	108,431	$	(21,138)	$	307,711

Balance, January 1, 2019	$	227,587	$	77,689	$	(16,541)	$	288,735
Impact of adoption of new accounting standards⁽¹⁾	—		(821)		—		(821)
Net income	—		11,817		—		11,817

Other comprehensive income	—		—		963		963
Dividends declared ($0.12 per share)	—		(1,231)		—		(1,231)

Recognition of the fair value of share-based compensation	862		—		—		862
Repurchase of common stock	(4,133)						(4,133)
Deferred stock rights and restricted stock units issued in lieu of cash dividends payable on outstanding deferred stock rights and restricted stock units	22		—		—		22
Common stock redeemed for the net settlement of share-based awards	(94)		—		—		(94)

Balance, June 30, 2019	$	224,244	$	87,454	$	(15,578)	$	296,120

⁽¹⁾ Represents the impact of adopting Accounting Standards Update (“ASU”) 2017-08.

See Notes to Condensed Consolidated Financial Statements

First Internet Bancorp

Condensed Consolidated Statements of Changes in Shareholders’ Equity - Unaudited

Three Months Ended June 30, 2020 and 2019

(Amounts in thousands except per share data)


	Voting and Nonvoting Common Stock		Retained Earnings		Accumulated Other Comprehensive Loss		Total Shareholders’ Equity
Balance, April 1, 2020	$	219,893	$	105,100	$	(19,866)	$	305,127

Net income	—		3,932		—		3,932

Other comprehensive loss	—		—		(1,272)		(1,272)
Dividends declared ($0.06 per share)	—		(601)		—		(601)

Recognition of the fair value of share-based compensation	517		—		—		517

Deferred stock rights and restricted stock units issued in lieu of cash dividends payable on outstanding deferred stock rights and restricted stock units	8		—		—		8


Balance, June 30, 2020	$	220,418	$	108,431	$	(21,138)	$	307,711

Balance, April 1, 2019	$	226,235	$	81,946	$	(14,168)	$	294,013

Net income	—		6,121		—		6,121

Other comprehensive loss	—		—		(1,410)		(1,410)
Dividends declared ($0.06 per share)	—		(613)		—		(613)

Recognition of the fair value of share-based compensation	383		—		—		383
Repurchase of common stock	(2,387)						(2,387)
Deferred stock rights and restricted stock units issued in lieu of cash dividends payable on outstanding deferred stock rights and restricted stock units	13		—		—		13


Balance, June 30, 2019	$	224,244	$	87,454	$	(15,578)	$	296,120

See Notes to Condensed Consolidated Financial Statements

First Internet Bancorp

Condensed Consolidated Statements of Cash Flows – Unaudited

(Amounts in thousands)


	Six Months Ended June 30,
	2020		2019
Operating Activities
Net income	$	9,951	$	11,817
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization	3,515		3,747
Increase in cash surrender value of bank-owned life insurance	(472)		(468)
Provision for loan losses	3,952		2,674
Share-based compensation expense	1,073		862
Loss on other-than-temporary impairment of securities	—		—
(Loss) gain on sale of available-for-sale securities	(41)		458
Loans originated for sale	(427,323)		(220,266)
Proceeds from sale of loans	454,737		211,432
Gain on loans sold	(11,069)		(3,128)
Gain on sale of other real estate owned	—		—
Decrease (increase) in fair value of loans held-for-sale	939		(352)
Loss (gain) on derivatives	377		(553)
Settlement of derivatives	(46,109)		—
Net change in servicing asset	(41)		—
Amortization of operating lease right-of-use assets	360		353
Net change in accrued income and other assets	(2,221)		(44,383)
Net change in accrued expenses and other liabilities	(1,840)		4,476
Net cash used in operating activities	(14,212)		(33,331)
Investing Activities
Net loan activity, excluding purchases	(18,907)		(153,259)


Maturities and calls of securities available-for-sale	74,828		30,950
Proceeds from sale of securities available-for-sale	795		30,137
Purchase of securities available-for-sale	(116,993)		(76,834)
Purchase of securities held-to-maturity	(2,000)		(13,116)
Purchase of Federal Home Loan Bank of Indianapolis stock	—		(2,025)

Purchase of premises and equipment	(10,580)		(2,852)

Loans purchased	(172,250)		(159,068)
Net proceeds from sale of portfolio loans	205,023		184,095

Net cash used in investing activities	(40,084)		(161,972)
Financing Activities
Net increase in deposits	226,826		334,912
Short-term borrowings	—		—
Cash dividends paid	(1,179)		(1,214)

Net proceeds from issuance of subordinated debt	—		35,418
Repurchase of common stock	—		(4,133)
Proceeds from advances from Federal Home Loan Bank	220,000		375,000
Repayment of advances from Federal Home Loan Bank	(220,000)		(385,000)

Other, net	(93)		(94)
Net cash provided by financing activities	225,554		354,889
Net Increase in Cash and Cash Equivalents	171,258		159,586
Cash and Cash Equivalents, Beginning of Period	327,361		188,712
Cash and Cash Equivalents, End of Period	$	498,619	$	348,298
Supplemental Disclosures
Initial recognition of right-of-use asset	$	—	$	2,096
Initial recognition of operating lease liabilities	—		2,096
Cash paid during the period for interest	43,716		37,672
Cash paid during the period for taxes	91		1,793
Loans transferred to other real estate owned	—		—
Loans transferred to held-for-sale from portfolio	204,258		184,021
Cash dividends declared, paid in subsequent period	588		601
Securities purchased during the period, settled in subsequent period	—		14,247
Transfer of available-for-sale municipal securities to held-to-maturity municipal securities	4,479		—

See Notes to Condensed Consolidated Financial Statements

First Internet Bancorp

Notes to Condensed Consolidated Financial Statements – Unaudited

(Table amounts in thousands except share and per share data)

Note 1: Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information or footnotes necessary for a complete presentation of financial condition, results of operations, changes in shareholders’ equity, or cash flows in accordance with GAAP. In our opinion, all adjustments (consisting only of normal recurring adjustments) necessary for a fair presentation have been included. The results of operations for the three and six months ended June 30, 2020 are not necessarily indicative of the results expected for the year ending December 31, 2020 or any other period. The June 30, 2020 condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the First Internet Bancorp Annual Report on Form 10-K for the year ended December 31, 2019.

The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments, or assumptions that could have a material effect on the carrying value of certain assets and liabilities. These estimates, judgments, and assumptions affect the amounts reported in the condensed consolidated financial statements and the disclosures provided. The determination of the allowance for loan losses, valuations and impairments of investment securities, valuation of the servicing asset and the accounting for income tax expense are highly dependent upon management’s estimates, judgments, and assumptions, and changes in any of these could have a significant impact on the condensed consolidated financial statements.

The condensed consolidated financial statements include the accounts of First Internet Bancorp (the “Company”), its wholly owned subsidiary, First Internet Bank of Indiana (the “Bank”), and the Bank’s three wholly owned subsidiaries, First Internet Public Finance Corp., JKH Realty Services, LLC and SPF15, Inc. All significant intercompany accounts and transactions have been eliminated in consolidation.

The Company is subject to claims and lawsuits that arise primarily in the ordinary course of business. It is the opinion of management that the disposition or ultimate resolution of such claims and lawsuits will not have a material adverse effect on the consolidated financial position, results of operations, and cash flows of the Company.

Certain reclassifications have been made to the 2019 financial statements to conform to the presentation of the 2020 financial statements. These reclassifications had no effect on net income.

Note 2: Earnings Per Share

Earnings per share of common stock are based on the weighted-average number of basic shares and dilutive shares outstanding during the period.

The following is a reconciliation of the weighted-average common shares for the basic and diluted earnings per share computations for the three and six months ended June 30, 2020 and 2019.


(dollars in thousands, except per share data)	Three Months Ended June 30,						Six Months Ended June 30,
	2020		2019		2020		2019
Basic earnings per share
Net income	$	3,932	$	6,121	$	9,951	$	11,817
Weighted-average common shares	9,768,227		10,148,285		9,798,528		10,182,770
Basic earnings per common share	$	0.40	$	0.60	$	1.02	$	1.16
Diluted earnings per share
Net income	$	3,932	$	6,121	$	9,951	$	11,817
Weighted-average common shares	9,768,227		10,148,285		9,798,528		10,182,770

Dilutive effect of equity compensation	—		—		3,899		4,063
Weighted-average common and incremental shares	9,768,227		10,148,285		9,802,427		10,186,833
Diluted earnings per common share ⁽¹⁾	$	0.40	$	0.60	$	1.02	$	1.16

⁽¹⁾ Potential dilutive common shares are excluded from the computation of diluted EPS in the periods where the effect would be antidilutive. Excluded from the computation of diluted EPS were weighted-average antidilutive shares totaling 79,893 and 29,606 for the three and six months ended June 30, 2020, respectively and 30,250 and 23,305 for the three and six months ended June 30, 2019, respectively.

Note 3: Securities

The following tables summarize securities available-for-sale and securities held-to-maturity as of June 30, 2020 and December 31, 2019.


	June 30, 2020
	Amortized		Gross Unrealized						Fair
(in thousands)	Cost		Gains		Losses		Value
Securities available-for-sale
U.S. Government-sponsored agencies	$	68,203	$	384	$	(2,043)	$	66,544
Municipal securities	91,906		3,140		(4,484)		90,562
Agency mortgage-backed securities	275,433		6,632		(3,535)		278,530
Private label mortgage-backed securities	101,110		1,044		(229)		101,925
Asset-backed securities	5,000		—		(163)		4,837
Corporate securities	48,394		309		(2,084)		46,619

Total available-for-sale	$	590,046	$	11,509	$	(12,538)	$	589,017


	June 30, 2020
	Amortized		Gross Unrealized						Fair
(in thousands)	Cost		Gains		Losses		Value
Securities held-to-maturity
Municipal securities	$	14,603	$	671	$	—	$	15,274
Corporate securities	53,692		768		(582)		53,878
Total held-to-maturity	$	68,295	$	1,439	$	(582)	$	69,152


	December 31, 2019
	Amortized		Gross Unrealized						Fair
(in thousands)	Cost		Gains		Losses		Value
Securities available-for-sale
U.S. Government-sponsored agencies	$	77,715	$	99	$	(1,942)	$	75,872
Municipal securities	97,447		1,706		(1,501)		97,652
Agency mortgage-backed securities	264,142		1,304		(4,006)		261,440
Private label mortgage-backed securities	63,704		97		(188)		63,613
Asset-backed securities	5,000		—		(45)		4,955
Corporate securities	38,632		220		(1,532)		37,320

Total available-for-sale	$	546,640	$	3,426	$	(9,214)	$	540,852


	December 31, 2019
	Amortized		Gross Unrealized						Fair
(in thousands)	Cost		Gains		Losses		Value
Securities held-to-maturity
Municipal securities	$	10,142	$	226	$	—	$	10,368
Corporate securities	51,736		588		(132)		52,192
Total held-to-maturity	$	61,878	$	814	$	(132)	$	62,560

The Company elected to transfer ten available-for-sale (“AFS”) securities with an aggregate fair value of $4.5 million to a classification of held-to-maturity (“HTM”) on March 1, 2020. The net unrealized holding gain of $0.1 million, net of tax, as the date of the transfer was retained in accumulated other comprehensive loss, with the associated pretax amount retained in the carrying value of the HTM securities. Such amounts will be amortized to interest income over the remaining life of the securities. The fair value of the transferred AFS securities became the book value of the HTM securities as of March 1, 2020, with no unrealized gain or loss at that date.

The carrying value of securities at June 30, 2020 is shown below by their contractual maturity date. Actual maturities will differ because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.


	Available-for-Sale
(in thousands)	Amortized Cost		Fair Value
Within one year	$	15	$	15
One to five years	30,141		25,364
Five to ten years	82,174		79,991
After ten years	96,173		98,355
	208,503		203,725
Agency mortgage-backed securities	275,433		278,530
Private label mortgage-backed securities	101,110		101,925
Asset-backed securities	5,000		4,837

Total	$	590,046	$	589,017


	Held-to-Maturity
(in thousands)	Amortized Cost		Fair Value

One to five years	$	1,505	$	1,557
Five to ten years	54,272		54,642
After ten years	12,518		12,953
Total	$	68,295	$	69,152

There were no gross gains or losses resulting from sales of available-for-sale securities during the three months ended June 30, 2020 and gross gains of less than $0.1 million resulting from the sales of available-for-sale securities during the

six months ended June 30, 2020. There were $0.5 million of gross losses resulting from sales of available-for-sale securities during the three and six months ended June 30, 2019.

Certain investments in debt securities are reported in the condensed consolidated financial statements at an amount less than their historical cost. The total fair value of these investments at June 30, 2020 and December 31, 2019 was $237.5 million and $317.5 million, which was approximately 36% and 53%, respectively, of the Company’s available-for-sale and held-to-maturity securities portfolios. These declines resulted primarily from fluctuations in market interest rates after purchase. Management believes the declines in fair value for these securities are temporary. Should the impairment of any of these securities become other than temporary, the cost basis of the investment will be reduced, with the resulting loss recognized in net income in the period the other-than-temporary impairment (“OTTI”) is identified.

U. S. Government-Sponsored Agencies, Municipal Securities and Corporate Securities

The unrealized losses on the Company’s investments in securities issued by U.S. Government-sponsored agencies, municipal organizations and corporate entities were caused primarily by interest rate changes. The contractual terms of those investments do not permit the issuer to settle the securities at a price less than the amortized cost bases of the investments. Because the Company does not intend to sell the investments and it is not likely that the Company will be required to sell the investments before recovery of their amortized cost bases, which may be upon maturity, the Company does not consider those investments to be other-than-temporarily impaired at June 30, 2020.

Agency Mortgage-Backed, Private Label Mortgage-Backed and Asset-Backed Securities

The unrealized losses on the Company’s investments in agency mortgage-backed, private label mortgage-backed and asset-backed securities were caused primarily by interest rate changes. The Company expects to recover the amortized cost bases over the term of the securities. Because the Company does not intend to sell the investments and it is not likely that the Company will be required to sell the investments before recovery of their amortized cost bases, which may be upon maturity, the Company does not consider those investments to be other-than-temporarily impaired at June 30, 2020.

The following tables show the securities portfolio’s gross unrealized losses and fair value, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position at June 30, 2020 and December 31, 2019.


	June 30, 2020
	Less Than 12 Months						12 Months or Longer						Total
(in thousands)	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Securities available-for-sale
U.S. Government-sponsored agencies	$	1,195	$	(15)	$	56,494	$	(2,028)	$	57,689	$	(2,043)
Municipal securities	61,167		(4,484)		—		—		61,167		(4,484)
Agency mortgage-backed securities	22,419		(391)		10,727		(3,144)		33,146		(3,535)
Private label mortgage-backed securities	21,781		(160)		2,777		(69)		24,558		(229)
Asset-backed securities	—		—		4,837		(163)		4,837		(163)
Corporate securities	12,512		(122)		20,038		(1,962)		32,550		(2,084)

Total	$	119,074	$	(5,172)	$	94,873	$	(7,366)	$	213,947	$	(12,538)


	June 30, 2020
	Less Than 12 Months						12 Months or Longer						Total
(in thousands)	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Securities held-to-maturity

Corporate securities	$	23,527	$	(582)	$	—	$	—	$	23,527	$	(582)
Total	$	23,527	$	(582)	$	—	$	—	$	23,527	$	(582)


	December 31, 2019
	Less Than 12 Months						12 Months or Longer						Total
(in thousands)	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Securities available-for-sale
U.S. Government-sponsored agencies	$	4,820	$	(61)	$	62,182	$	(1,881)	$	67,002	$	(1,942)
Municipal securities	1,279		(1,501)		—		—		1,279		(1,501)
Agency mortgage-backed securities	91,159		(829)		83,212		(3,177)		174,371		(4,006)
Private label mortgage-backed securities	30,077		(180)		2,884		(8)		32,961		(188)
Asset-backed securities	—		—		4,955		(45)		4,955		(45)
Corporate securities	—		—		22,985		(1,532)		22,985		(1,532)

Total	$	127,335	$	(2,571)	$	176,218	$	(6,643)	$	303,553	$	(9,214)


	December 31, 2019
	Less Than 12 Months						12 Months or Longer						Total
(in thousands)	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Securities held-to-maturity

Corporate securities	13,977		(132)		—		—		13,977		(132)
Total	$	13,977	$	(132)	$	—	$	—	$	13,977	$	(132)

Amounts reclassified from accumulated other comprehensive loss and the affected line items in the condensed consolidated statements of income during the three and six months ended June 30, 2020 and June 30, 2019 were as follows:


(in thousands) Details About Accumulated Other Comprehensive Loss Components														Affected Line Item in the Statements of Income
			Three Months Ended June 30, 2020			Six Months Ended June 30, 2020			Three Months Ended June 30, 2019			Six Months Ended June 30, 2019
Realized gains (losses) on securities available-for-sale
Gain (loss) realized in earnings	$	—		$	41		$	(458)		$	(458)		Gain (loss) on sale of securities

Total reclassified amount before tax	—			41			(458)			(458)			Income Before Income Taxes
Tax expense (benefit)	—			11			(124)			(124)			Income Tax Provision (Benefit)
Total reclassifications out of accumulated other comprehensive loss	$	—		$	30		$	(334)		$	(334)		Net Income

Note 4: Loans

Loan balances as of June 30, 2020 and December 31, 2019 are summarized in the table below. Categories of loans include:


(in thousands)	June 30, 2020		December 31, 2019
Commercial loans
Commercial and industrial	$	81,687	$	96,420
Owner-occupied commercial real estate⁽¹⁾	86,897		86,726
Investor commercial real estate	13,286		12,567
Construction	77,591		60,274
Single tenant lease financing	980,292		995,879
Public finance	647,107		687,094
Healthcare finance	380,956		300,612
Small business lending⁽¹⁾	118,526		46,945
Total commercial loans	2,386,342		2,286,517
Consumer loans
Residential mortgage	208,728		313,849
Home equity	22,640		24,306
Other consumer	291,632		295,309
Total consumer loans	523,000		633,464
Total commercial and consumer loans	2,909,342		2,919,981
Net deferred loan origination costs and premiums and discounts on purchased loans and other⁽²⁾	64,332		43,566
Total loans	2,973,674		2,963,547
Allowance for loan losses	(24,465)		(21,840)
Net loans	$	2,949,209	$	2,941,707

⁽¹⁾ As of June 30, 2020, $13.3 million of commercial real estate loan balances were reclassified from small business lending to owner-occupied commercial real estate.

⁽²⁾ Includes carrying value adjustments of $46.0 million related to terminated interest rate swaps associated with public finance loans as of June 30, 2020 and $21.4 million related to interest rate swaps associated with public finance loans as of December 31, 2019.

The risk characteristics of each loan portfolio segment are as follows:

Commercial and Industrial: Commercial and industrial loans’ sources of repayment are primarily based on the identified cash flows of the borrower and secondarily on the underlying collateral provided by the borrower. The cash flows of borrowers, however, may not be as expected, and the collateral securing these loans may fluctuate in value. Loans are made for working capital, equipment purchases, or other purposes. Most commercial and industrial loans are secured by the assets being financed and may incorporate a personal guarantee. This portfolio segment is generally concentrated in Central Indiana and adjacent markets and the greater Phoenix, Arizona market.

Owner-Occupied Commercial Real Estate: The primary source of repayment is the cash flow from the ongoing operations and activities conducted by the borrower, or an affiliate of the borrower, who owns the property. This portfolio segment is generally concentrated in Central Indiana and adjacent markets and the greater Phoenix, Arizona market and its loans are often secured by manufacturing and service facilities, as well as office buildings.

Investor Commercial Real Estate: These loans are underwritten primarily based on the cash flow expected to be generated from the property and are secondarily supported by the value of the real estate. These loans typically incorporate a personal guarantee from the primary sponsor or sponsors. This portfolio segment generally involves larger loan amounts with repayment primarily dependent on the successful leasing and operation of the property securing the loan or the business conducted on the property securing the loan. Investor commercial real estate loans may be more adversely affected by changing economic conditions in the real estate markets, industry dynamics or the overall health of the local economy where the property is located. The properties securing the Company’s investor commercial real estate portfolio tend to be diverse in terms of property type and are generally located in the state of Indiana or markets immediately adjacent to Indiana. Management monitors and evaluates commercial real estate loans based on property financial performance, collateral value, guarantor strength, economic and industry conditions together with other risk grade criteria. As a general rule, the Company avoids financing special use projects or properties outside of its designated market areas unless other underwriting factors are present to mitigate these additional risks.

Construction: Construction loans are secured by land and related improvements and are made to assist in the construction of new structures, which may include commercial (retail, industrial, office, multi-family) properties or single family residential properties offered for sale by the builder. These loans generally finance a variety of project costs, including land, site preparation, architectural services, construction, closing and soft costs and interim financing needs. The cash flows of builders, while initially predictable, may fluctuate with market conditions, and the value of the collateral securing these loans may be subject to fluctuations based on general economic changes. This portfolio segment is generally concentrated in Central Indiana.

Single Tenant Lease Financing: These loans are made on a nationwide basis to property owners of real estate subject to long-term lease arrangements with single tenant operators. The real estate is typically operated by regionally, nationally or globally branded businesses. The loans are underwritten based on the financial strength of the borrower, characteristics of the real estate, cash flows generated from the lease arrangements and the financial strength of the tenant. Similar to the other loan portfolio segments, management monitors and evaluates these loans based on borrower and tenant financial performance, collateral value, industry trends and other risk grade criteria.

Public Finance: These loans are made to governmental and not-for-profit entities to provide both tax-exempt and taxable loans for a variety of purposes including: short-term cash-flow needs; debt refinancing; economic development; quality of life projects; infrastructure improvements; and equipment financing. The primary sources of repayment for public finance loans include pledged revenue sources including but not limited to: general obligations; property taxes; income taxes; tax increment revenue; utility revenue; gaming revenues; sales tax; and pledged general revenue. Certain loans may also include an additional collateral pledge of mortgaged property or a security interest in financed equipment. Public finance loans have been completed primarily in the Midwest, but continues to expand nationwide.

Healthcare Finance: These loans are made to healthcare providers, primarily dentists, for practice acquisition refinancing that occasionally includes owner-occupied commercial real estate and equipment purchases. The sources of repayment are primarily based on the identified cash flows from operations of the borrower and related entities if the real estate is held in a separate entity and secondarily on the underlying collateral provided by the borrower. This portfolio segment was initially concentrated in the Western United States but has been growing rapidly throughout the rest of the country with the addition of a growing sales force located in Eastern and Midwestern markets.

Small Business Lending: These loans are to small businesses and generally carry a partial guaranty from the U.S. Small Business Administration ("SBA") under its 7(a) loan program. We generally sell the government guaranteed portion of SBA loans into the secondary market while retaining the non-guaranteed portion of the loan and the servicing rights. Loans in the small business lending portfolio have sources of repayment that are primarily based on the identified cash flows of the borrower and secondarily on any underlying collateral provided by the borrower. Loans may, but do not always, have a collateral shortfall. For SBA loans where the guaranteed portion is retained, the SBA guaranty provides a tertiary source of repayment to the Bank in event of borrower default. Cash flows of borrowers, however, may not be as expected and collateral securing these loans may fluctuate in value. Loans are made for a broad array of purposes including, but not limited to, providing operating cash flow, funding ownership changes, and facilitating equipment purchases. These loans also include loans originated by the Bank under the SBA’s Paycheck Protection Program, which are fully guaranteed by the SBA. This portfolio segment has an emerging geography, with a nationwide focus.

Residential Mortgage: With respect to residential loans that are secured by 1-to-4 family residences and are generally owner occupied, the Company typically establishes a maximum loan-to-value ratio and requires private mortgage insurance if that ratio is exceeded. Repayment of these loans is primarily dependent on the financial circumstances of the borrowers, which can be impacted by economic conditions in their market areas such as unemployment levels.

Repayment can also be impacted by changes in residential property values. Risk is mitigated by the fact that the loans are of smaller individual amounts and spread over a large number of borrowers in geographically diverse locations throughout the country.

Home Equity: Home equity loans and lines of credit are typically secured by a subordinate interest in 1-to-4 family residences. The properties securing the home equity portfolio segment are generally geographically diverse as the Company offers these products on a nationwide basis. Repayment of these loans and lines of credit is primarily dependent on the financial circumstances of the borrowers and may be impacted by changes in unemployment levels and property values on residential properties, among other economic conditions in the market.

Other Consumer: These loans primarily consist of consumer loans and credit cards. Consumer loans may be secured by consumer assets such as horse trailers or recreational vehicles. Some consumer loans are unsecured, such as small installment loans, home improvement loans and certain lines of credit. Repayment of consumer loans is primarily dependent upon the personal income of the borrowers, which can be impacted by economic conditions in their market areas such as unemployment levels. Risk is mitigated by the fact that the loans are of smaller individual amounts and spread over a large number of borrowers in geographically diverse locations throughout the country.

Allowance for Loan Losses Methodology

Company policy is designed to maintain an adequate allowance for loan losses (“ALLL”). The portfolio is segmented by loan type, and the required ALLL for types of performing homogeneous loans which do not have a specific reserve is determined by applying a factor based on average historical losses, adjusted for current economic factors and portfolio trends. Management adds qualitative factors for observable trends, changes in internal practices, changes in delinquencies and impairments, and external factors. Observable factors include changes in the composition and size of portfolios, as well as loan terms or concentration levels. The Company evaluates the impact of internal changes such as management and staff experience levels or modification to loan underwriting processes. Delinquency trends are scrutinized for both volume and severity of past due, nonaccrual, or classified loans, as well as any changes in the value of underlying collateral. Finally, the Company considers the effect of other external factors such as national, regional, and local economic and business conditions, as well as competitive, legal, and regulatory requirements. Loans that are considered to be impaired are evaluated to determine the need for a specific allowance by applying at least one of three methodologies: present value of future cash flows; fair value of collateral less costs to sell; or the loan’s observable market price. All troubled debt restructurings (“TDR”) are considered impaired loans. Loans evaluated for impairment are removed from other pools to prevent double-counting. Accounting Standards Codification (“ASC”) Topic 310, Receivables, requires that impaired loans be measured based on the present value of expected future cash flows discounted at the loans’ effective interest rates or the fair value of the underlying collateral less costs to sell and allows existing methods for recognizing interest income.

Provision for Loan Losses

A provision for estimated losses on loans is charged to income based upon management’s evaluation of the potential losses. Such an evaluation, which includes a review of all loans for which full repayment may not be reasonably assured, considers, among other matters, the estimated net realizable value of the underlying collateral, as applicable, economic conditions, loan loss experience, and other factors that are particularly susceptible to changes that could result in a material adjustment in the near term. While management attempts to use the best information available in making its evaluations, future allowance adjustments may be necessary if economic conditions change substantially from the assumptions used in making the evaluations.

Policy for Charging Off Loans

The Company’s policy is to charge off a loan at any point in time when it no longer can be considered a bankable asset, meaning collectible within the parameters of policy. A secured loan is generally charged down to the estimated fair value of the collateral, less costs to sell, no later than when it is 120 days past due as to principal or interest. An unsecured loan generally is charged off no later than when it is 180 days past due as to principal or interest. A home improvement loan generally is charged off no later than when it is 90 days past due as to principal or interest.

The following tables present changes in the balance of the ALLL during the three and six months ended June 30, 2020 and 2019.


(in thousands)	Three Months Ended June 30, 2020
Allowance for loan losses:	Balance, Beginning of Period		Provision (Credit) Charged to Expense		Losses Charged Off		Recoveries		Balance, End of Period
Commercial and industrial	$	1,670	$	(141)	$	(57)	$	5	$	1,477
Owner-occupied commercial real estate	645		201		—		—		846
Investor commercial real estate	128		2		—		—		130
Construction	460		261		—		—		721
Single tenant lease financing	10,755		563		—		—		11,318
Public finance	1,483		59		—		—		1,542
Healthcare finance	4,318		1,187		(743)		—		4,762
Small business lending	265		(20)		—		6		251
Residential mortgage	500		36		—		3		539
Home equity	53		(4)		—		2		51
Other consumer	2,580		347		(216)		117		2,828
Total	$	22,857	$	2,491	$	(1,016)	$	133	$	24,465


	Six Months Ended June 30, 2020
Allowance for loan losses:	Balance, Beginning of Period		Provision (Credit) Charged to Expense		Losses Charged Off		Recoveries		Balance, End of Period
Commercial and industrial	$	1,521	$	205	$	(254)	$	5	$	1,477
Owner-occupied commercial real estate	561		285		—		—		846
Investor commercial real estate	109		21		—		—		130
Construction	380		341		—		—		721
Single tenant lease financing	11,175		143		—		—		11,318
Public finance	1,580		(38)		—		—		1,542
Healthcare finance	3,247		2,258		(743)		—		4,762
Small business lending	54		183		—		14		251
Residential mortgage	657		(107)		(15)		4		539
Home equity	46		—		—		5		51
Other consumer	2,510		661		(502)		159		2,828
Total	$	21,840	$	3,952	$	(1,514)	$	187	$	24,465


(in thousands)	Three Months Ended June 30, 2019
Allowance for loan losses:	Balance, Beginning of Period		Provision (Credit) Charged to Expense		Losses Charged Off		Recoveries		Balance, End of Period
Commercial and industrial	$	1,351	$	444	$	—	$	—	$	1,795
Owner-occupied commercial real estate	847		(223)		—		—		624
Investor commercial real estate	103		66		—		—		169
Construction	267		35		—		—		302
Single tenant lease financing	9,368		293		—		—		9,661
Public finance	1,650		113		—		—		1,763
Healthcare finance	1,731		562		—		—		2,293
Small business lending	93		36		—		—		129
Residential mortgage	1,044		(383)		—		1		662
Home equity	49		(5)		—		4		48
Other consumer	2,338		451		(337)		78		2,530
Total	$	18,841	$	1,389	$	(337)	$	83	$	19,976


	Six Months Ended June 30, 2019
Allowance for loan losses:	Balance, Beginning of Period		Provision (Credit) Charged to Expense		Losses Charged Off		Recoveries		Balance, End of Period
Commercial and industrial	$	1,384	$	523	$	(112)	$	—	$	1,795
Owner-occupied commercial real estate	891		(267)		—		—		624
Investor commercial real estate	61		108		—		—		169
Construction	251		51		—		—		302
Single tenant lease financing	8,827		834		—		—		9,661
Public finance	1,670		93		—		—		1,763
Healthcare finance	1,264		1,029		—		—		2,293
Small business lending	95		34		—		—		129
Residential mortgage	1,079		(419)		—		2		662
Home equity	53		(11)		—		6		48
Other consumer	2,321		699		(654)		164		2,530
Total	$	17,896	$	2,674	$	(766)	$	172	$	19,976

The following tables present the recorded investment in loans based on portfolio segment and impairment method as of June 30, 2020 and December 31, 2019.


(in thousands)	Loans										Allowance for Loan Losses
June 30, 2020	Ending Balance: Collectively Evaluated for Impairment		Ending Balance: Individually Evaluated for Impairment		Ending Balance		Ending Balance: Collectively Evaluated for Impairment		Ending Balance: Individually Evaluated for Impairment		Ending Balance
Commercial and industrial	$	80,871	$	816	$	81,687	$	1,368	$	109	$	1,477
Owner-occupied commercial real estate	82,974		3,922		86,897		846		—		846
Investor commercial real estate	13,286		—		13,286		130		—		130
Construction	77,591		—		77,591		721		—		721
Single tenant lease financing	975,612		4,680		980,292		9,658		1,660		11,318
Public finance	647,107		—		647,107		1,542		—		1,542
Healthcare finance	380,956		—		380,956		4,762		—		4,762
Small business lending	118,526		—		118,526		251				251
Residential mortgage	207,320		1,408		208,728		539		—		539
Home equity	22,640		—		22,640		51		—		51
Other consumer	291,518		115		291,632		2,828		—		2,828
Total	$	2,898,401	$	10,941	$	2,909,342	$	22,696	$	1,769	$	24,465


(in thousands)	Loans										Allowance for Loan Losses
December 31, 2019	Ending Balance: Collectively Evaluated for Impairment		Ending Balance: Individually Evaluated for Impairment		Ending Balance		Ending Balance: Collectively Evaluated for Impairment		Ending Balance: Individually Evaluated for Impairment		Ending Balance
Commercial and industrial	$	93,520	$	2,900	$	96,420	$	1,412	$	109	$	1,521
Owner-occupied commercial real estate	81,063		5,663		86,726		561		—		561
Investor commercial real estate	12,567		—		12,567		109		—		109
Construction	60,274		—		60,274		380		—		380
Single tenant lease financing	991,199		4,680		995,879		9,515		1,660		11,175
Public finance	687,094		—		687,094		1,580		—		1,580
Healthcare finance	300,612		—		300,612		3,247		—		3,247
Small business lending	46,945		—		46,945		54		—		54
Residential mortgage	312,714		1,135		313,849		657		—		657
Home equity	24,306		—		24,306		46		—		46
Other consumer	295,266		43		295,309		2,510		—		2,510
Total	$	2,905,560	$	14,421	$	2,919,981	$	20,071	$	1,769	$	21,840

The Company utilizes a risk grading matrix to assign a risk grade to each of its commercial loans. A description of the general characteristics of the risk grades is as follows:

•“Pass” - Higher quality loans that do not fit any of the other categories described below.

•“Special Mention” - Loans that possess some credit deficiency or potential weakness, which deserve close attention.

•“Substandard” - Loans that possess a defined weakness or weaknesses that jeopardize the liquidation of the debt. Loans characterized by the distinct possibility that the institution will sustain some loss if the deficiencies are not corrected. Loans that are inadequately protected by the current net worth and paying capacity of the obligor or of the collateral pledged, if any.

•“Doubtful” - Such loans have been placed on nonaccrual status and may be heavily dependent upon collateral possessing a value that is difficult to determine or based upon some near-term event that lacks clear certainty. These loans have all of the weaknesses of those classified as Substandard; however, based on existing conditions, these weaknesses make full collection of the principal balance highly improbable.

•“Loss” - Loans that are considered uncollectible and of such little value that continuing to carry them as assets is not warranted.

Nonaccrual Loans

Any loan which becomes 90 days delinquent or for which the full collection of principal and interest may be in doubt will be considered for nonaccrual status. At the time a loan is placed on nonaccrual status, all accrued but unpaid interest will be reversed from interest income. Placing the loan on nonaccrual status does not relieve the borrower of the obligation to repay interest. A loan placed on nonaccrual status may be restored to accrual status when all delinquent principal and interest has been brought current, and the Company expects full payment of the remaining contractual principal and interest.

The following tables present the credit risk profile of the Company’s commercial and consumer loan portfolios based on rating category and payment activity as of June 30, 2020 and December 31, 2019.


	June 30, 2020
(in thousands)	Pass		Special Mention		Substandard		Total
Commercial and industrial	$	77,447	$	3,465	$	775	$	81,687
Owner-occupied commercial real estate	80,389		2,585		3,923		86,897
Investor commercial real estate	13,286		—		—		13,286
Construction	77,591		—		—		77,591
Single tenant lease financing	966,782		8,830		4,680		980,292
Public finance	647,107		—		—		647,107
Healthcare finance	379,899		1,057		—		380,956
Small business lending	118,526		—		—		118,526
Total commercial loans	$	2,361,027	$	15,937	$	9,378	$	2,386,342


	June 30, 2020
(in thousands)	Performing		Nonaccrual		Total
Residential mortgage	$	207,686	$	1,042	$	208,728
Home equity	22,640		—		22,640
Other consumer	291,524		108		291,632
Total consumer loans	$	521,850	$	1,150	$	523,000


	December 31, 2019
(in thousands)	Pass		Special Mention		Substandard		Total
Commercial and industrial	$	89,818	$	3,973	$	2,629	$	96,420
Owner-occupied commercial real estate	79,329		3,462		3,935		86,726
Investor commercial real estate	12,567		—		—		12,567
Construction	60,274		—		—		60,274
Single tenant lease financing	983,448		7,751		4,680		995,879
Public finance	687,094		—		—		687,094
Healthcare finance	300,612		—		—		300,612
Small business lending	46,945		—		—		46,945
Total commercial loans	$	2,260,087	$	15,186	$	11,244	$	2,286,517


	December 31, 2019
(in thousands)	Performing		Nonaccrual		Total
Residential mortgage	$	313,088	$	761	$	313,849
Home equity	24,306		—		24,306
Other consumer	295,276		33		295,309
Total consumer loans	$	632,670	$	794	$	633,464

The following tables present the Company’s loan portfolio delinquency analysis as of June 30, 2020 and December 31, 2019.


	June 30, 2020
(in thousands)	30-59 Days Past Due		60-89 Days Past Due		90 Days or More Past Due		Total Past Due		Current		Total Loans		Non- accrual Loans		Total Loans 90 Days or More Past Due and Accruing
Commercial and industrial	$	80	$	—	$	212	$	292	$	81,395	$	81,687	$	299	$	—
Owner-occupied commercial real estate	—		—		2,066		2,066		84,831		86,897		2,066		—
Investor commercial real estate	—		—		—		—		13,286		13,286		—		—
Construction	—		—		—		—		77,591		77,591		—		—
Single tenant lease financing	—		—		4,680		4,680		975,612		980,292		4,680		—
Public finance	—		—		—		—		647,107		647,107		—		—
Healthcare finance	—		—		—		—		380,956		380,956		—		—
Small business lending	—		—		—		—		118,526		118,526		—		—
Residential mortgage	—		—		281		281		208,447		208,728		1,042		—
Home equity	—		—		—		—		22,640		22,640		—		—
Other consumer	80		56		25		161		291,471		291,632		108		—
Total	$	160	$	56	$	7,264	$	7,480	$	2,901,862	$	2,909,342	$	8,195	$	—


	December 31, 2019
(in thousands)	30-59 Days Past Due		60-89 Days Past Due		90 Days or More Past Due		Total Past Due		Current		Total Loans		Non- accrual Loans		Total Loans 90 Days or More Past Due and Accruing
Commercial and industrial	$	15	$	96	$	122	$	233	$	96,187	$	96,420	$	226	$	—
Owner-occupied commercial real estate	—		—		464		464		86,262		86,726		464		—
Investor commercial real estate	—		—		—		—		12,567		12,567		—		—
Construction	—		—		—		—		60,274		60,274		—		—
Single tenant lease financing	—		4,680		—		4,680		991,199		995,879		4,680		—
Public finance	—		—		—		—		687,094		687,094		—		—
Healthcare finance	—		—		—		—		300,612		300,612		—		—
Small business lending	54				—		54		46,891		46,945		—		—
Residential mortgage	—		—		1,177		1,177		312,672		313,849		761		416
Home equity	—		—		—		—		24,306		24,306		—		—
Other consumer	240		107		—		347		294,962		295,309		33		—
Total	$	309	$	4,883	$	1,763	$	6,955	$	2,913,026	$	2,919,981	$	6,164	$	416

Impaired Loans

A loan is designated as impaired, in accordance with the impairment accounting guidance, when, based on current information or events, it is probable that the Company will be unable to collect all amounts due (principal and interest) according to the contractual terms of the loan agreement. Payments with delays generally not exceeding 90 days outstanding are not considered impaired. Certain nonaccrual and substantially all delinquent loans more than 90 days past due may be considered to be impaired. Generally, loans are placed on nonaccrual status at 90 days past due and accrued interest is reversed against earnings, unless the loan is well-secured and in the process of collection. The accrual of interest on impaired and nonaccrual loans is discontinued when, in management’s opinion, the borrower may be unable to meet payments as they become due.

Impaired loans include nonperforming loans as well as loans modified in TDRs where concessions have been granted to borrowers experiencing financial difficulties. These concessions could include a reduction in the interest rate on the loan, payment extensions, forgiveness of principal, forbearance, or other actions intended to maximize collection.

ASC Topic 310, Receivables, requires that impaired loans be measured based on the present value of expected future cash flows discounted at the loans’ effective interest rates or the fair value of the underlying collateral, less costs to sell, and allows existing methods for recognizing interest income.

The following table presents the Company’s impaired loans as of June 30, 2020 and December 31, 2019.


	June 30, 2020										December 31, 2019
(in thousands)	Recorded Balance		Unpaid Principal Balance		Specific Allowance		Recorded Balance		Unpaid Principal Balance		Specific Allowance
Loans without a specific valuation allowance
Commercial and industrial	$	613	$	672	$	—	$	2,693	$	2,694	$	—
Owner-occupied commercial real estate	3,922		3,925		—		5,663		5,665		—





Residential mortgage	1,408		1,498		—		1,135		1,209		—

Other consumer	115		215		—		43		107		—
Total	6,058		6,310		—		9,534		9,675		—
Loans with a specific valuation allowance
Commercial and industrial	203		240		109		207		244		109



Single tenant lease financing	4,680		4,680		1,660		4,680		4,680		1,660





Total	4,883		4,920		1,769		4,887		4,924		1,769
Total impaired loans	$	10,941	$	11,230	$	1,769	$	14,421	$	14,599	$	1,769

The table below presents average balances and interest income recognized for impaired loans during the three and six months ended June 30, 2020 and 2019.


	Three Months Ended														Six Months Ended
	June 30, 2020						June 30, 2019						June 30, 2020				June 30, 2019
(in thousands)	Average Balance		Interest Income		Average Balance		Interest Income		Average Balance		Interest Income		Average Balance		Interest Income
Loans without a specific valuation allowance
Commercial and industrial	$	594	$	18	$	4,053	$	86	$	1,330	$	36	$	4,376	$	167
Owner-occupied commercial real estate	3,923		29		2,723		66		4,573		31		2,464		93




Small business lending	—		—		—		—
Residential mortgage	1,352		—		3,538		—		1,313		—		2,796		—
Home equity	—		—		—		—		—		—		21		—
Other consumer	75		—		83		—		60		—		79		—
Total	5,944		47		10,397		152		7,276		67		9,736		260
Loans with a specific valuation allowance
Commercial and industrial	204		—		353		—		204		—		177		—



Single tenant lease financing	4,680		—		—		—		4,680		—		—		—





Total	4,884		—		353		—		4,884		—		177		—
Total impaired loans	$	10,828	$	47	$	10,750	$	152	$	12,160	$	67	$	9,913	$	260

The Company had no residential mortgage other real estate owned as of June 30, 2020 and December 31, 2019. There was one loan with a balance of $0.1 million in the process of foreclosure at June 30, 2020 and no loans in the process of foreclosure at December 31, 2019.

Troubled Debt Restructurings

The loan portfolio includes TDRs, which are loans that have been modified to grant economic concessions to borrowers who have experienced financial difficulties. These concessions typically result from loss mitigation efforts and could include reductions in the interest rate, payment extensions, forgiveness of principal, forbearance, or other actions. Certain TDRs are classified as nonperforming at the time of restructuring and typically are returned to performing status after

considering the borrower’s sustained repayment performance for a reasonable period, generally not less than six consecutive months.

When loans are modified in a TDR, any possible impairment similar to other impaired loans is evaluated based on the present value of expected future cash flows, discounted at the contractual interest rate of the original loan agreement, or using the current fair value of the collateral, less selling costs, for collateral dependent loans. If it is determined that the value of the modified loan is less than the recorded balance of the loan, impairment is recognized through a specific allowance or charge-off to the allowance. In periods subsequent to modification, all TDRs, including those that have payment defaults, are evaluated for possible impairment, and impairment is recognized through the allowance.

In the course of working with troubled borrowers, the Company may choose to restructure the contractual terms of certain loans in an effort to work out an alternative payment schedule with the borrower in order to optimize the collectability of the loan. Any loan modification is reviewed by the Company to identify whether a TDR has occurred when the Company grants a concession to the borrower that it would not otherwise consider based on economic or legal reasons related to a borrower’s financial difficulties. Terms may be modified to fit the ability of the borrower to repay in line with its current financial status or the loan may be restructured to secure additional collateral and/or guarantees to support the debt, or a combination of the two.

There was one portfolio residential mortgage loan classified as a new TDR during the three and six months ended June 30, 2020 with a pre-modification and post-modification outstanding recorded investment of $0.8 million. The Company did not allocate a specific allowance for that loan as of June 30, 2020. The modification consisted of an extension of the maturity date. There were four commercial and industrial loans classified as new TDRs during the three and six months ended June 30, 2019 with a pre-modification and post-modification outstanding recorded investment of $2.0 million. The Company did not allocate a specific allowance for those loans as of June 30, 2019. The modifications consisted of interest-only payments for a period of time. There were no performing TDRs that had payment defaults within the twelve months following modification during the three and six months ended June 30, 2020 and 2019, respectively.

Non-TDR Loan Modifications due to COVID-19

The “Interagency Statement on Loan Modifications and Reporting for Financial Institutions Working with Customers Affected by the Coronavirus” was issued by our banking regulators on March 22, 2020. This guidance encourages financial institutions to work prudently with borrowers who are or may be unable to meet their contractual payment obligations due to the effects of COVID-19.

Additionally, Section 4013 of the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”) provides that loan modifications due to the impact of COVID-19 that would otherwise be classified as TDRs under GAAP will not be so classified. Modifications within the scope of this relief are in effect from the period beginning March 1, 2020 until the earlier of December 31, 2020 or 60 days after the date on which the national emergency related to the COVID-19 pandemic formally terminates.

In accordance with this guidance, the Company offered modifications to borrowers who were both impacted by COVID-19 and current on all principal and interest payments. The modifications completed in the six months ended June 30, 2020 totaled $392.4 million and consisted of payment deferrals.

Note 5: Premises and Equipment

The following table summarizes premises and equipment at June 30, 2020 and December 31, 2019.


(in thousands)	June 30, 2020		December 31, 2019
Land	$	2,500	$	2,500
Right of use leased asset	1,242		1,602
Building and improvements	19,821		10,004
Furniture and equipment	10,452		9,689
Less: accumulated depreciation	(10,076)		(9,165)
Total	$	23,939	$	14,630

During 2018, the Bank's subsidiary, SPF15, Inc., (“SPF15”) acquired several parcels of land consisting of approximately 3.3 acres located in Fishers, Indiana for approximately $10.2 million, inclusive of acquisition costs. Pursuant to a Land Acquisition Agreement with the City of Fishers, Indiana (the “City”), and its Redevelopment Commission, among others, the City agreed to reimburse SPF15 for the purchase price and other specified land acquisition costs. The Land Acquisition Agreement was replaced by a Project Agreement in December 2018, which extended the reimbursement deadline to October 31, 2019 and made additional financial incentives available to the Company for constructing an office building and associated parking garage on the property. As contemplated under the Project Agreement, the City transferred to SPF15 two additional parcels of land consisting of approximately 0.75 acres and SPF15 transferred to the Fishers Town Hall Building Corporation and third parties a certain parcel of land consisting of approximately 1.65 acres in connection with the development of the property. On October 25, 2019, the City satisfied its reimbursement obligation, resulting in the payment of SPF15 of an aggregate of $11.1 million for purchase prices and other specified land acquisition costs.

Site demolition has been completed and construction of a multi-use development, to include the Company's future headquarters, began on October 7, 2019. Development of the site is estimated to be substantially completed by October 12, 2021.

Note 6: Leases

A lease is defined as a contract, or part of a contract, that conveys the right to control the use of identified property or equipment for a period of time in exchange for consideration. On January 1, 2019, the Company adopted ASU 2016-02 - Leases (Topic 842) and elected the optional transition method, which allows the Company to not separate non-lease components from the associated lease component if certain conditions are met. In addition, the Company elected not to adjust prior comparative periods.

The Company has three operating leases that are used for general office operations with remaining lease terms of two to four years. With the adoption of ASU 2016-02, operating lease agreements are required to be recognized on the condensed consolidated balance sheets as a right-of-use asset and a corresponding lease liability.

The following table shows the components of lease expense.


(in thousands)	Three Months Ended								Six Months Ended
	June 30, 2020		June 30, 2019		June 30, 2020		June 30, 2019
Operating lease cost	$	251	$	187	$	466	$	368

The following table shows supplemental cash flow information related to leases.


(in thousands)	Six Months Ended
	June 30, 2020		June 30, 2019
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	497	$	394

The following table shows the operating leases’ impact on the condensed consolidated balance sheets. The Company elected not to include short-term leases (leases with original terms of 12 months or less) or equipment leases, as those amounts are insignificant. The Company’s leases do not provide an implicit rate. The discount rate utilized to determine the present value of lease payments is the Company’s incremental borrowing rate based on the information available at the lease inception date. The incremental borrowing rate is the rate of interest the Company would have to pay to borrow on a collateralized basis over a similar term in an amount equal to the lease payments in a similar economic environment.


(dollars in thousands)
	June 30, 2020			December 31, 2019
Operating lease right-of-use assets	$	1,242		$	1,602
Operating lease liabilities	1,242			1,602

Weighted-average remaining lease term (years)
Operating leases	2.1			2.4

Weighted-average discount rate
Operating leases	2.0		%	2.0		%

The following table shows the future minimum payments of operating leases with initial or remaining terms of one year or more as of June 30, 2020.


(in thousands)
Twelve months ended June 30,
2021	$	691
2022	290
2023	232
2024	—
2025	—
Thereafter	—
Total lease payments	1,213
Less: imputed interest	(30)
Total	$	1,183

Note 7: Goodwill

As of June 30, 2020 and December 31, 2019, the carrying amount of goodwill was $4.7 million. There have been no changes in the carrying amount of goodwill for the three months ended June 30, 2020. Goodwill is tested for impairment on an annual basis as of August 31, or whenever events or changes in circumstances indicate the carrying amount of goodwill exceeds its implied fair value. The annual test indicated no impairment existed as of August 31, 2019.

Due to the impact of COVID-19 on the economy and the financial markets, the Company evaluated goodwill and determined no triggering event has occurred since the last goodwill impairment test was conducted.

Note 8: Servicing Asset

Activity for the servicing asset and the related changes in fair value for the six months ended June 30, 2020 and 2019 are shown in the table below.


(in thousands)	Six Months Ended
	June 30, 2020		June 30, 2019
Beginning balance	$	2,481	$	—
Additions	310		—
Changes in fair value	(269)		—
Ending balance	$	2,522	$	—

Loans serviced for others are not included in the condensed consolidated balance sheets. The unpaid principal balances of these loans serviced for others as of June 30, 2020 and December 31, 2019 are shown in the table below.


(in thousands)
	June 30, 2020		December 31, 2019
Loan portfolios serviced for:
SBA guaranteed loans	$	113,927	$	103,981

Total	$	113,927	$	103,981

Loan servicing revenue totaled $0.3 million and $0.5 million during the three and six months ended June 30, 2020, respectively. There was no loan servicing revenue during the three and six months ended June 30, 2019. Loan servicing asset revaluation, which represents the change in fair value of the servicing asset, resulted in a $0.1 million and $0.3 million downward valuation for the three and six months ended June 30, 2020, respectively. There was no loan servicing asset revaluation during the three and six months ended June 30, 2019.

The fair value of servicing rights is highly sensitive to changes in underlying assumptions. Though fluctuations in prepayment speeds and changes in secondary market premiums generally have the most substantial impact on the fair value of servicing rights, other influencing factors include changing economic conditions, changes to the discount rate assumption and the weighted average life of the servicing portfolio. Measurement of fair value is limited to the conditions existing and the assumptions used as of a particular point in time; however, those assumptions may change over time. Refer to Note 12 - Fair Value of Financial Instruments for further details.

Note 9: Subordinated Debt

In October 2015, the Company entered into a term loan in the principal amount of $10.0 million, evidenced by a term note due 2025 (the “2025 Note”). The 2025 Note bears a fixed interest rate of 6.4375% per year, payable quarterly, and is scheduled to mature on October 1, 2025. The 2025 Note is an unsecured subordinated obligation of the Company and may be repaid, without penalty, on any interest payment date on or after October 15, 2020. The 2025 Note is intended to qualify as Tier 2 capital under regulatory guidelines.

In September 2016, the Company issued $25.0 million aggregate principal amount of 6.0% Fixed-to-Floating Rate Subordinated Notes due 2026 (the “2026 Notes”) in a public offering. The 2026 Notes initially bear a fixed interest rate of 6.0% per year to, but excluding September 30, 2021, and thereafter a floating rate equal to the then-current three-month LIBOR rate plus 485 basis points. All interest on the 2026 Notes is payable quarterly. The 2026 Notes are scheduled to mature on September 30, 2026. The 2026 Notes are unsecured subordinated obligations of the Company and may be repaid, without penalty, on any interest payment date on or after September 30, 2021. The 2026 Notes are intended to qualify as Tier 2 capital under regulatory guidelines.

In June 2019, the Company issued $37.0 million aggregate principal amount of 6.0% Fixed-to-Floating Rate Subordinated Notes due 2029 (the “2029 Notes”) in a public offering. The 2029 Notes initially bear a fixed interest rate of 6.0% per year to, but excluding, June 30, 2024, and thereafter a floating rate equal to the then-current benchmark rate (initially three-month LIBOR rate) plus 411 basis points. All interest on the 2029 Notes is payable quarterly. The 2029 Notes are scheduled to mature on June 30, 2029. The 2029 Notes are unsecured subordinated obligations of the Company and may be repaid, without penalty, on any interest payment date on or after June 30, 2024. The 2029 Notes are intended to qualify as Tier 2 capital under regulatory guidelines.

The following table presents the principal balance and unamortized debt issuance costs for the 2025 Note, the 2026 Notes and the 2029 Notes as of June 30, 2020 and December 31, 2019.


	June 30, 2020						December 31, 2019
(in thousands)	Principal		Unamortized Debt Issuance Costs		Principal		Unamortized Debt Issuance Costs

2025 Note	10,000		(126)		10,000		(138)
2026 Notes	25,000		(777)		25,000		(839)
2029 Notes	37,000		(1,416)		37,000		(1,495)
Total	$	72,000	$	(2,319)	$	72,000	$	(2,472)

Note 10: Benefit Plans

Employment Agreement

The Company is party to an employment agreement with its Chief Executive Officer that provides for an annual base salary and an annual bonus, if any, as determined from time to time by the Compensation Committee of our Board of Directors. The annual bonus is to be determined with reference to the achievement of annual performance objectives established by the Compensation Committee for the Chief Executive Officer and other senior officers. The agreement also provides that the Chief Executive Officer may be awarded additional compensation, benefits, or consideration as the Compensation Committee may determine.

The agreement provides for the continuation of salary and certain other benefits for a specified period of time upon termination of his employment under certain circumstances, including his resignation for “good reason” or termination by the Company without “cause” at any time or any termination of his employment for any reason within twelve months following a “change in control,” along with other specific conditions.

2013 Equity Incentive Plan

The 2013 Equity Incentive Plan (the “2013 Plan”) authorizes the issuance of 750,000 shares of the Company’s common stock in the form of equity-based awards to employees, directors, and other eligible persons. Under the terms of the 2013 Plan, the pool of shares available for issuance may be used for available types of equity awards under the 2013 Plan, which includes stock options, stock appreciation rights, restricted stock awards, stock unit awards, and other share-based awards. All employees, consultants, and advisors of the Company or any subsidiary, as well as all non-employee directors of the Company, are eligible to receive awards under the 2013 Plan.

The Company recorded $0.5 million and $1.1 million of share-based compensation expense for the three and six months ended June 30, 2020, respectively, related to awards made under the 2013 Plan. The Company recorded $0.4 million and $0.9 million of share-based compensation expense for the three and six months ended June 30, 2019, respectively, related to awards made under the 2013 Plan.

The following table summarizes the status of the 2013 Plan awards as of June 30, 2020, and activity for the six months ended June 30, 2020.


	Restricted Stock Units	Weighted-Average Grant Date Fair Value Per Share		Restricted Stock Awards	Weighted-Average Grant Date Fair Value Per Share		Deferred Stock Units	Weighted-Average Grant Date Fair Value Per Share
Nonvested at December 31, 2019	107,244	$	29.03	—	$	—	—	$	—
Granted	66,808	27.56		16,090	25.58		6	19.41
Vested	(48,499)	30.34		(6,808)	26.37		(6)	19.41
Forfeited	—	—		(1,638)	27.56		—	—
Nonvested at June 30, 2020	125,553	$	27.74	7,644	$	24.44	—	$	—

At June 30, 2020, the total unrecognized compensation cost related to nonvested awards was $3.1 million with a weighted-average expense recognition period of 1.9 years.

Directors Deferred Stock Plan

Until January 1, 2014, the Company had a practice of granting awards under a stock compensation plan for members of the Board of Directors (“Directors Deferred Stock Plan”). The Company reserved 180,000 shares of common stock that could have been issued pursuant to the Directors Deferred Stock Plan. The Directors Deferred Stock Plan provided directors the option to elect to receive up to 100% of their annual retainer in either common stock or deferred stock rights. Deferred stock rights were to be settled in common stock following the end of the deferral period payable on the basis of one share of common stock for each deferred stock right.

The following table summarizes the status of deferred stock rights related to the Directors Deferred Stock Plan for the six months ended June 30, 2020.


						Deferred Stock Rights
Outstanding, beginning of period						84,505
Granted						428
Exercised						—
Outstanding, end of period						84,933

All deferred stock rights granted during the 2020 period were additional rights issued in lieu of cash dividends payable on outstanding deferred stock rights.

Note 11: Commitments and Credit Risk

In the normal course of business, the Company makes various commitments to extend credit which are not reflected in the accompanying condensed consolidated financial statements. At June 30, 2020 and December 31, 2019, the Company had outstanding loan commitments totaling approximately $267.4 million and $254.4 million, respectively.

In addition, the Company is a limited partner in a Small Business Investment Company fund (the “SBIC Fund”). As of June 30, 2020, the Company has committed to contribute up to $1.7 million of capital to the SBIC Fund.

Capital Commitments

Capital expenditures contracted to at the balance sheet date but not yet recognized in the financial statements are associated with the construction of premises intended to house our future corporate headquarters. The Company has entered into construction-related contracts in the amount of $65.1 million. As of June 30, 2020, $51.6 million of such contract commitments had not yet been incurred. These commitments are due within two years.

Note 12: Fair Value of Financial Instruments

ASC Topic 820, Fair Value Measurement, defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 also specifies a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:

Level 1 Quoted prices in active markets for identical assets or liabilities

Level 2 Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities

Level 3 Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities

Following is a description of the valuation methodologies and inputs used for assets measured at fair value on a recurring basis and recognized in the accompanying condensed consolidated balance sheets, as well as the general classification of such assets pursuant to the valuation hierarchy.

Available-for-Sale Securities

Where quoted market prices are available in an active market, securities are classified within Level 1 of the valuation hierarchy. Level 1 securities include highly liquid mutual funds. If quoted market prices are not available, then fair values are estimated by using pricing models, quoted prices of securities with similar characteristics or discounted cash flows.

Level 2 securities include U.S. Government-sponsored agencies, municipal securities, mortgage and asset-backed securities and certain corporate securities. Matrix pricing is a mathematical technique widely used in the banking industry to value investment securities without relying exclusively on quoted prices for specific investment securities but also on the investment securities’ relationship to other benchmark quoted investment securities.

In certain cases where Level 1 or Level 2 inputs are not available, securities are classified within Level 3 of the hierarchy. Fair values are calculated using discounted cash flows. Discounted cash flows are calculated based off of the anticipated future cash flows updated to incorporate loss severities. Rating agency and industry research reports as well as default and deferral activity are reviewed and incorporated into the calculation. The Company did not own any securities classified within Level 3 of the hierarchy as of June 30, 2020 or December 31, 2019.

Loans Held-for-Sale (mandatory pricing agreements)

The fair value of loans held-for-sale is determined using quoted prices for similar assets, adjusted for specific attributes of that loan (Level 2).

Servicing Asset

Fair value is based on a loan-by-loan basis taking into consideration the original maturity of the loans, the current age of the loans and the remaining term to maturity. The valuation methodology utilized for the servicing assets begins with generating estimated future cash flows for each servicing asset, based on their unique characteristics and market-based assumptions for prepayment speeds and costs to service. The present value of the future cash flows is then calculated utilizing market-based discount rate assumptions (Level 3).

Interest Rate Swap Agreements

The fair value of interest rate swap agreements is estimated using current market interest rates as of the balance sheet date and calculated using discounted cash flows that are observable or that can be corroborated by observable market data and, therefore, are classified within Level 2 of the valuation hierarchy.

Forward Contracts

The fair values of forward contracts on to-be-announced securities are determined using quoted prices in active markets or benchmarked thereto (Level 1).

Interest Rate Lock Commitments

The fair values of interest rate lock commitments (“IRLCs”) are determined using the projected sale price of individual loans based on changes in market interest rates, projected pull-through rates (the probability that an IRLC will ultimately result in an originated loan), the reduction in the value of the applicant’s option due to the passage of time, and the remaining origination costs to be incurred based on management’s estimate of market costs (Level 3).

The following tables present the fair value measurements of assets and liabilities recognized in the accompanying condensed consolidated balance sheets measured at fair value on a recurring basis and the level within the fair value hierarchy in which the fair value measurements fall at June 30, 2020 and December 31, 2019.


			June 30, 2020 Fair Value Measurements Using
(in thousands)	Fair Value		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
U.S. Government-sponsored agencies	$	66,544	$	—	$	66,544	$	—
Municipal securities	90,562		—		90,562		—
Agency mortgage-backed securities	278,530		—		278,530		—
Private label mortgage-backed securities	101,925				101,925		—
Asset-backed securities	4,837		—		4,837		—
Corporate securities	46,619		—		46,619		—

Total available-for-sale securities	589,017		—		589,017		—
Servicing asset	2,522		—		—		2,522

Interest rate swap liabilities	(34,494)		—		(34,494)		—
Loans held-for-sale (mandatory pricing agreements)	2,001		—		2,001		—
Forward contracts	(17)		(17)		—		—
IRLCs	282		—		—		282


			December 31, 2019 Fair Value Measurements Using
(in thousands)	Fair Value		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
U.S. Government-sponsored agencies	$	75,872	$	—	$	75,872	$	—
Municipal securities	97,652		—		97,652		—
Agency mortgage-backed securities	261,440		—		261,440		—
Private label mortgage-backed securities	63,613		—		63,613		—
Asset-backed securities	4,955		—		4,955		—
Corporate securities	37,320		—		37,320		—

Total available-for-sale securities	540,852		—		540,852		—
Servicing asset	2,481		—		—		2,481

Interest rate swap liabilities	(37,786)		—		(37,786)		—
Loans held-for-sale (mandatory pricing agreements)	56,097		—		56,097		—
Forward contracts	(153)		(153)		—		—
IRLCs	910		—		—		910

The following tables reconcile the beginning and ending balances of recurring fair value measurements recognized in the accompanying condensed consolidated balance sheets using significant unobservable (Level 3) inputs for the three and six months ended June 30, 2020 and 2019.


	Three Months Ended
(in thousands)	Servicing Asset		Interest Rate Lock Commitments
Balance, April 1, 2020	$	2,415	$	2,064
Total realized gains (losses)
Additions	197		—
Change in fair value	(90)		(1,782)

Balance, June 30, 2020	2,522		282

Balance as of April 1, 2019	$	—	$	781
Total realized gains

Change in fair value	—		428

Balance, June 30, 2019	$	—	$	1,209



(in thousands)	Six Months Ended
	Servicing Asset		Interest Rate Lock Commitments
Balance January 1, 2020	$	2,481	$	910
Total realized gains (losses)
Additions	310		—
Change in fair value	(269)		(628)

Balance, June 30, 2020	$	2,522	282

Balance as of January 1, 2019	$	—	$	389
Total realized gains
Change in fair value	—		820

Balance, June 30, 2019	$	—	$	1,209

The following describes the valuation methodologies and inputs used for assets measured at fair value on a nonrecurring basis, as well as the general classification of such assets pursuant to the valuation hierarchy.

Impaired Loans (Collateral Dependent)

Loans for which it is probable that the Company will not collect all principal and interest due according to contractual terms are measured for impairment. The amount of impairment may be determined based on the fair value of the underlying collateral, less costs to sell, the estimated present value of future cash flows or the loan’s observable market price.

If the impaired loan is identified as collateral dependent, the fair value of the underlying collateral, less costs to sell, is used to measure impairment. This method requires obtaining a current independent appraisal of the collateral and applying a discount factor to the value. If the impaired loan is not collateral dependent, the Company utilizes a discounted cash flow analysis to measure impairment.

Impaired loans with a specific valuation allowance based on the value of the underlying collateral or a discounted cash flow analysis are classified as Level 3 assets.

The following table presents the fair value measurements of assets and liabilities recognized in the accompanying condensed consolidated balance sheets measured at fair value on a nonrecurring basis and the level within the fair value

hierarchy in which the fair value measurement falls at December 31, 2019. The Company did not have any measurements on a nonrecurring basis at June 30, 2020.


			December 31, 2019
(in thousands)			Fair Value Measurements Using
	Fair Value		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Impaired loans	$	3,019	$	—	$	—	$	3,019

Significant Unobservable (Level 3) Inputs

The following tables present quantitative information about unobservable inputs used in recurring and nonrecurring Level 3 fair value measurements.

(dollars in thousands)

Fair Value at
June 30, 2020

Valuation
Technique

Significant Unobservable
Inputs

Range

Weighted-Average Range

IRLCs

282

Discounted cash flow

Loan closing rates

63% - 100%

73%

Servicing asset

2,522

Discounted cash flow

Prepayment speeds

0% - 25%

13.0%

Expected weighted-average loan life

3.6 - 5.6 years

4.8 years

(dollars in thousands)

Fair Value at
December 31, 2019

Valuation
Technique

Significant Unobservable
Inputs

Range

Weighted-Average Range

Impaired loans

3,019

Fair value of collateral

Discount for type of property and current market conditions

10%

IRLCs

910

Discounted cash flow

Loan closing rates

50% - 100%

84%

Servicing asset

2,481

Discounted cash flow

Prepayment speeds

0% - 25%

13.5%

Expected weighted-average loan life

3.2 - 5.7 years

5.0 years

The following methods were used to estimate the fair value of all other financial instruments recognized in the accompanying condensed consolidated balance sheets at amounts other than fair value.

Cash and Cash Equivalents

For these instruments, the carrying amount is a reasonable estimate of fair value.

Securities Held-to-Maturity

Fair values are determined by using models that are based on security-specific details, as well as relevant industry and economic factors. The most significant of these inputs are quoted market prices and interest rate spreads on relevant benchmark securities.

Loans Held-for-Sale (best efforts pricing agreements)

The fair value of these loans approximates carrying value.

Loans

The fair value of loans is estimated on an exit price basis incorporating discounts for credit, liquidity and marketability factors.

Accrued Interest Receivable

The fair value of these financial instruments approximates carrying value.

Federal Home Loan Bank of Indianapolis Stock

The fair value approximates carrying value.

Deposits

The fair value of noninterest-bearing and interest-bearing demand deposits, savings and money market accounts approximates carrying value. The fair value of fixed maturity certificates of deposit and brokered deposits are estimated using rates currently offered for deposits of similar remaining maturities.

Advances from Federal Home Loan Bank

The fair value of fixed rate advances is estimated using rates currently available for advances with similar remaining maturities. The carrying value of variable rate advances approximates fair value.

Subordinated Debt

The fair value of the Company’s publicly traded subordinated debt is obtained from quoted market prices. The fair value of the Company’s remaining subordinated debt is estimated using discounted cash flow analysis, based on current borrowing rates for similar types of debt instruments.

Accrued Interest Payable

The fair value of these financial instruments approximates carrying value.

Commitments

The fair value of commitments to extend credit are based on fees currently charged to enter into similar agreements with similar maturities and interest rates. The Company determined that the fair value of commitments was zero based on the contractual value of outstanding commitments at each of June 30, 2020 and December 31, 2019.

The following tables present the carrying value and estimated fair value of all financial assets and liabilities at June 30, 2020 and December 31, 2019.


	June 30, 2020 Fair Value Measurements Using
(in thousands)	Carrying Amount		Fair Value		Quoted Prices In Active Market for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Cash and cash equivalents	$	498,619	$	498,619	$	498,619	$	—	$	—

Securities held-to-maturity	68,295		69,152		—		69,152		—
Loans held-for-sale (best efforts pricing agreements)	23,493		23,493		—		23,493		—
Net loans	2,949,209		3,006,369		—		—		3,006,369
Accrued interest receivable	21,093		21,093		21,093		—		—
Federal Home Loan Bank of Indianapolis stock	25,650		25,650		—		25,650		—
Deposits	3,380,789		3,428,960		1,520,495		—		1,908,465
Advances from Federal Home Loan Bank	514,913		548,015		—		548,015		—
Subordinated debt	69,681		65,349		55,154		10,195		—
Accrued interest payable	1,073		1,073		1,073		—		—


	December 31, 2019 Fair Value Measurements Using
(in thousands)	Carrying Amount		Fair Value		Quoted Prices In Active Market for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Cash and cash equivalents	$	327,361	$	327,361	$	327,361	$	—	$	—

Securities held-to-maturity	61,878		62,560		—		62,560		—

Net loans	2,941,707		2,876,688		—		—		2,876,688
Accrued interest receivable	18,607		18,607		18,607		—		—
Federal Home Loan Bank of Indianapolis stock	25,650		25,650		—		25,650		—
Deposits	3,153,963		3,232,065		1,002,141		—		2,229,924
Advances from Federal Home Loan Bank	514,910		520,950		—		520,950		—
Subordinated debt	69,528		75,206		64,996		10,210		—
Accrued interest payable	3,767		3,767		3,767		—		—

Note 13: Mortgage Banking Activities

The Company’s residential real estate lending business originates mortgage loans for customers and typically sells a majority of the originated loans into the secondary market. For most of the mortgages it sells in the secondary market, the Company hedges its mortgage banking pipeline by entering into forward contracts for the future delivery of mortgage loans to third party investors and entering into IRLCs with potential borrowers to fund specific mortgage loans that will be sold into the secondary market. To facilitate the hedging of the loans, the Company has elected the fair value option for loans originated and intended for sale in the secondary market under mandatory pricing agreements. Changes in the fair value of loans held-for-sale, IRLCs and forward contracts are recorded in the mortgage banking activities line item within noninterest income. Refer to Note 14 for further information on derivative financial instruments.

During the three months ended June 30, 2020 and 2019, the Company originated mortgage loans held-for-sale of $211.9 million and $145.0 million, respectively, and sold $229.2 million and $130.4 million of mortgage loans, respectively, into the secondary market. During the six months ended June 30, 2020 and 2019, the Company originated mortgage loans held-for-sale of $427.3 million and $220.3 million, respectively, and sold $454.7 million and $211.4 million of mortgage loans, respectively, into the secondary market.

The following table presents the components of income from mortgage banking activities for the three and six months ended June 30, 2020 and 2019.


	Three Months Ended June 30,						Six Months Ended June 30,
(in thousands)	2020		2019		2020		2019
Gain on loans sold	$	4,164	$	1,825	$	8,507	$	3,298
(Loss) gain resulting from the change in fair value of loans held-for-sale	(1,255)		534		(939)		352
Gain (loss) resulting from the change in fair value of derivatives	499		305		(492)		631
Net revenue from mortgage banking activities	$	3,408	$	2,664	$	7,076	$	4,281

Fluctuations in interest rates and changes in IRLC and loan volume within the mortgage banking pipeline may cause volatility in the fair value of loans held-for-sale and the fair value of derivatives used to hedge the mortgage banking pipeline.

Note 14: Derivative Financial Instruments

The Company uses derivative financial instruments to help manage exposure to interest rate risk and the effects that changes in interest rates may have on net income and the fair value of assets and liabilities. The Company enters into interest rate swap agreements as part of its asset/liability management strategy to help manage its interest rate risk position. Additionally, the Company enters into forward contracts for the future delivery of mortgage loans to third-party investors and enters into IRLCs with potential borrowers to fund specific mortgage loans that will be sold into the secondary market. The forward contracts are entered into in order to economically hedge the effect of changes in interest rates resulting from the Company’s commitment to fund the loans.

The Company had various interest rate swap agreements designated and qualifying as accounting hedges during the reported periods. Designating an interest rate swap as an accounting hedge allows the Company to recognize gains and losses, less any ineffectiveness, in the condensed consolidated statements of income within the same period that the hedged item affects earnings. The Company includes the gain or loss on the hedged items in the same line item as the offsetting loss or gain on the related interest rate swaps. For derivative instruments that are designated and qualify as cash flow hedges, any gains or losses related to changes in fair value are recorded in accumulated other comprehensive loss, net of tax. The fair value of interest rate swaps with a positive fair value are reported in accrued income and other assets in the condensed consolidated balance sheets, while interest rate swaps with a negative fair value are reported in accrued expenses and other liabilities in the condensed consolidated balance sheets.

The IRLCs and forward contracts are not designated as accounting hedges and are recorded at fair value with changes in fair value reflected in noninterest income on the condensed consolidated statements of income. The fair value of derivative instruments with a positive fair value are reported in accrued income and other assets in the condensed consolidated balance sheets, while derivative instruments with a negative fair value are reported in accrued expenses and other liabilities in the condensed consolidated balance sheets.

The following table presents amounts that were recorded on the condensed consolidated balance sheets related to cumulative basis adjustments for interest rate swap derivatives designated as fair value accounting hedges as of June 30, 2020 and December 31, 2019.


(in thousands)	Carrying amount of the hedged asset						Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged assets
Line item in the condensed consolidated balance sheets in which the hedged item is included	June 30, 2020		December 31, 2019		June 30, 2020		December 31, 2019
Loans	$	—	$	474,957	$	—	$	21,440
Securities available-for-sale ⁽¹⁾	145,872		151,538		7,095		2,802

⁽¹⁾These amounts include the amortized cost basis of closed portfolios used to designate hedging relationships in which the hedged item is the last layer expected to be remaining at the end of the hedging relationship. At both June 30, 2020 and December 31, 2019, the amounts of the designated hedged items were $88.2 million.

The following tables present a summary of interest rate swap derivatives designated as fair value accounting hedges of fixed-rate receivables used in the Company’s asset/liability management activities at June 30, 2020 and December 31, 2019, identified by the underlying interest rate-sensitive instruments.


(dollars in thousands) June 30, 2020	Notional		Weighted- Average Remaining Maturity			Weighted-Average Ratio
Instruments Associated With	Value		(years)	Fair Value		Receive	Pay

Securities available-for-sale	88,200		3.6	(7,097)		3-month LIBOR	2.54	%
Total at June 30, 2020	$	88,200	3.6	$	(7,097)	3-month LIBOR	2.54	%


(dollars in thousands) December 31, 2019	Notional		Weighted- Average Remaining Maturity			Weighted-Average Ratio
Instruments Associated With	Value		(years)	Fair Value		Receive	Pay
Loans	$	427,446	5.5	$	(21,551)	3-month LIBOR	2.86	%
Securities available-for-sale	88,200		4.1	(2,806)		3-month LIBOR	2.54	%
Total at December 31, 2019	$	515,646	5.3	$	(24,357)	3-month LIBOR	2.80	%

In June 2020, the Company terminated all fair value hedging relationships associated with loans, which resulted in swap termination payments to counterparties totaling $46.1 million. The corresponding loan fair value hedging adjustment as of the date of termination is being amortized over the remaining lives of the designated loans, which have a weighted-average term to maturity of 13.6 years as of June 30, 2020.

The following tables present a summary of interest rate swap derivatives designated as cash flow accounting hedges of variable-rate liabilities used in the Company’s asset/liability management activities at June 30, 2020 and December 31, 2019.


(dollars in thousands) June 30, 2020	Notional		Weighted- Average Remaining Maturity			Weighted-Average Ratio
Cash Flow Hedges	Value		(years)	Fair Value		Receive	Pay
Interest rate swaps	$	110,000	6.6	$	(17,993)	3-month LIBOR	2.88	%
Interest rate swaps	100,000		3.5	(9,404)		1-month LIBOR	2.88	%


(dollars in thousands) December 31, 2019	Notional		Weighted- Average Remaining Maturity			Weighted-Average Ratio
Cash Flow Hedges	Value		(years)	Fair Value		Receive	Pay
Interest rate swaps	$	110,000	7.1	$	(8,390)	3-month LIBOR	2.88	%
Interest rate swaps	100,000		4.0	(5,040)		1-month LIBOR	2.88	%

These derivative financial instruments were entered into for the purpose of managing the interest rate risk of certain assets and liabilities. The Company pledged $34.6 million and $42.3 million of cash collateral to counterparties as security for its obligations related to these interest rate swap transactions at June 30, 2020 and December 31, 2019, respectively. Collateral posted and received is dependent on the market valuation of the underlying hedges.

The following table presents the notional amount and fair value of interest rate swaps, IRLCs and forward contracts utilized by the Company at June 30, 2020 and December 31, 2019.


	June 30, 2020						December 31, 2019
(in thousands)	Notional Amount		Fair Value		Notional Amount		Fair Value
Asset Derivatives




Derivatives not designated as hedging instruments
IRLCs	14,527		282		56,256		910

Total contracts	$	14,527	$	282	$	56,256	$	910
Liability Derivatives
Derivatives designated as hedging instruments
Interest rate swaps associated with loans	$	—	$	—	$	427,446	$	(21,551)
Interest rate swaps associated with securities available-for-sale	88,200		(7,097)		88,200		(2,806)
Interest rate swaps associated with liabilities	210,000		(27,397)		210,000		(13,429)
Derivatives not designated as hedging instruments
Forward contracts	11,710		(17)		115,000		(153)

Total contracts	$	309,910	$	(34,511)	$	840,646	$	(37,939)

The fair value of interest rate swaps was estimated using a discounted cash flow method that incorporates current market interest rates as of the balance sheet date. Fair values of IRLCs and forward contracts were estimated using changes in mortgage interest rates from the date the Company entered into the IRLC and the balance sheet date.

The following table presents the effects of the Company’s cash flow hedge relationships on the condensed consolidated statements of comprehensive income during the three and six months ended June 30, 2020 and 2019.


	Amount of Loss Recognized in Other Comprehensive Loss in The Three Months Ended						Amount of Loss Recognized in Other Comprehensive Loss in the Six Months Ended
(in thousands)	June 30, 2020		June 30, 2019		June 30, 2020		June 30, 2019

Interest rate swap agreements	$	(509)	$	(5,892)	$	(13,967)	$	(9,464)

The following table summarizes the periodic changes in the fair value of derivatives not designated as hedging instruments on the condensed consolidated statements of income for the three and six months ended June 30, 2020 and 2019.


	Amount of Gain / (Loss) Recognized in the Three Months Ended						Amount of Gain / (Loss) Recognized in the Six Months Ended
(in thousands)	June 30, 2020		June 30, 2019		June 30, 2020		June 30, 2019
Asset Derivatives
Derivatives not designated as hedging instruments
IRLCs	$	(1,781)	$	428	$	(628)	$	820


Liability Derivatives
Derivatives not designated as hedging instruments

Forward contracts	$	2,281	$	(122)	$	136	$	(189)

The following table presents the effects of the Company’s interest rate swap agreements on the condensed consolidated statements of income during the three and six months ended June 30, 2020 and 2019.


(in thousands) Line item in the condensed consolidated statements of income	Three Months Ended									Six Months Ended
			June 30, 2020			June 30, 2019			June 30, 2020			June 30, 2019
Interest income
Loans	$	(1,221)		$	(285)		$	(2,445)		$	(264)
Securities - taxable	(159)			(10)			(250)			(17)
Securities - non-taxable	(164)			27			(230)			72
Total interest income	(1,544)			(268)			(2,925)			(209)
Interest expense
Deposits	593			104			899			194
Other borrowed funds	589			79			911			113
Total interest expense	1,182			183			1,810			307
Net interest income	$	(2,726)		$	(451)		$	(4,735)		$	(516)

Note 15: Accumulated Other Comprehensive Loss

The components of accumulated other comprehensive loss, included in stockholders' equity, for the six months ended June 30, 2020 and 2019, respectively, are presented in the table below.


(in thousands)	Available-For-Sale Securities		Cash Flow Hedges		Total
Balance, January 1, 2020	$	(4,388)	$	(9,803)	$	(14,191)
Net change in unrealized gain (loss)	4,801		(13,967)		(9,166)
Reclassification of gain realized and included in earnings	(41)		—		(41)
Accumulated other comprehensive income (loss) before income tax	372		(23,770)		(23,398)
Income tax provision (benefit)	1,760		(4,020)		(2,260)
Balance, June 30, 2020	$	(1,388)	$	(19,750)	$	(21,138)

Balance, January 1, 2019	$	(13,360)	$	(3,181)	$	(16,541)
Net change in unrealized gain (loss)	10,577		(9,464)		1,113
Reclassification of net loss realized and included in earnings	458		—		458
Accumulated other comprehensive loss before income tax	(2,325)		(12,645)		(14,970)
Income tax provision (benefit)	3,163		(2,555)		608
Balance, June 30, 2019	$	(5,488)	$	(10,090)	$	(15,578)

The components of accumulated other comprehensive loss, included in stockholders' equity, for the three months ended June 30, 2020 and 2019, respectively, are presented in the table below.


(in thousands)	Available-For-Sale Securities		Cash Flow Hedges		Total
Balance, April 1, 2020	$	(239)	$	(19,627)	$	(19,866)
Net change in unrealized loss	(1,498)		(509)		(2,007)

Accumulated other comprehensive loss before income tax	(1,737)		(20,136)		(21,873)
Income tax benefit	(349)		(386)		(735)
Balance, June 30, 2020	$	(1,388)	$	(19,750)	$	(21,138)

Balance, April 1, 2019	$	(8,380)	$	(5,788)	$	(14,168)
Net change in unrealized gain (loss)	3,667		(5,892)		(2,225)
Reclassification of net loss realized and included in earnings	458		—		458
Accumulated other comprehensive loss before income tax	(4,255)		(11,680)		(15,935)
Income tax provision (benefit)	1,233		(1,590)		(357)
Balance, June 30, 2019	$	(5,488)	$	(10,090)	$	(15,578)

Note 16: Recent Accounting Pronouncements

ASU 2016-13 - Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (June 2016)

The main objective of this update is to provide financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date. To achieve this objective, the amendments in this update replace the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates.

The amendments affect entities holding financial assets that are not accounted for at fair value through net income. The amendments affect loans, debt securities, off-balance-sheet credit exposures, and any other financial assets not excluded from the scope that have the contractual right to receive cash. The amendments in this update affect an entity to varying degrees depending on the credit quality of the assets held by the entity, their duration, and how the entity applies current GAAP. There is diversity in practice in applying the incurred loss methodology, which means that before transition some entities may be more aligned under current GAAP than others to the new measure of expected credit losses. The following describes the main provisions of this update.

•Assets Measured at Amortized Cost: The amendments in this update require a financial asset (or a group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset(s) to present the net carrying value at the amount expected to be collected on the financial asset. The statements of income reflect the measurement of credit losses for newly recognized financial assets, as well as the expected increase or decrease of credit losses that have taken place during the period. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. An entity must use judgment in determining the relevant information and estimation methods that are appropriate in its circumstances.

•Available-for-Sale Debt Securities: Credit losses relating to available-for-sale debt securities should be recorded through an allowance for credit losses. Available-for-sale accounting recognizes that value may be realized either through collection of contractual cash flows or through sale of the security. Therefore, the amendments limit the amount of the allowance for credit losses to the amount by which fair value is below amortized cost because the classification as available-for-sale is premised on an investment strategy that recognizes that the investment could be sold at fair value if cash collection would result in the realization of an amount less than fair value.

•In May 2019, the FASB issued ASU 2019-05 - Financial Instruments - Credit Losses (Topic 326) - Targeted Transition Relief. This ASU allows an option for preparers to irrevocably elect the fair value option, on an instrument-by-instrument basis, for eligible financial assets measured at amortized cost basis upon adoption of the credit losses standard. This increases the comparability of financial statement information provided by institutions that otherwise would have reported similar financial instruments using different measurement methodologies, potentially decreasing costs for financial statement preparers while providing more useful information to investors and other users.

For public business entities that are SEC filers, the amendments in this update are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. All entities may early adopt the amendments in this update as of the fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. In October 2019, the FASB voted to delay the effective date for smaller reporting companies to fiscal years beginning after December 15, 2022. An entity will apply the amendments in this update through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective (that is, a modified-retrospective approach). A prospective transition approach is required for debt securities for which an OTTI had been recognized before the effective date. The effect of a prospective transition approach is to maintain the same amortized cost basis before and after the effective date of this update.

The Company does not expect to early adopt and is currently evaluating the impact of the amendments on the Company’s condensed consolidated financial statements. The Company currently cannot determine or reasonably quantify the impact of the adoption of the amendments due to the complexity and extensive changes. The Company intends to develop processes and procedures prior to the effective date to ensure it is fully compliant with the amendments at the adoption date. The Company has formed an implementation committee and has engaged a third-party consultant to assist in developing current expected credit losses (“CECL”) models using appropriate methodologies.

ASU 2017-04 - Intangibles - Goodwill and other (Topic 350) - Simplifying the Test for Goodwill Impairment” (January 2017)

The amendments in this update simplify the goodwill impairment test by eliminating Step 2 of the goodwill impairment process, which requires an entity to determine the implied fair value of its goodwill by assigning fair value to all its assets and liabilities. Under the new guidance, an entity will record an impairment charge if a reporting unit’s carrying amount exceeds its fair value. Entities still have the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment is necessary. The amendments in this ASU are effective for smaller reporting companies for annual and interim impairment tests performed in periods beginning after December 15, 2022. Early adoption is permitted. The Company adopted this guidance effective July 1, 2020 and it did not have a material impact on the condensed consolidated financial statements.

ASU 2018-13 - Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement (August 2018)

The amendments in this update modify the disclosure requirements on fair value measurements in ASC Topic 820. This ASU eliminates the requirements to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels and the valuation processes for Level 3 fair value measurements. In addition, this ASU requires entities that calculate net asset value to disclose the timing of liquidation of an investee’s assets and the date when restrictions from redemption might lapse only if the investee has communicated the timing to the entity or announced the timing publicly. This ASU also adds new requirements, which include the disclosure of the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. The amendments in this ASU are effective for public companies for fiscal years, and interim fiscal periods within those fiscal years, beginning after December 15, 2019. The Company adopted this guidance and it did not have a material impact on the condensed consolidated financial statements.

ASU 2019-04 - Codification Improvements to Topic 326, Financial Instruments - Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments (April 2019)

The amendments in this ASU clarify or correct the guidance in ASC Topic 326, Topic 815 and Topic 825. With respect to Topic 326, ASU 2019-04 addresses a number of issues as it relates to the CECL standard including consideration of accrued interest, recoveries, variable-rate financial instruments, prepayments, extension and renewal options, among other things, in the measurement of expected credit losses. The amendments to Topic 326 have the same effective dates as ASU 2016-13 and the Company is currently evaluating the potential impact of these amendments on the condensed consolidated financial statements. With respect to Topic 815, ASU 2019-04 clarifies issues related to partial-term hedges, hedged debt securities, and transitioning from a quantitative method of assessing hedge effectiveness to a more simplified method. The amendments to Topic 815 are effective for interim and annual reporting periods beginning after December 15, 2019 and are not expected to have a material impact on the condensed consolidated financial statements. With respect to Topic 825, ASU 2019-04 addresses the scope of the guidance, the requirement for remeasurement under ASC Topic 820 when using the measurement alternative, certain disclosure requirements, and which equity securities must be remeasured at historical exchanges rates. The amendments to Topic 825 are effective for interim and annual reporting periods beginning after December 15, 2019 and are not expected to have a material impact on the condensed consolidated financial statements.

Coronavirus Aid, Relief and Economic Security Act (“CARES Act”)

In March 2020 in connection with the implementation of the CARES Act and related provisions, the Company elected the temporary relief in the CARES Act not to apply the guidance in ASC 310-40 on accounting for TDRs to loan modifications related to COVID-19. Section 4013 of the CARES Act further provides that loan modifications due to the impact of COVID-19 that would otherwise be classified as TDRs under GAAP will not be so classified. Modifications within the scope of this relief are in effect from the period beginning March 1, 2020 until the earlier of December 31, 2020 or 60 days after the date on which the national emergency related to the COVID-19 pandemic formally terminates. See the “Non-TDR Loan Modifications due to COVID-19” section of Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations for more information.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and related notes appearing elsewhere in this report. This discussion and analysis includes certain forward-looking statements that involve risks, uncertainties, and assumptions. You should review the “Risk Factors” sections of this report, our Quarterly Report on Form 10-Q for the quarter ended March 31, 2020 and our Annual Report on Form 10-K for the year ended December 31, 2019 for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by such forward-looking statements. See also “Cautionary Note Regarding Forward-Looking Statements” at the beginning of this report.

Overview

First Internet Bancorp (“we,” “our,” “us,” or the “Company”) is a bank holding company that conducts its primary business activities through its wholly owned subsidiary, First Internet Bank of Indiana, an Indiana chartered bank (the “Bank”). The Bank was the first state-chartered, Federal Deposit Insurance Corporation (“FDIC”) insured Internet bank and commenced banking operations in 1999. The Company was incorporated under the laws of the State of Indiana on September 15, 2005. On March 21, 2006, we consummated a plan of exchange by which we acquired all of the outstanding shares of the Bank.

The Bank has three wholly owned subsidiaries. First Internet Public Finance Corp. provides a range of public and municipal finance lending and leasing products to governmental entities throughout the United States and acquires securities issued by state and local governments and other municipalities. JKH Realty Services, LLC, manages other real estate owned (“OREO”) properties as needed. SPF15, Inc. is a real estate holding company.

We offer a wide range of commercial, small business, consumer and municipal banking products and services. We conduct our consumer and small business deposit operations primarily through online channels on a nationwide basis and have no traditional branch offices. Our residential mortgage products are offered nationwide primarily through an online direct-to-consumer platform and are supplemented with Central Indiana-based mortgage and construction lending. Our consumer

lending products are primarily originated on a nationwide basis over the Internet, as well as through relationships with dealerships and financing partners.

Our commercial banking products and services are delivered through a relationship banking model and include commercial real estate (“CRE”) banking, commercial and industrial (“C&I”) banking, public finance, healthcare finance, small business lending and commercial deposits and treasury management. Through our CRE team, we offer single tenant lease financing on a nationwide basis in addition to traditional investor CRE and construction loans primarily within Central Indiana and adjacent markets. To meet the needs of commercial borrowers and depositors located primarily in Central Indiana, Phoenix, Arizona and adjacent markets, our C&I banking team provides credit solutions such as lines of credit, term loans, owner-occupied CRE loans and corporate credit cards. Our public finance team provides a range of public and municipal lending and leasing products to government entities on a nationwide basis. Our healthcare finance team was established in conjunction with our strategic partnership with Lendeavor, Inc., a San Francisco-based technology-enabled lender to healthcare practices, and provides lending for healthcare practice finance or acquisition, acquisition or refinancing of owner-occupied CRE and equipment purchases. This portfolio segment is generally concentrated in the Western and Southwestern regions of the United States with plans to continue expanding nationwide. Our commercial deposits and treasury management team works with the other commercial teams to provide deposit products and treasury management services to our commercial and municipal lending customers as well as pursues commercial deposit opportunities in business segments where we have no credit relationships.

In 2018, we identified small business as an area for potential growth in loans, revenue and deposits. We believe that we can differentiate ourselves from larger financial institutions through providing a full suite of services to emerging small businesses and entrepreneurs. We have been focused on adding experienced personnel to build out our capabilities in small business lending and U.S. government guaranteed lending programs, including loans originated under the Small Business Administration (“SBA”) guidelines. To accelerate our efforts in this area, on November 1, 2019 we acquired a loan portfolio, a servicing portfolio and a team of experienced SBA professionals from First Colorado National Bank. During 2020, we have continued to hire additional small business sales, credit and operations personnel and plan to continue our efforts in onboarding talent as we build out our nationwide small business platform.

COVID-19 Pandemic

The coronavirus pandemic (“COVID-19”) continues to pose health and economic challenges globally. In response, federal, state and local governments have passed laws and enacted policy changes intended to provide relief to affected businesses and individuals and to stimulate national and local economies. While the effect of COVID-19, including the responses from governmental agencies, did have an impact on our operating results as of June 30, 2020, we believe the impact was consistent with the effect of COVID-19 on the overall banking industry and was minimal on our operations. However, a prolonged outbreak could have an adverse effect on our financial condition and results of operations in future periods. The ultimate impact of COVID-19 on our business remains uncertain as we cannot predict with confidence when the economies in which we operate will return to conditions existing prior to COVID-19. As a result of continued measures to either contain or reduce the impact of COVID-19, we may experience issues that negatively impact our business, such as a decline in the liquidity of our borrowers or volatility in interest rates.

Throughout the COVID-19 pandemic, our top priority has been the health of our team and clients. A significant number of our employees are still working remotely, and for those that continue to come into the office we have implemented social distancing policies and increased cleaning frequency and protocols at all Company locations.

As a digitally-focused institution without branch locations, we were able to continue serving clients when they needed us most, while minimizing operational disruptions caused by COVID-19. Beginning in the first quarter 2020, we offered loan payment deferral programs for clients affected by COVID-19. Loan balances on payment deferral programs peaked in late May 2020. As certain parts of the economy re-opened during the second quarter 2020, loan balances under deferral agreements have been reduced significantly from the peak and all borrowers coming off deferrals have resumed normal payment schedules. As a preferred SBA lender, we also assisted clients by participating in the Paycheck Protection Program (“PPP”). Despite the challenging environment, we have continued to prudently extend credit to both commercial and consumer clients.

U.S. Small Business Administration Paycheck Protection Program

Section 1102 of the CARES Act created the PPP, which is jointly administered by the SBA and the Department of the Treasury. The PPP is designed to provide a direct incentive to small businesses to retain employees on their payroll during COVID-19 as well as to help cover certain utility costs and rent payments. Loans originated under the PPP bear an interest rate of 1.00% and do not require payments for the first six months. Originally, all PPP Loans carried a two-year term, however Congressional amendments to the CARES Act changed the maturity of loans approved after June 5, 2020 to a five-year term. These loans may be forgiven if the loan proceeds were used for payroll costs and other qualifying business expenses as long as a minimum of 60% of the forgiven amount was used to maintain payroll costs. The federal government approved an initial appropriation of $349.0 billion for PPP loans and when that was depleted, approved an additional $310.0 billion. As a preferred SBA lender, we assisted our clients in participating in both rounds of the PPP. Through June 30, 2020, we approved and funded 449 PPP loans totaling $58.9 million to help small businesses maintain their workforces in an uncertain and challenging environment. All of the loans the Company originated have two-year maturities as they were originated prior to June 5, 2020.

Results of Operations

The following table presents a summary of the Company’s financial performance for the last five completed fiscal quarters and the six months ended June 30, 2020 and 2019.


(dollars in thousands except for per share data)	Three Months Ended																												Six Months Ended
				June 30, 2020				March 31, 2020				December 31, 2019				September 30, 2019				June 30, 2019				June 30, 2020				June 30, 2019
Income Statement Summary:
Net interest income	$	14,426			$	15,018			$	15,374			$	15,244			$	16,105			$	29,444			$	32,349
Provision for loan losses	2,491				1,461				468				2,824				1,389				3,952				2,674
Noninterest income	4,973				6,211				5,405				5,558				3,454				11,184				5,826
Noninterest expense	13,244				13,486				12,613				11,203				11,709				26,730				22,818
Income tax (benefit) provision	(268)				263				602				449				340				(5)				866
Net income	$	3,932			$	6,019			$	7,096			$	6,326			$	6,121			$	9,951			$	11,817
Per Share Data:
Earnings per share - basic	$	0.40			$	0.62			$	0.72			$	0.63			$	0.60			$	1.02			$	1.16
Earnings per share - diluted	$	0.40			$	0.62			$	0.72			$	0.63			$	0.60			$	1.02			$	1.16
Dividends declared per share	$	0.06			$	0.06			$	0.06			$	0.06			$	0.06			$	0.12			$	0.12
Book value per common share	$	31.40			$	31.13			$	31.30			$	30.30			$	29.56			$	31.40			$	29.56
Tangible book value per common share ¹	$	30.92			$	30.65			$	30.82			$	29.82			$	29.10			$	30.92			$	29.10
Common shares outstanding	9,799,047				9,801,825				9,741,800				9,741,800				10,016,458				9,799,047				10,016,458
Average common shares outstanding:
Basic	9,768,227				9,721,485				9,825,784				9,979,603				10,148,285				9,798,528				10,182,770
Diluted	9,768,227				9,750,528				9,843,829				9,980,612				10,148,285				9,802,427				10,186,833
Dividend payout ratio ²	15.00		%		9.68		%		8.33		%		9.52		%		10.00		%		11.76		%		10.34		%
Performance Ratios:
Return on average assets	0.37		%		0.59		%		0.69		%		0.63		%		0.65		%		0.47		%		0.64		%
Return on average shareholders’ equity	5.15		%		7.78		%		9.46		%		8.40		%		8.26		%		6.48		%		8.09		%
Return on average tangible common equity ¹	5.23		%		7.90		%		9.61		%		8.53		%		8.39		%		6.58		%		8.22		%
Net interest margin	1.37		%		1.50		%		1.51		%		1.54		%		1.73		%		1.43		%		1.79		%
Net interest margin - FTE ^1,3	1.50		%		1.65		%		1.67		%		1.70		%		1.91		%		1.58		%		1.97		%
Noninterest expense to average assets	1.22		%		1.32		%		1.22		%		1.11		%		1.23		%		0.94		%		1.55		%
Capital Ratios:
Total shareholders’ equity to assets	7.12		%		7.32		%		7.44		%		7.21		%		7.48		%		7.12		%		7.48		%
Tangible common equity to tangible assets ratio ¹	7.01		%		7.22		%		7.33		%		7.10		%		7.37		%		7.01		%		7.37		%
Tier 1 leverage ratio	7.49		%		7.82		%		7.64		%		7.66		%		8.06		%		7.49		%		8.06		%
Common equity tier 1 capital ratio	10.94		%		10.76		%		10.84		%		10.93		%		11.08		%		10.94		%		11.08		%
Tier 1 capital ratio	10.94		%		10.76		%		10.84		%		10.93		%		11.08		%		10.94		%		11.08		%
Total risk-based capital ratio	14.13		%		13.87		%		13.99		%		14.17		%		14.31		%		14.13		%		14.31		%

¹This information represents a non-GAAP financial measure. See “Reconciliation of Non-GAAP Financial Measures” for a reconciliation of this measure to its most directly comparable GAAP measure.

² Dividends per share divided by diluted earnings per share.

³On a fully-taxable equivalent (“FTE”) basis assuming a 21% tax rate. Net interest income is adjusted to reflect income from assets such as municipal loans and securities that are exempt from Federal income taxes. This is to recognize the income tax savings that facilitates a comparison between taxable and tax-exempt assets. The Company believes that it is a standard practice in the banking industry to present net interest margin and net interest income on a fully-taxable equivalent basis, as these measures provide useful information to make peer comparisons.

During the second quarter 2020, net income was $3.9 million, or $0.40 per diluted share, compared to the second quarter 2019 net income of $6.1 million, or $0.60 per diluted share, representing a decrease in net income of $2.2 million, or 35.8%. During the six months ended June 30, 2020, net income was $10.0 million, or $1.02 per diluted share, compared to the six months ended June 30, 2019 net income of $11.8 million, or $1.16 per diluted share, resulting in a decrease in net income of $1.9 million, or 15.8%.

The $2.2 million decrease in net income in the second quarter 2020 compared to the second quarter 2019 was due primarily to a decrease of $1.7 million, or 10.4%, in net interest income, a $1.5 million, or 13.1%, increase in noninterest expense and a $1.1 million, or 79.3%, increase in provision for loan losses, partially offset by a $1.5 million, or 44.0%, increase in noninterest income and a decrease of $0.6 million, or 178.8%, in income tax expense.

The $1.9 million decrease in net income in the six months ended June 30, 2020 compared to the six months ended June 30, 2019 was due primarily to a $3.9 million, or 17.1%, increase in noninterest expense, a $2.9 million, or 9.0%, decrease in net interest income and a $1.3 million, or 47.8% increase in provision for loan losses, partially offset by a $5.4 million, or 92.0%, increase in noninterest income and a $0.9 million, or 100.6%, decrease in income tax expense.

During the second quarter 2020, return on average assets (“ROAA”) and return on average shareholders’ equity (“ROAE”) were 0.37% and 5.15%, respectively, compared to 0.65% and 8.26%, respectively, for the second quarter 2019. During the six months ended June 30, 2020, ROAA and ROAE were 0.47% and 6.48%, respectively, compared to 0.64% and 8.09%, respectively, for the six months ended June 30, 2019. The decrease in ROAA for both the three and six months ended June 30, 2020 compared to the three and six months ended June 30, 2019 was due primarily to the combination of lower net income and the Company’s growth in average assets. The decrease in ROAE during the three and six months ended June 30, 2020 compared to the three and six months ended June 30, 2019 was mainly the result of the combination of lower net income and the Company’s growth in average shareholders’ equity. The increase in average shareholder’s equity was due mainly to an increase in the average balance of retained earnings, but partially offset by an increase in the average balance of accumulated other comprehensive loss.

Consolidated Average Balance Sheets and Net Interest Income Analyses

For the periods presented, the following tables provide the average balances of interest-earning assets and interest-bearing liabilities and the related yields and cost of funds. The tables do not reflect any effect of income taxes except for net interest margin - FTE, as discussed below. Balances are based on the average of daily balances. Nonaccrual loans are included in average loan balances.


(dollars in thousands)	Three Months Ended
	June 30, 2020										March 31, 2020								June 30, 2019
	Average Balance		Interest /Dividends		Yield /Cost		Average Balance		Interest /Dividends		Yield /Cost		Average Balance		Interest /Dividends		Yield /Cost
Assets
Interest-earning assets
Loans, including loans held-for-sale	$	2,989,772	$	29,730	4.00	%	$	2,977,994	$	30,408	4.11	%	$	2,916,076	$	30,842	4.24	%
Securities - taxable	560,947		3,276		2.35	%	531,046		3,619		2.74	%	460,816		3,540		3.08	%
Securities - non-taxable	96,675		457		1.90	%	99,833		572		2.30	%	97,536		668		2.75	%
Other earning assets	594,296		759		0.51	%	415,927		1,645		1.59	%	248,996		1,794		2.89	%
Total interest-earning assets	4,241,690		34,222		3.24	%	4,024,800		36,244		3.62	%	3,723,424		36,844		3.97	%

Allowance for loan losses	(23,388)						(22,059)						(19,275)
Noninterest-earning assets	111,872						97,191						100,872
Total assets	$	4,330,174					$	4,099,932					$	3,805,021

Liabilities
Interest-bearing liabilities
Interest-bearing demand deposits	$	137,487	$	237	0.69	%	$	122,925	$	219	0.72	%	$	117,665	$	214	0.73	%
Regular savings accounts	37,204		92		0.99	%	30,345		78		1.03	%	37,507		106		1.13	%
Money market accounts	1,089,063		3,541		1.31	%	866,605		3,743		1.74	%	592,106		2,995		2.03	%
Certificates and brokered deposits	2,006,966		11,893		2.38	%	2,069,170		13,168		2.56	%	2,131,729		13,832		2.60	%
Total interest-bearing deposits	3,270,720		15,763		1.94	%	3,089,045		17,208		2.24	%	2,879,007		17,147		2.39	%
Other borrowed funds	584,543		4,033		2.77	%	584,465		4,018		2.76	%	548,932		3,592		2.62	%
Total interest-bearing liabilities	3,855,263		19,796		2.07	%	3,673,510		21,226		2.32	%	3,427,939		20,739		2.43	%
Noninterest-bearing deposits	73,758						60,456						42,566
Other noninterest-bearing liabilities	94,285						54,961						37,368
Total liabilities	4,023,306						3,788,927						3,507,873

Shareholders’ equity	306,868						311,005						297,148
Total liabilities and shareholders’ equity	$	4,330,174					$	4,099,932					$	3,805,021

Net interest income			$	14,426					$	15,018					$	16,105

Interest rate spread ¹					1.17%						1.30%						1.54	%
Net interest margin ²					1.37%						1.50%						1.73	%
Net interest margin - FTE ³					1.50%						1.65%						1.91	%

¹Yield on total interest-earning assets minus cost of total interest-bearing liabilities.

² Net interest income divided by total average interest-earning assets (annualized).

³On an FTE basis assuming a 21% tax rate. Net interest income is adjusted to reflect income from assets such as municipal loans and securities that are exempt from Federal income taxes. This is to recognize the income tax savings that facilitates a comparison between taxable and tax-exempt assets. The Company believes that it is a standard practice in the banking industry to present net interest margin and net interest income on a fully-taxable equivalent basis, as these measures provide useful information to make peer comparisons. Net interest margin - FTE represents a non-GAAP financial measure. See “Reconciliation of Non-GAAP Financial Measures” for a reconciliation of this measure to its most directly comparable GAAP measure.


(dollars in thousands)	Six Months Ended
	June 30, 2020										June 30, 2019
	Average Balance		Interest /Dividends		Yield /Cost		Average Balance		Interest /Dividends		Yield /Cost
Assets
Interest-earning assets
Loans, including loans held-for-sale	$	2,983,883	$	60,138	4.05	%	$	2,845,854	$	60,060	4.26	%
Securities - taxable	545,997		6,895		2.54	%	445,006		6,864		3.11	%
Securities - non-taxable	98,254		1,029		2.11	%	95,899		1,352		2.84	%
Other earning assets	505,111		2,404		0.96	%	247,871		3,567		2.90	%
Total interest-earning assets	4,133,245		70,466		3.43	%	3,634,630		71,843		3.99	%

Allowance for loan losses	(22,724)						(18,755)
Noninterest-earning assets	104,532						100,880
Total assets	$	4,215,053					$	3,716,755

Liabilities
Interest-bearing liabilities
Interest-bearing demand deposits	$	130,206	$	456	0.70	%	$	113,582	$	427	0.76	%
Regular savings accounts	33,774		170		1.01	%	38,177		213		1.13	%
Money market accounts	977,834		7,284		1.50	%	577,686		5,747		2.01	%
Certificates and brokered deposits	2,038,068		25,061		2.47	%	2,074,812		26,146		2.54	%
Total interest-bearing deposits	3,179,882		32,971		2.09	%	2,804,257		32,533		2.34	%
Other borrowed funds	584,504		8,051		2.77	%	544,841		6,961		2.58	%
Total interest-bearing liabilities	3,764,386		41,022		2.19	%	3,349,098		39,494		2.38	%
Noninterest-bearing deposits	67,107						42,558
Other noninterest-bearing liabilities	74,623						30,569
Total liabilities	3,906,116						3,422,225

Shareholders’ equity	308,937						294,530
Total liabilities and shareholders’ equity	$	4,215,053					$	3,716,755

Net interest income			$	29,444					$	32,349

Interest rate spread ¹					1.24	%					1.61	%
Net interest margin ²					1.43	%					1.79	%
Net interest margin - FTE ³					1.58	%					1.97	%

¹Yield on total interest-earning assets minus cost of total interest-bearing liabilities.

² Net interest income divided by total average interest-earning assets (annualized).

Rate/Volume Analysis

The following table illustrates the impact of changes in the volume of interest-earning assets and interest-bearing liabilities and interest rates on net interest income for the periods indicated. The change in interest not due solely to volume or rate has been allocated in proportion to the absolute dollar amounts of the change in each.


(dollars in thousands)	Three Months Ended June 30, 2020 vs. March 31, 2020 Due to Changes in										Three Months Ended June 30, 2020 vs. June 30, 2019 Due to Changes in								Six Months Ended June 30, 2020 vs. June 30, 2019 Due to Changes in
	Volume		Rate		Net		Volume		Rate		Net		Volume		Rate		Net
Interest income
Loans, including loans held-for-sale	$	756	$	(1,434)	$	(678)	$	3,978	$	(5,090)	$	(1,112)	$	5,966	$	(5,888)	$	78
Securities – taxable	1,077		(1,420)		(343)		3,092		(3,356)		(264)		2,824		(2,793)		31
Securities – non-taxable	(18)		(97)		(115)		(6)		(205)		(211)		94		(417)		(323)
Other earning assets	3,134		(4,020)		(886)		6,787		(7,822)		(1,035)		5,141		(6,304)		(1,163)
Total	4,949		(6,971)		(2,022)		13,851		(16,473)		(2,622)		14,025		(15,402)		(1,377)

Interest expense
Interest-bearing deposits	5,215		(6,660)		(1,445)		10,289		(11,673)		(1,384)		8,044		(7,606)		438
Other borrowed funds	—		14		14		234		207		441		542		548		1,090
Total	5,215		(6,646)		(1,431)		10,523		(11,466)		(943)		8,586		(7,058)		1,528

Increase (decrease) in net interest income	$	(266)	$	(325)	$	(591)	$	3,328	$	(5,007)	$	(1,679)	$	5,439	$	(8,344)	$	(2,905)

Net interest income for the second quarter 2020 was $14.4 million, a decrease of $1.7 million, or 10.4%, compared to $16.1 million for the second quarter 2019. The decrease in net interest income was primarily the result of a $2.6 million, or 7.1%, decrease in total interest income to $34.2 million for the second quarter 2020 from $36.8 million for the second quarter 2019. The decrease in total interest income was partially offset by a $0.9 million, or 4.5%, decrease in total interest expense to$19.8 million for the second quarter 2020 from $20.7 million for the second quarter 2019.

Net interest income for the six months ended June 30, 2020 was $29.4 million, a decrease of $2.9 million, or 9.0%, compared to $32.3 million for the six months ended June 30, 2019. The decrease in net interest income was the result of a $1.5 million, or 3.9%, increase in total interest expense to $41.0 million for the six months ended June 30, 2020 from $39.5 million for the six months ended June 30, 2019 and a $1.4 million, or 1.9%, decrease in total interest income to $70.5 million for the six months ended June 30, 2020 from $71.8 million for the six months ended June 30, 2019.

The decrease in total interest income for the second quarter 2020 compared to the second quarter 2019 was due to decreases in interest earned on loans, including loans held-for-sale, other earning assets and securities. Interest income earned on loans decreased $1.1 million, or 3.6%, due primarily to a decline of 24 basis points (“bps”) in the yield earned on average loan balances, partially offset by an increase of $73.7 million, or 2.5%, in average loan balances. Interest income earned on other earning assets declined $1.0 million, or 57.7%, due mainly to a 238 bp decline in the yield earned on these assets, partially offset by an increase of $345.3 million, or 138.7%, in the average balance of other earning assets. The increase in other earning assets was due to higher cash balances driven by growth in the average balance of deposits. Additionally, interest income earned on securities decreased $0.5 million, or 11.3%, due to a decline of 74 bps in the yield earned on securities, partially offset by an increase of $99.3 million, or 17.8%, in the average balance of securities.

The decrease in total interest income for the six months ended June 30, 2020 compared to the six months ended June 30, 2019 was due to decreases in interest income earned on other earning assets and securities. Interest income earned on other earning assets decreased $1.2 million, or 32.6%, due to a decline of 194 bps in the yield earned on these assets, partially offset by an increase of $257.2 million, or 103.8%, in the average balance of other earning assets. The increase in other earning assets was due to higher cash balances driven by growth in the average balance of deposits. Interest income earned on securities decreased $0.3 million, or 3.6%, due to a decline of 59 bps in the yield earned on securities, partially offset by an increase of $103.3 million, or 19.1%, in the average balance of securities. Interest income earned on loans, including loans held-for-sale, increased slightly as an increase of $138.0 million, or 4.9%, in the average balance of loans was partially offset by a decline of 21 bps in the yield earned on loans.

Overall, the yield on interest-earning assets for the second quarter 2020 declined 73 bps to 3.24% from 3.97% for the second quarter 2019. Additionally, the yield on interest-earning assets for the six months ended June 30, 2020 declined 56 bps

to 3.43% from 3.99% for the six months ended June 30, 2019. The declines in the yields earned on interest-earning assets were due to the continued decrease in market interest rates from the year-ago periods. Interest rates began declining during 2019 and have declined significantly in 2020 following Federal Reserve interest rate cuts in March 2020 in response to the economic effects of COVID-19. The decline in interest rates negatively impacted the yields earned on variable rate loans, including fixed rate loans that have been effectively converted to variable rate loans through the use of interest rate swap agreements, and new loan originations as well as variable rate securities and cash balances, which were elevated throughout both the second quarter 2020 and the six months ended June 30, 2020 as discussed above.

The decrease in total interest expense for the second quarter 2020 compared to the second quarter 2019 was due to a decrease in interest expense related to certificates and brokered deposits, partially offset by increases in expense related to money market accounts and other borrowed funds. Interest expense on certificates and brokered deposits decreased $1.9 million, or 14.2%, due to a decline of 22 bps in the cost of these deposits as well as a $124.8 million, or 5.9%, decrease in the average balance of these deposits. The decrease in certificates and brokered deposit balances was driven by the Company’s pricing strategy to reduce the level of these higher cost deposits. The increase in expense related to money market accounts of $0.5 million, or 18.2%, was driven by an increase of $497.0 million, or 83.9%, in the average balance of these deposits, partially offset by a decline of 72 bps in the cost of these deposits. Money market balances have increased throughout 2020 as consumers, small businesses and commercial clients have increased cash balances due to the economic uncertainty resulting from COVID-19. The increase in expense related to other borrowed funds of $0.4 million, or 12.3%, was due to the impact of the 2029 Notes (subordinated debt) issued in June 2019 with an aggregate principal amount of $37.0 million and an initial fixed interest rate of 6.00%.

The increase in total interest expense for the six months ended June 30, 2020 compared to the six months ended June 30, 2019 was due to increases in interest expense on money market accounts and other borrowed funds, partially offset by a decrease in interest expense related to certificates and brokered deposits. Interest expense on money market accounts increased $1.5 million, or 26.7%, driven by an increase of $400.1 million, or 69.3%, in the average balance of these deposits, partially offset by a decline of 51 bps in the cost of these deposits. Money market balances have increased throughout 2020 as consumers, small businesses and commercial clients have increased cash balances due to the economic uncertainty resulting from COVID-19. The increase in expense related to other borrowed funds of $1.1 million, or 15.7%, was due to the impact of the issuance of the 2029 Notes discussed above. The decrease in expense related to certificates and brokered deposits of $1.1 million, or 4.2%, was due to a decline of 7 bps in the cost of these deposits as well as a $36.7 million, or 1.8%, decrease in the average balance of these deposits.

Overall, the cost of total interest-bearing liabilities for the second quarter 2020 declined 36 bps to 2.07% from 2.43% for the second quarter 2019. Additionally, the cost of total interest-bearing liabilities for the six months ended June 30, 2020 declined 19 bps to 2.19% from 2.38% for the six months ended June 30, 2019. Similar to asset yields, the declines in the cost of funds were due to the continued decrease in market interest rates from the year-ago periods. The sharp declines in both short- and long-term interest rates due to COVID-19 have allowed the Company to reprice all of its deposit products at lower rates. Furthermore, a shift in the deposit composition from higher cost certificates and brokered deposits to lower cost money market accounts also contributed to the decline in the cost of deposit funding.

Net interest margin (“NIM”) was 1.37% for the second quarter 2020 compared to 1.73% for the second quarter 2019. On a fully-taxable equivalent basis, NIM was 1.50% for the second quarter 2020 compared to 1.91% for the second quarter 2019.

NIM was 1.43% for the six months ended June 30, 2020 compared to 1.79% for the six months ended June 30, 2019. On a fully-taxable equivalent basis, NIM was 1.58% for the six months ended June 30, 2020 compared to 1.97% for the six months ended June 30, 2019.

The decrease in NIM reflects the greater decline in asset yields compared to the decline in the cost of funds during the applicable periods. Following the Federal Reserve’s interest rate cuts in March 2020 in response to COVID-19, variable rate assets tied to market rates repriced faster than deposits. However, as the pace of short-term market interest rate declines has slowed over the course of the second quarter 2020, the Company believes that yields on interest-earning assets have largely stabilized. Furthermore, the Company has approximately $1.0 billion of certificates and brokered deposits with a weighted average cost of 2.18% that mature over the next twelve months. As the weighted average cost of these deposits is significantly higher than current new production costs, the Company expects the cost of deposit funding to continue to decline.

Noninterest Income

The following table presents noninterest income for the last five completed fiscal quarters and the six months ended June 30, 2020 and 2019.


(in thousands)	Three Months Ended														Six Months Ended
	June 30, 2020		March 31, 2020		December 31, 2019		September 30, 2019		June 30, 2019		June 30, 2020		June 30, 2019
Service charges and fees	$	182	$	212	$	213	$	211	$	225	$	394	$	461
Loan servicing revenue	255		251		166		—		—		506		—
Loan servicing asset revaluation	(90)		(179)		—		—		—		(269)		—
Mortgage banking activities	3,408		3,668		2,953		4,307		2,664		7,076		4,281
Gain (loss) on sale of loans	762		1,801		1,721		523		(66)		2,563		(170)
Gain (loss) on sale of securities	—		41		—		—		(458)		41		(458)
Other	456		417		352		517		1,089		873		1,712
Total noninterest income	$	4,973	$	6,211	$	5,405	$	5,558	$	3,454	$	11,184	$	5,826

During the second quarter 2020, noninterest income was $5.0 million, representing an increase of $1.5 million, or 44.0%, compared to $3.5 million for the second quarter 2019. The increase in noninterest income was due primarily to increases in revenue from mortgage banking activities, gain on sale of loans, gain on sale of securities and loan servicing revenue, which were partially offset by lower other income. The increase in mortgage banking revenue was due mainly to an increase in mandatory pipeline and best efforts sales volumes as the year-over-year decline in market interest rates drove increased origination activity. The increase in gain on sale of loans was due to the Company selling $11.5 million of SBA 7(a) guaranteed loans during the second quarter 2020, recognizing a net gain of $0.8 million, as compared to a $0.1 million net loss on the sale of loans in the second quarter 2019. The increase in gain on sale of securities was due to the sale of lower-yielding mortgage-backed and U.S. Government Agency securities in the second quarter 2019 that resulted in a loss of $0.5 million, compared to no sales of securities in the second quarter 2020. Additionally, compared to the second quarter 2019, the Company recognized $0.2 million of loan servicing revenue, net of the loan servicing asset revaluation, in the second quarter 2020, in connection with the SBA 7(a) servicing portfolio acquired in the fourth quarter 2019. The decrease in other noninterest income was due primarily to the Company recognizing a $0.5 million gain on the sale of its ownership of Visa Class B shares in the second quarter 2019.

During the six months ended June 30, 2020, noninterest income was $11.2 million, an increase of $5.4 million, or 92.0%, from the six months ended June 30, 2019. The increase in noninterest income was due primarily to increases in revenue from mortgage banking activities, gain on sale of loans, loan servicing revenue and gain on sale of securities, which were partially offset by a decrease in other income. The increase in mortgage banking revenue was due mainly to an increase in mandatory pipeline and best efforts sales volumes as the year-over-year decline in market interest rates drove increased origination activity. The increase in gain on sale of loans was due to sales of portfolio loans with book values totaling $185.1 million that resulted in a gain of $1.3 million, as well as a gain of $1.2 million on the sale of SBA 7(a) guaranteed loans during the six months ended June 30, 2020 compared to the Company selling portfolio loans with book values of $148.4 million that resulted in a net loss of $0.2 million during the six months ended June 30, 2019. The increase in gain on sale of securities was due to a gain of less than $0.1 million being recorded during the six months ended June 30, 2020 compared to the six months ended June 30, 2019 when the Company sold lower-yielding mortgage-backed and U.S. Government Agency securities that resulted in a loss of $0.5 million. The Company also recognized loan servicing revenue, net of servicing asset revaluation, of $0.2 million, during the six months ended June 30, 2020, in connection with the SBA 7(a) servicing portfolio acquired in the fourth quarter 2019. The decrease in other noninterest income was mainly the result of income recognized in the prior year associated with the sale of the Company’s Visa Class B shares and income associated with the Company’s temporary ownership of the land associated with the Company’s new headquarters. Refer to Note 11 to the condensed consolidated financial statements for additional information about the Company’s new headquarters.

Noninterest Expense

The following table presents noninterest expense for the last five completed fiscal quarters and the six months ended June 30, 2020 and 2019.


(in thousands)	Three Months Ended														Six Months Ended
	June 30, 2020		March 31, 2020		December 31, 2019		September 30, 2019		June 30, 2019		June 30, 2020		June 30, 2019
Salaries and employee benefits	$	7,789	$	7,774	$	7,168	$	6,883	$	6,642	$	15,563	$	12,963
Marketing, advertising and promotion	411		375		409		456		466		786		935
Consulting and professional services	932		1,177		1,242		778		835		2,109		1,649
Data processing	339		375		312		381		328		714		645
Loan expenses	399		599		289		247		292		998		606
Premises and equipment	1,602		1,625		1,556		1,506		1,497		3,227		2,997
Deposit insurance premium	435		485		601		—		747		920		1,302

Other	1,337		1,076		1,036		952		902		2,413		1,721
Total noninterest expense	$	13,244	$	13,486	$	12,613	$	11,203	$	11,709	$	26,730	$	22,818

Noninterest expense for the second quarter 2020 was $13.2 million, compared to $11.7 million for the second quarter 2019. The increase of $1.5 million, or 13.1%, compared to the second quarter 2019 was due primarily to increases of $1.1 million in salaries and employee benefits and $0.4 million in other expenses. The increase in salaries and employee benefits was due mainly to an increase in headcount, which includes the impact of personnel growth associated with the Company’s small business lending platform, as well as increased mortgage and small business lending incentive compensation. The increase in other expenses was due primarily to a $0.3 million charitable contribution the Company made to assist small businesses and nonprofits address the economic challenges of the COVID-19 pandemic.

Noninterest expense for the six months ended June 30, 2020 was $26.7 million, compared to $22.8 million for the six months ended June 30, 2019. The increase of $3.9 million, or 17.1%, compared to the six months ended June 30, 2019 was due primarily to increases of $2.6 million in salaries and employee benefits, $0.7 million in other expenses, $0.5 million in consulting and professional services, $0.4 million in loan expenses, and $0.2 million in premises and equipment, partially offset by a decrease of $0.4 million in deposit insurance premium. The increase in salaries and employee benefits was primarily the result of personnel growth, mostly associated with the Company’s small business lending platform, as well as increased mortgage and small business lending incentive compensation. The increase in other expenses was due primarily to the $0.3 million charitable contribution mentioned above. The increase in consulting and professional services was due primarily to increased recruitment costs and directors’ fees. The increase in loan expenses was driven primarily by costs associated with nonperforming loans. The increase in premises and equipment was due primarily to higher software expense. The decrease in deposit insurance premium was due primarily to declines in the balance of brokered deposits and year-over-year asset growth, both of which positively impact the formula used to calculate deposit insurance expense.

The Company recorded an income tax benefit of $0.3 million for the second quarter 2020, compared to a $0.3 million income tax provision and an effective tax rate of 5.3% for the second quarter 2019. The Company’s income tax benefit was less than $0.1 million for the six months ended June 30, 2020, compared to a $0.9 million income tax provision and an effective tax rate of 6.8% for the six months ended June 30, 2019. The decrease in income tax provision for the three months ended June 30, 2020 compared to the three months ended June 30, 2019 was due primarily to lower income before income taxes in the 2020 period. The decrease in the income tax provision for the six months ended June 30, 2020 compared to the six months ended June 30, 2019 was due to lower income before income taxes, as well as the impact of the CARES Act, which was signed into law on March 27, 2020. The CARES Act provided the opportunity to carryback certain federal net operating losses based on the difference between the current statutory rate and the statutory rate in effect during the period to which the net operating loss will be carried back.

Financial Condition

The following table presents summary balance sheet data for the last five completed fiscal quarters.


(in thousands)
Balance Sheet Data:	June 30, 2020		March 31, 2020		December 31, 2019		September 30, 2019		June 30, 2019
Total assets	$	4,324,600	$	4,168,146	$	4,100,083	$	4,095,491	$	3,958,829
Loans	2,973,674		2,892,093		2,963,547		2,881,272		2,861,156
Total securities	657,312		675,013		602,730		591,549		558,160


Loans held-for-sale	38,813		52,394		56,097		41,119		30,642
Noninterest-bearing deposits	82,864		70,562		57,115		50,560		44,040
Interest-bearing deposits	3,297,925		3,107,944		3,096,848		3,097,682		2,962,223
Total deposits	3,380,789		3,178,506		3,153,963		3,148,242		3,006,263
Advances from Federal Home Loan Bank	514,913		514,911		514,910		514,908		514,906
Total shareholders’ equity	307,711		305,127		304,913		295,140		296,120

Total assets increased $224.5 million, or 5.5%, to $4.3 billion at June 30, 2020 compared to $4.1 billion at December 31, 2019. Balance sheet growth was driven by an increase in deposits of $226.8 million, or 7.2%. As loan balances remained relatively consistent since December 31, 2019, the deposit growth resulted in an increase in liquid assets as cash balances increased $171.3 million, or 52.3%, and securities balances increased $54.6 million, or 9.1%. The increase in balance sheet liquidity was reflected in the percentage of loans to deposits, which declined to 88.0% as of June 30, 2020, compared to 94.0% as of December 31, 2019.

Loan Portfolio Analysis

The following table presents a summary of the Company’s loan portfolio for the last five completed fiscal quarters.


(dollars in thousands)	June 30, 2020						March 31, 2020						December 31, 2019						September 30, 2019		June 30, 2019
Commercial loans
Commercial and industrial	$	81,687	2.7	%	$	95,227	3.3	%	$	96,420	3.3	%	$	83,481	2.9	%	$	101,218	3.5	%
Owner-occupied commercial real estate⁽¹⁾	86,897		2.9	%	87,957		3.0	%	86,726		2.9	%	86,357		3.0	%	83,979		2.9	%
Investor commercial real estate	13,286		0.4	%	13,421		0.5	%	12,567		0.4	%	11,852		0.4	%	21,179		0.7	%
Construction	77,591		2.6	%	64,581		2.2	%	60,274		2.0	%	54,131		1.9	%	47,849		1.7	%
Single tenant lease financing	980,292		33.0	%	972,275		33.6	%	995,879		33.6	%	1,008,247		35.0	%	1,001,196		35.1	%
Public finance	647,107		21.8	%	627,678		21.7	%	687,094		23.2	%	686,622		23.8	%	706,161		24.7	%
Healthcare finance	380,956		12.8	%	372,266		12.9	%	300,612		10.1	%	251,530		8.6	%	212,351		7.4	%
Small business lending⁽¹⁾	118,526		4.0	%	54,055		1.9	%	46,945		1.6	%	11,597		0.4	%	8,925		0.3	%
Total commercial loans	2,386,342		80.2	%	2,287,460		79.1	%	2,286,517		77.1	%	2,193,817		76.0	%	2,182,858		76.3	%
Consumer loans
Residential mortgage	208,728		7.0	%	218,730		7.6	%	313,849		10.6	%	320,451		11.1	%	318,678		11.1	%
Home equity	22,640		0.8	%	23,855		0.8	%	24,306		0.8	%	25,042		0.9	%	26,825		0.9	%
Other consumer	291,632		9.8	%	296,605		10.2	%	295,309		10.0	%	296,573		10.4	%	294,251		10.4	%
Total consumer loans	523,000		17.6	%	539,190		18.6	%	633,464		21.4	%	642,066		22.4	%	639,754		22.4	%
Net deferred loan origination costs, premiums and discounts on purchased loans and other ⁽²⁾	64,332		2.2	%	65,443		2.3	%	43,566		1.5	%	45,389		1.6	%	38,544		1.3	%
Total loans	2,973,674		100.0	%	2,892,093		100.0	%	2,963,547		100.0	%	2,881,272		100.0	%	2,861,156		100.0	%
Allowance for loan losses	(24,465)				(22,857)				(21,840)				(21,683)				(19,976)
Net loans	$	2,949,209			$	2,869,236			$	2,941,707			$	2,859,589			$	2,841,180

⁽¹⁾ As of December 31, 2019, the Company held $13.3 million of SBA 7(a) 504 loans which were classified within the small business lending category. In the second quarter 2020, those balances were reclassified into the owner-occupied commercial real estate category.

⁽²⁾ Includes carrying value adjustments of $46.0 million related to terminated interest rate swaps associated with public finance loans as of June 30, 2020 and $44.6 million, $21.4 million, $27.6 million and $22.2 million as of March 31, 2020, December 31, 2019, September 30, 2019 and June 30, 2019, respectively, related to interest rate swaps associated with public finance loans.

Total loans were $3.0 billion as of June 30, 2020, an increase of $10.1 million, or 0.3%, compared to December 31, 2019. Total commercial balances were $2.4 billion as of June 30, 2020, up slightly from $2.3 billion in December 31, 2019. Compared to December 31, 2019, production in healthcare finance, small business lending and construction was partially offset by lower balances in the public finance and single tenant lease financing loan portfolios due primarily to sales of $94.4 million of loans in these categories during the first quarter 2020. The growth in small business lending was driven by $58.9 million of PPP loan balances originated during the second quarter 2020, partially offset by sales of SBA 7(a) guaranteed loans. The Company did not execute any portfolio loan sales during the second quarter 2020 due to market conditions resulting from COVID-19; however, it expects to resume portfolio loan sales in the future to help further its objectives of managing balance sheet growth and capital, providing liquidity and improving NIM and profitability.

Total consumer loan balances were $523.0 million as of June 30, 2020, a decrease of $110.5 million, or 17.4%, compared to December 31, 2019. The decline in consumer loan balances from December 31, 2019 was due primarily to the sale of $90.8 million of portfolio residential mortgage loans, which included seasoned lower-yielding loans.

The Company has identified loan exposures to certain industries that may be impacted by COVID-19. Our healthcare finance portfolio, which represents 12.8% of our total loan portfolio, is comprised primarily of loans to dentists and other specialists that have been impacted by government actions to contain COVID-19 occurring late in the first quarter 2020 and into the second quarter 2020. As certain states reopened their economies later in the second quarter 2020, we experienced a

decline in healthcare finance loan balances under deferral agreements. See “Non-TDR Loan Modifications due to COVID-19” below for additional information on this portfolio.

Within the rest of the portfolio, as of June 30, 2020, additional exposures represent approximately 17.7% of our total loan portfolio and include full-service restaurants of $221.1 million, quick-service restaurants of $229.8 million, consumer services of $35.7 million, healthcare and social assistance of $21.2 million and hotels and accommodations of $16.8 million. Given the economic uncertainty related to COVID-19, the ultimate impact of the pandemic on these exposures is unknown at this time. We currently have no exposure to other highly impacted industries such as airlines, cruise ships, oil & gas or multifamily lending.

Asset Quality

Nonperforming loans are comprised of nonaccrual loans and loans 90 days past due and accruing. Nonperforming assets include nonperforming loans, OREO and other nonperforming assets, which consist of repossessed assets. The following table provides a summary of the Company’s nonperforming assets for the last five completed fiscal quarters.


(dollars in thousands)	June 30, 2020			March 31, 2020			December 31, 2019			September 30, 2019			June 30, 2019
Nonaccrual loans
Commercial loans:
Commercial and industrial	$	299		$	218		$	226		$	585		$	1,604
Owner-occupied commercial real estate	2,066			1,390			464			465			478


Single tenant lease financing	4,680			4,680			4,680			4,691			—

Total commercial loans	7,045			6,288			5,370			5,741			2,082
Consumer loans:
Residential mortgage	1,042			991			761			—			3,134

Other consumer	108			39			33			41			49
Total consumer loans	1,150			1,030			794			41			3,183
Total nonaccrual loans	8,195			7,318			6,164			5,782			5,265

Past Due 90 days and accruing loans
Commercial loans:
Commercial and industrial	—			73			—			—			—




Total commercial loans	—			73			—			—			—
Consumer loans:
Residential mortgage	—			51			568			—			121

Other consumer	—			1			—			1			—
Total consumer loans	—			52			568			1			121
Total past due 90 days and accruing loans	—			125			568			1			121

Total nonperforming loans	8,195			7,443			6,732			5,783			5,386

Other real estate owned
Investor commercial real estate	2,065			2,065			2,065			2,066			2,066
Residential mortgage	—			—			—			553			553
Total other real estate owned	2,065			2,065			2,065			2,619			2,619

Other nonperforming assets	44			114			75			95			36

Total nonperforming assets	$	10,304		$	9,622		$	8,872		$	8,497		$	8,041

Total nonperforming loans to total loans	0.28		%	0.26		%	0.23		%	0.20		%	0.19		%
Total nonperforming assets to total assets	0.24		%	0.23		%	0.22		%	0.21		%	0.20		%
Allowance for loan losses to total loans	0.82		%	0.79		%	0.74		%	0.75		%	0.70		%
Allowance for loan losses to total loans, excluding PPP loans⁽¹⁾	0.84		%	0.79		%	0.74		%	0.75		%	0.70		%
Allowance for loan losses to nonperforming loans	298.5		%	307.1		%	324.4		%	374.9		%	370.9		%

¹This information represents a non-GAAP financial measure. See “Reconciliation of Non-GAAP Financial Measures” for a reconciliation of this measure to its most directly comparable GAAP measure.

Troubled Debt Restructurings

The following table provides a summary of troubled debt restructurings for the last five completed fiscal quarters.


(in thousands)	June 30, 2020		March 31, 2020		December 31, 2019		September 30, 2019		June 30, 2019
Troubled debt restructurings – nonaccrual	$	854	$	94	$	94	$	171	$	174
Troubled debt restructurings – performing	372		378		427		470		1,985
Total troubled debt restructurings	$	1,226	$	472	$	521	$	641	$	2,159

The increase in nonperforming loans of $1.5 million, or 21.7%, to $8.2 million as of June 30, 2020 compared to $6.7 million as of December 31, 2019 was due primarily to an increase in nonperforming owner-occupied commercial real estate loans with unpaid principal balanced of $1.6 million that were placed on nonaccrual status during 2020, partially offset by a decrease in accruing residential mortgage loans that were 90 days past due. Total nonperforming assets increased $1.4 million, or 16.1%, as of June 30, 2020 compared to December 31, 2019. The ratio of nonperforming loans to total loans increased to 0.28% as of June 30, 2020 compared to 0.23% as of December 31, 2019 and the ratio of nonperforming assets to total assets increased to 0.24% as of June 30, 2020 compared to 0.22% as of December 31, 2019, due primarily to the loans mentioned above.

Total TDRs as of June, 2020 were $1.2 million, up $0.7 million from December 31, 2019. The increase was driven by one residential mortgage loan that became a TDR during the second quarter 2020.

As of June 30, 2020 and December 31, 2019, the Company had one commercial property in OREO with a carrying value of $2.1 million. This property consists of two buildings that are residential units adjacent to a university campus.

As of June 30, 2020, our financial results have reflected little impact on asset quality as a result of COVID-19. Actions taken to either contain or reduce the impact of the pandemic have had a detrimental effect on the national and our local economies. The ultimate impact it may have on our business and asset quality is still uncertain; however, we remain optimistic that the combination of government stimulus programs and relief programs we have provided to our clients will lessen the economic stress on our borrowers. However, if the pandemic extends for a prolonged period of time, we may experience negative trends in nonperforming loans and assets.

Non-TDR Loan Modifications due to COVID-19

Additionally, Section 4013 of the CARES Act further provides that loan modifications due to the impact of COVID-19 that would otherwise be classified as TDRs under GAAP will not be so classified. Modifications within the scope of this relief are in effect from the period beginning March 1, 2020 until the earlier of December 31, 2020 or 60 days after the date on which the national emergency related to the COVID-19 pandemic formally terminates.

In accordance with this guidance, the Company has offered modifications to borrowers who were both impacted by COVID-19 and current on all principal and interest payments.

The following table shows the Company’s deferrals by loan portfolio type that have been granted through July 31, 2020. The balances shown are as of June 30, 2020.


(dollars in thousands)	Deferrals		Total Loan Balance		% Of Balances With Deferrals
Commercial loans
Commercial and industrial	$	517	$	81,687	0.6	%
Owner-occupied commercial real estate	14,929		86,897		17.2	%
Investor commercial real estate	411		13,286		3.1	%
Construction	—		77,591		0.0	%
Single tenant lease financing	276,716		980,292		28.2	%
Public finance	—		647,107		0.0	%
Healthcare finance	20,631		380,956		5.4	%
Small business lending	1,823		118,526		1.5	%
Total commercial loans	315,027		2,386,342		13.2	%
Consumer loans
Residential mortgage	6,393		208,728		3.1	%
Home equity	229		22,640		1.0	%
Other consumer	1,692		291,632		0.6	%
Total consumer loans	8,314		523,000		1.6	%

Total commercial and consumer loans	$	323,341	$	2,909,342	11.1	%

The single tenant lease financing and healthcare finance portfolios comprise approximately 92% of the total loan deferrals granted as of July 31, 2020. Borrowers in these portfolios have experienced short-term cash flow challenges due to broad-based federal and state government actions to contain COVID-19. Within the single tenant lease financing portfolio, the portfolio average loan-to-value ratio is 54% and all borrowers, except for the single relationship on nonaccrual status, made their April 2020 loan payments in a timely manner, prior to entering a deferral program. Furthermore, a significant majority of these loans are scheduled to resume making payments in August 2020 and there are no delinquencies for nonperforming loans not on deferral status. Related to the healthcare finance portfolio, over 90% of the loans are made to dental practices, many of which have been allowed to resume seeing patients as certain states across the country have reopened their economies. The amount of healthcare finance loans on deferral status peaked in late May when approximately 80% of this portfolio balance was under deferral. As of July 31, 2020, this percentage had dropped to 5.4%. The majority of healthcare finance loans under deferral listed above are scheduled to resume making payments within the next 30 days. Furthermore, all borrowers who have come off a deferral program have resumed making scheduled loan payments in a timely manner.

U.S. Small Business Administration Paycheck Protection Program

Section 1102 of the CARES Act created the PPP, which is jointly administered by the U.S. Small Business Administration (“SBA”) and the Department of the Treasury. Loans originated under the PPP bear an interest rate of 1.00% and do not require payments for the first six months. Originally, all PPP Loans carried a two-year term; however, Congressional amendments to the CARES Act changed the maturity of loans approved after June 5, 2020 to a five-year term. The PPP is designed to provide a direct incentive to small businesses to retain employees on their payroll during COVID-19 as well as to help cover certain utility costs and rent payments. These loans may be forgiven if the funds were used for payroll costs and other qualifying business expenses as long as a minimum of 60% of the forgiven amount was used to maintain payroll costs. The federal government approved an initial appropriation of $349.0 billion for PPP loans and when that was depleted approved an additional $310.0 billion. As a preferred SBA lender, we assisted our clients in participating in both rounds of the PPP. Through June 30, 2020, we provided 449 PPP loans totaling $58.9 million, to help small businesses maintain their workforces in an uncertain and challenging environment. The weighted average fee was 3.86% of the amount funded, or approximately $2.3 million in total. The Company received this fee revenue from the SBA in late June and it will be deferred over the life of the PPP loans and recognized as interest income.

Allowance for Loan Losses

The following table provides a rollforward of the allowance for loan losses for the last five completed fiscal quarters.


(dollars in thousands)	Three Months Ended
	June 30, 2020			March 31, 2020			December 31, 2019			September 30, 2019			June 30, 2019
Balance, beginning of period	$	22,857		$	21,840		$	21,683		$	19,976		$	18,841
Provision charged to expense	2,491			1,461			468			2,824			1,389
Losses charged off	(1,016)			(498)			(409)			(1,182)			(337)
Recoveries	133			54			98			65			83
Balance, end of period	$	24,465		$	22,857		$	21,840		$	21,683		$	19,976

Net charge-offs to average loans	0.12		%	0.06		%	0.04		%	0.15		%	0.05		%

The allowance for loan losses was $24.5 million as of June 30, 2020, compared to $21.8 million as of December 31, 2019. While total loan balances experienced a slight increase of $10.2 million, or 0.3%, compared to December 31, 2019, the Company made additional adjustments to qualitative factors in its allowance model to reflect the continued economic uncertainty resulting from COVID-19. As a result, both the allowance for loan losses and the allowance as a percentage of total loans increased compared to December 31, 2019. During the second quarter 2020, the Company recorded net charge-offs of $0.9 million, compared to net charge-offs of $0.3 million for the second quarter 2019. The increase in net charge-offs was due primarily to a $0.7 million charge-off in the healthcare finance portfolio.

The allowance for loan losses as a percentage of total loans was 0.82% at June 30, 2020, or 0.84% when excluding PPP Loans, and 0.74% at December 31, 2019. The allowance for loan losses as a percentage of nonperforming loans decreased to 298.5% as of June 30, 2020, compared to 324.4% as of December 31, 2019. The provision for loan losses in the second quarter 2020 was $2.5 million, compared to $1.4 million for the second quarter 2019. The increase of 1.1 million, or 79.3%, compared to the second quarter 2019 was due primarily to the healthcare finance charge-off discussed above and adjustments to the economic qualitative factors in the allowance model discussed above.

Investment Securities Portfolio

The following tables present the amortized cost and approximate fair value of our investment portfolio by security type for the last five completed fiscal quarters.


(in thousands)
Amortized Cost	June 30, 2020		March 31, 2020		December 31, 2019		September 30, 2019		June 30, 2019
Securities available-for-sale
U.S. Government-sponsored agencies	$	68,203	$	71,387	$	77,715	$	83,024	$	89,088
Municipal securities	91,906		94,981		97,447		96,076		96,202
Agency mortgage-backed securities	275,433		279,458		264,142		278,327		257,050
Private label mortgage-backed securities	101,110		114,363		63,704		45,969		40,695
Asset-backed securities	5,000		5,000		5,000		5,000		5,000
Corporate securities	48,394		43,378		38,632		38,638		38,644

Total available-for-sale	590,046		608,567		546,640		547,034		526,679
Securities held-to-maturity
Municipal securities	14,603		14,617		10,142		10,145		10,147
Corporate securities	53,692		51,714		51,736		36,662		25,679
Total held-to-maturity	68,295		66,331		61,878		46,807		35,826
Total securities	$	658,341	$	674,898	$	608,518	$	593,841	$	562,505


(in thousands)
Approximate Fair Value	June 30, 2020		March 31, 2020		December 31, 2019		September 30, 2019		June 30, 2019
Securities available-for-sale
U.S. Government-sponsored agencies	$	66,544	$	70,004	$	75,872	$	81,435	$	87,737
Municipal securities	90,562		94,819		97,652		97,942		96,988
Agency mortgage-backed securities	278,530		282,632		261,440		277,530		254,876
Private label mortgage-backed securities	101,925		115,024		63,613		46,459		41,112
Asset-backed securities	4,837		4,713		4,955		4,931		4,928
Corporate securities	46,619		41,490		37,320		36,445		36,693

Total available-for-sale	589,017		608,682		540,852		544,742		522,334
Securities held-to-maturity
Municipal securities	15,274		15,678		10,368		10,490		10,296
Corporate securities	53,878		53,790		52,192		37,065		25,992
Total held-to-maturity	69,152		69,468		62,560		47,555		36,288
Total securities	$	658,169	$	678,150	$	603,412	$	592,297	$	558,622

The approximate fair value of available-for-sale investment securities increased $48.1 million, or 8.9%, to $589.0 million as of June 30, 2020, compared to $540.9 million as of December 31, 2019. The increase was due primarily to increases of $38.3 million in private label mortgage-backed securities and $17.1 million in agency mortgage-backed securities. These increases were driven primarily by purchases as liquidity from deposit growth was deployed and, to a lesser extent, increases in market value due to changes in interest rates. As of June 30, 2020, the Company had securities with an amortized cost basis of $68.3 million designated as held-to-maturity compared to $61.9 million as of December 31, 2019.

Accrued Income and Other Assets

Accrued income and other assets were $63.2 million at June 30, 2020 compared to $67.1 million at December 31, 2019. The decrease of $3.8 million, or 5.74%, was due primarily to cash collateral pledged for interest rate swap agreements. The Company pledged $34.6 million and $42.3 million of cash collateral to counterparties as security for its obligations related to these agreements at June 30, 2020 and December 31, 2019, respectively. Collateral posted and received is dependent on the fair value of the underlying agreements as of the respective date.

Accrued Expenses and Other Liabilities

Accrued expenses and other liabilities were $50.4 million at June 30, 2020 compared to $53.0 million at December 31, 2019.

Deposits

The following table presents the composition of the Company’s deposit base for the last five completed fiscal quarters.


(dollars in thousands)	June 30, 2020						March 31, 2020						December 31, 2019						September 30, 2019		June 30, 2019
Noninterest-bearing deposits	$	82,864	2.5	%	$	70,562	2.2	%	$	57,115	1.8	%	$	50,560	1.6	%	$	44,040	1.5	%
Interest-bearing demand deposits	152,391		4.5	%	123,233		3.9	%	129,020		4.1	%	122,551		3.9	%	126,669		4.2	%
Savings accounts	43,366		1.3	%	32,485		1.0	%	29,616		0.9	%	34,886		1.1	%	31,445		1.0	%
Money market accounts	1,241,874		36.7	%	930,698		29.3	%	786,390		24.9	%	698,077		22.2	%	607,849		20.3	%
Certificates of deposits	1,470,905		43.5	%	1,493,644		47.0	%	1,613,453		51.2	%	1,681,377		53.4	%	1,629,886		54.2	%
Brokered deposits	389,389		11.5	%	527,884		16.6	%	538,369		17.1	%	560,791		17.8	%	566,374		18.8	%
Total deposits	$	3,380,789	100.0	%	$	3,178,506	100.0	%	$	3,153,963	100.0	%	$	3,148,242	100.0	%	$	3,006,263	100.0	%

Total deposits increased $226.8 million, or 7.2%, to $3.4 billion as of June 30, 2020, compared to $3.2 billion as of December 31, 2019. This increase was due primarily to an increase of $455.5 million, or 57.9%, in money market accounts, largely offset by declines of $142.5 million, or 8.8%, in certificates of deposits and $149.0 million, or 2.8%, in brokered deposits. The Company experienced strong growth in money market balances from consumers, small businesses and commercial clients as our customers have increased their cash balances due to the economic uncertainty resulting from the COVID-19 pandemic. The declines in certificates of deposits and brokered deposits were due to the maturity of higher cost balances and reduced pricing strategies designed to limit the volume of new production.

Recent Debt and Equity Offerings

In June 2019, the Company issued $37.0 million aggregate principal amount of 6.0% Fixed-to-Floating Rate Subordinated Notes due 2029 (the “2029 Notes”) in a public offering. The 2029 Notes initially bear a fixed interest rate of 6.0% per year to, but excluding June 30, 2024, and thereafter a floating rate equal to the then-current Benchmark rate (initially three-month LIBOR rate) plus 411 basis points. All interest on the 2029 Notes is payable quarterly. The 2029 Notes are scheduled to mature on June 30, 2029. The 2029 Notes are unsecured subordinated obligations of the Company and may be repaid, without penalty, on any interest payment date on or after June 30, 2024. The 2029 Notes are intended to qualify as Tier 2 capital under regulatory guidelines. The 2029 Notes are trading on the Nasdaq Global Select Market under the symbol “INBKZ.”

Regulatory Capital Requirements

The Company and the Bank are subject to various regulatory capital requirements administered by state and federal banking agencies. Capital adequacy guidelines and, additionally for banks, prompt corrective action regulations, involve quantitative measures of assets, liabilities, and certain off-balance-sheet items calculated under regulatory accounting practices. Capital amounts and classifications are also subject to qualitative judgments by regulators about components, risk weighting and other factors.

The Basel III Capital Rules became effective for the Company and the Bank on January 1, 2015, subject to a phase-in period for certain provisions. Quantitative measures established by the Basel III Capital Rules to ensure capital adequacy require the maintenance of minimum amounts and ratios of Common Equity Tier 1 capital, Tier 1 capital and Total capital, as defined in the regulations, to risk-weighted assets, and of Tier 1 capital to adjusted quarterly average assets (“Leverage Ratio”).

The Basel III Capital Rules were fully phased in on January 1, 2019 and require the Company and the Bank to maintain: 1) a minimum ratio of Common Equity Tier 1 capital to risk-weighted assets of 4.5%, plus a 2.5% “capital conservation buffer” (resulting in a minimum ratio of Common Equity Tier 1 capital to risk-weighted assets of 7.0%); 2) a minimum ratio of Tier 1 capital to risk-weighted assets of 6.0%, plus the capital conservation buffer (resulting in a minimum Tier 1 capital ratio of 8.5%); 3) a minimum ratio of Total capital to risk-weighted assets of 8.0%, plus the capital conservation buffer (resulting in a minimum Total capital ratio of 10.5%); and 4) a minimum Leverage Ratio of 4.0%.

The implementation of the capital conservation buffer began on January 1, 2016 at the 0.625% level and was phased in over a four-year period, increasing by increments of that amount on each subsequent January 1 until it reached 2.5% on January 1, 2019. The capital conservation buffer is designed to absorb losses during periods of economic stress. Failure to maintain the minimum Common Equity Tier 1 capital ratio plus the capital conservation buffer will result in potential restrictions on a banking institution’s ability to pay dividends, repurchase stock and/or pay discretionary compensation to its employees.

The following tables present actual and required capital ratios as of June 30, 2020 and December 31, 2019 for the Company and the Bank under the Basel III Capital Rules. The minimum required capital amounts presented include the minimum required capital levels as of June 30, 2020 and December 31, 2019 based on the Basel III Capital Rules and the minimum required capital levels as of January 1, 2019. Capital levels required to be considered well capitalized are based upon prompt corrective action regulations, as amended to reflect the changes under the Basel III Capital Rules.


	Actual						Minimum Capital Required - Basel III						Minimum Required to be Considered Well Capitalized
(dollars in thousands)	Capital Amount		Ratio		Capital Amount		Ratio		Capital Amount		Ratio
As of June 30, 2020:
Common equity tier 1 capital to risk-weighted assets
Consolidated	$	323,415	10.94	%	$	206,854	7.00	%	N/A		N/A
Bank	354,978		12.02	%	206,662		7.00	%	$	191,900	6.50	%
Tier 1 capital to risk-weighted assets
Consolidated	323,415		10.94	%	177,303		8.50	%	N/A		N/A
Bank	354,978		12.02	%	177,139		8.50	%	236,185		8.00	%
Total capital to risk-weighted assets
Consolidated	417,561		14.13	%	236,404		10.50	%	N/A		N/A
Bank	379,443		12.85	%	236,185		10.50	%	295,231		10.00	%
Leverage ratio
Consolidated	323,415		7.49	%	172,813		4.00	%	N/A		N/A
Bank	354,978		8.22	%	172,708		4.00	%	215,885		5.00	%


	Actual						Minimum Capital Required - Basel III						Minimum Required to be Considered Well Capitalized
(dollars in thousands)	Capital Amount		Ratio		Capital Amount		Ratio		Capital Amount		Ratio
As of December 31, 2019:
Common equity tier 1 capital to risk-weighted assets
Consolidated	$	313,803	10.84	%	$	202,661	7.00	%	N/A		N/A
Bank	341,242		11.80	%	202,480		7.00	%	$	188,017	6.50	%
Tier 1 capital to risk-weighted assets
Consolidated	313,803		10.84	%	246,088		8.50	%	N/A		N/A
Bank	341,242		11.80	%	245,869		8.50	%	231,406		8.00	%
Total capital to risk-weighted assets
Consolidated	405,171		13.99	%	303,991		10.50	%	N/A		N/A
Bank	363,082		12.55	%	303,720		10.50	%	289,257		10.00	%
Leverage ratio
Consolidated	313,803		7.64	%	164,219		4.00	%	N/A		N/A
Bank	341,242		8.32	%	164,121		4.00	%	205,151		5.00	%

Shareholders’ Dividends

The Company’s Board of Directors declared a cash dividend of $0.06 per share of common stock payable July 15, 2020 to shareholders of record as of June 30, 2020. The Company expects to continue to pay cash dividends on a quarterly basis; however, the declaration and amount of any future cash dividends will be subject to the sole discretion of the Board of Directors and will depend upon many factors, including its results of operations, financial condition, capital requirements, regulatory and contractual restrictions (including with respect to the Company’s outstanding subordinated debt), business strategy and other factors deemed relevant by the Board of Directors, including any potential impact resulting from COVID-19.

As of June 30, 2020, the Company had $72.0 million principal amount of subordinated debt outstanding pursuant its term loan evidenced by a term note due 2025, its 6.0% Fixed-to-Floating Rate Subordinated Notes due 2026 and the 2029 Notes. The agreements that govern our outstanding subordinated debt prohibit the Company from paying any dividends on its common stock or making any other distributions to shareholders at any time when there shall have occurred, and be continuing to occur, an event of default under the applicable agreement. If an event of default were to occur and the Company did not cure it, the Company would be prohibited from paying any dividends or making any other distributions to shareholders or from redeeming or repurchasing any common stock.

Capital Resources

The Company believes it has sufficient liquidity and capital resources to meet its cash and capital expenditure requirements for at least the next twelve months. The Company may explore strategic alternatives, including additional asset, deposit or revenue generation channels that complement our commercial and consumer banking platforms, which may require additional capital. If the Company is unable to secure such capital at favorable terms, its ability to take advantage of such opportunities could be adversely affected.

Liquidity

Liquidity management is the process used by the Company to manage the continuing flow of funds necessary to meet its financial commitments on a timely basis and at a reasonable cost while also maintaining safe and sound operations. Liquidity, represented by cash and investment securities, is a product of the Company’s operating, investing and financing activities. The primary sources of funds are deposits, principal and interest payments on loans and investment securities, maturing loans and investment securities, access to wholesale funding sources and collateralized borrowings. While scheduled payments and maturities of loans and investment securities are relatively predictable sources of funds, deposit flows are greatly influenced by interest rates, general economic conditions and competition. Therefore, the Company supplements deposit growth and enhances interest rate risk management through borrowings and wholesale funding, which are generally advances from the FHLB and brokered deposits.

Additionally, the Company has enhanced its liquidity management process during 2019 and 2020 through increased loan sale activity. During the first six months of 2020, the Company sold $111.4 million of public finance, single tenant lease financing and SBA 7(a) guaranteed loans at premiums to book value, as well as a $90.8 million pool of residential mortgage loans. During 2019, the Company sold $237.5 million of portfolio residential mortgage, single tenant lease financing and public finance loans. These loan sales have provided liquidity to manage overall loan portfolio growth and capital utilization.

The Company holds cash and investment securities that qualify as liquid assets to maintain adequate liquidity to ensure safe and sound operations and meet its financial commitments. We intend to reduce the size of our balance sheet during the second half of 2020 through continued deposit repricing in order to manage capital levels. A component of this balance sheet management strategy is expected to include reducing our cash balances from those as of June 30, 2020. However, given the uncertainty regarding the length and ultimate economic effect of COVID-19, we believe it will be prudent to maintain higher levels of cash on the balance sheet than we have historically until the crisis passes. We believe we have sufficient on-balance sheet liquidity, supplemented by access to additional funding sources, to manage the potential economic impact of COVID-19. At June 30, 2020, on a consolidated basis, the Company had $1.1 billion in cash and cash equivalents and investment securities available-for-sale and $38.8 million in loans held-for-sale that were generally available for its cash needs. The Company can also generate funds from wholesale funding sources and collateralized borrowings. At June 30, 2020, the Bank had the ability to borrow an additional $558.4 million from the FHLB, the Federal Reserve and correspondent bank Fed Funds lines of credit.

The Company is a separate legal entity from the Bank and must provide for its own liquidity. In addition to its operating expenses, the Company is responsible for paying any dividends declared to its common shareholders and interest and principal on outstanding debt. The Company’s primary sources of funds are cash maintained at the holding company level and dividends from the Bank, the payment of which is subject to regulatory limits. At June 30, 2020, the Company, on an unconsolidated basis, had $36.0 million in cash generally available for its cash needs, which is in excess of its current annual regular shareholder dividend and operating expenses.

The Company uses its sources of funds primarily to meet ongoing financial commitments, including withdrawals by depositors, credit commitments to borrowers, operating expenses and capital expenditures. At June 30, 2020, approved outstanding loan commitments, including unused lines of credit and standby letters of credit, amounted to $267.4 million. Certificates of deposits and brokered deposits scheduled to mature in one year or less at June 30, 2020 totaled $1.04 billion.

Management is not aware of any other events or regulatory requirements that, if implemented, are likely to have a material effect on either the Company’s or the Bank’s liquidity.

Reconciliation of Non-GAAP Financial Measures

This Management’s Discussion and Analysis contains financial information determined by methods other than in accordance with GAAP. Non-GAAP financial measures, specifically tangible common equity, tangible assets, tangible book value per common share, average tangible common equity, return on average tangible common equity, tangible common equity to tangible assets ratio, total interest income - FTE, net interest income - FTE, net interest margin - FTE and allowance for loan losses to loans, excluding PPP loans are used by the Company’s management to measure the strength of its capital and analyze profitability, including its ability to generate earnings on tangible capital invested by its shareholders. The Company also believes that it is a standard practice in the banking industry to present total interest income, net interest income and net interest margin on a fully-taxable equivalent basis, as those measures provide useful information for peer comparisons. Although the Company believes these non-GAAP financial measures provide a greater understanding of its business, they should not be considered a substitute for financial measures determined in accordance with GAAP, nor are they necessarily comparable to non-GAAP financial measures that may be presented by other companies. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures are included in the following table for the last five completed fiscal quarters and the six months ended June 30, 2020 and 2019.


(dollars in thousands, except share and per share data)	Three Months Ended																												Six Months Ended
				June 30, 2020				March 31, 2020				December 31, 2019				September 30, 2019				June 30, 2019				June 30, 2020				June 30, 2019
Total equity - GAAP	$	307,711			$	305,127			$	304,913			$	295,140			$	296,120			$	307,711			$	296,120
Adjustments:
Goodwill	(4,687)				(4,687)				(4,687)				(4,687)				(4,687)				(4,687)				(4,687)
Tangible common equity	$	303,024			$	300,440			$	300,226			$	290,453			$	291,433			$	303,024			$	291,433

Total assets - GAAP	$	4,324,600			$	4,168,146			$	4,100,083			$	4,095,491			$	3,958,829			$	4,324,600			$	3,958,829
Adjustments:
Goodwill	(4,687)				(4,687)				(4,687)				(4,687)				(4,687)				(4,687)				(4,687)
Tangible assets	$	4,319,913			$	4,163,459			$	4,095,396			$	4,090,804			$	3,954,142			$	4,319,913			$	3,954,142

Total common shares outstanding	9,799,047				9,801,825				9,741,800				9,741,800				10,016,458				9,799,047				10,016,458

Book value per common share	$	31.40			$	31.13			$	31.30			$	30.30			$	29.56			$	31.40			$	29.56
Effect of goodwill	(0.48)				(0.48)				(0.48)				(0.48)				(0.46)				(0.48)				(0.46)
Tangible book value per common share	$	30.92			$	30.65			$	30.82			$	29.82			$	29.10			$	30.92			$	29.10

Total shareholders’ equity to assets	7.12		%		7.32%				7.44		%		7.21		%		7.48		%		7.12		%		7.48		%
Effect of goodwill	(0.11)		%		(0.10)		%		(0.11)		%		(0.11)		%		(0.11)		%		(0.11)		%		(0.11)		%
Tangible common equity to tangible assets	7.01		%		7.22%				7.33		%		7.10		%		7.37		%		7.01		%		7.37		%

Total average equity - GAAP	$	306,868			$	311,005			$	297,623			$	298,782			$	297,148			$	308,937			$	294,530
Adjustments:
Average goodwill	(4,687)				(4,687)				(4,687)				(4,687)				(4,687)				(4,687)				(4,687)
Average tangible common equity	$	302,181			$	306,318			$	292,936			$	294,095			$	292,461			$	304,250			$	289,843

Return on average shareholders’ equity	5.15		%		7.78%				9.46		%		8.40		%		8.26		%		6.48		%		8.09		%
Effect of goodwill	0.08		%		0.12%				0.15		%		0.13		%		0.13		%		0.10		%		0.13		%
Return on average tangible common equity	5.23		%		7.90		%		9.61		%		8.53		%		8.39		%		6.58		%		8.22		%


(dollars in thousands, except share and per share data)	Three Months Ended																												Six Months Ended
				June 30, 2020				March 31, 2020				December 31, 2019				September 30, 2019				June 30, 2019				June 30, 2020				June 30, 2019
Total interest income	$	34,222			$	36,244			$	37,877			$	37,964			$	36,844			$	70,466			$	71,843
Adjustments:
Fully-taxable equivalent adjustments ¹	1,437				1,535				1,570				1,595				1,612				2,972				3,169
Total interest income - FTE	$	35,659			$	37,779			$	39,447			$	33,326			$	38,456			$	73,438			$	75,012

Net interest income	$	14,426			$	15,018			$	15,374			$	15,244			$	16,105			$	29,444			$	32,349
Adjustments:
Fully-taxable equivalent adjustments ¹	1,437				1,535				1,570				1,595				1,612				2,972				3,169
Net interest income - FTE	$	15,863			$	16,553			$	16,944			$	16,839			$	17,717			$	32,416			$	35,518

Net interest margin	1.37		%		1.50		%		1.51		%		1.54		%		1.73		%		1.43		%		1.79		%
Effect of fully-taxable equivalent adjustments ¹	0.13		%		0.15		%		0.16		%		0.16		%		0.18		%		0.15		%		0.18		%
Net interest margin - FTE	1.50		%		1.65		%		1.67		%		1.70		%		1.91		%		1.58		%		1.97		%

Allowance for loan losses	$	24,465			$	22,857			$	21,840			$	21,683			$	19,976			$	24,465			$	19,976

Loans	$	2,973,674			$	2,892,093			$	2,963,547			$	2,881,272			$	2,861,156			$	2,973,674			$	2,861,156
Adjustments:
PPP loans	(58,948)				—				—				—				—				(58,948)				—
Loans, excluding PPP loans	$	2,914,726			$	2,892,093			$	2,963,547			$	2,881,272			$	2,861,156			$	2,914,726			$	2,861,156

Allowance for loan losses to loans	0.82		%		0.79		%		0.74		%		0.75		%		0.70		%		0.82		%		0.70		%
Effect of PPP loans	0.02		%		0.00		%		0.00		%		0.00		%		0.00		%		0.02		%		0.00		%
Allowance for loan losses to loans, excluding PPP loans	0.84		%		0.79		%		0.74		%		0.75		%		0.70		%		0.84		%		0.70		%

¹ Assuming a 21% tax rate

Critical Accounting Policies and Estimates

There have been no material changes in the Company’s critical accounting policies or estimates from those disclosed in its Annual Report on Form 10-K for the year ended December 31, 2019.

Recent Accounting Pronouncements

Refer to Note 16 to the condensed consolidated financial statements.

Off-Balance Sheet Arrangements

In the ordinary course of business, the Company enters into financial transactions to extend credit, interest rate swap agreements and forms of commitments that may be considered off-balance sheet arrangements. Interest rate swaps are arranged to receive hedge accounting treatment and are classified as either fair value or cash flow hedges. Fair value hedges are purchased to convert certain fixed rate assets to floating rate. Cash flow hedges are used to convert certain variable rate liabilities into fixed rate liabilities. In June 2020, the Company terminated all fair value hedging instruments associated with loans. At June 30, 2020 and December 31, 2019, the Company had interest rate swaps with notional amounts of $298.2 million and $725.6 million, respectively. Additionally, we enter into forward contracts relating to our mortgage banking business to hedge the exposures we have from commitments to extend new residential mortgage loans to our customers and from our mortgage loans held-for-sale. At June 30, 2020 and December 31, 2019, the Company had commitments to sell residential real estate loans of $11.7 million and $115.0 million, respectively. These contracts mature in less than one year. Refer to Note 14 to the condensed consolidated financial statements for additional information about derivative financial instruments.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Market risk is the risk of loss arising from adverse changes in the fair value of financial instruments due to changes in interest rates, foreign exchange rates and equity prices. The primary source of market risk for the Company is interest rate risk. Interest rate risk is the risk to earnings and the value of the Company’s equity resulting from changes in market interest rates and arises in the normal course of business to the extent that there are timing and volume differences between the amount of interest-earning assets and the amount of interest-bearing liabilities that are prepaid, withdrawn, re-priced or mature in specified periods. The Company seeks to achieve consistent growth in net interest income and equity while managing volatility arising from shifts in market interest rates.

The Company monitors its interest rate risk position using income simulation models and economic value of equity (“EVE”) sensitivity analysis that capture both short-term and long-term interest rate risk exposure. Income simulation involves forecasting net interest income (“NII”) under a variety of interest rate scenarios. The Company uses EVE sensitivity analysis to understand the impact of changes in interest rates on long-term cash flows, income and capital. EVE is calculated by discounting the cash flows for all balance sheet instruments under different interest-rate scenarios. Modeling the sensitivity of NII and EVE to changes in market interest rates is highly dependent on the assumptions incorporated into the modeling process. The Company continually reviews and refines the assumptions used in its interest rate risk modeling.

Presented below is the estimated impact on the Company’s NII and EVE position as of June 30, 2020, assuming parallel shifts in interest rates and a static balance sheet:


	% Change from Base Case for Parallel Changes in Rates
	-50 Basis Points		-25 Basis Points		+100 Basis Points		+200 Basis Points
NII - Year 1	(0.73)	%	1.31	%	(1.13)	%	(4.78)	%
NII - Year 2	13.01	%	16.37	%	9.54	%	3.04	%
EVE	(3.07)	%	(0.73)	%	0.57	%	(8.09)	%

The Company’s objective is to manage the balance sheet with a “risk-neutral” position. A “risk-neutral” position refers to the absence of a strong bias toward either asset or liability sensitivity. An “asset sensitive” position refers to when the characteristics of the balance sheet are expected to generate higher NII when interest rates increase as rates earned on interest-earning assets would reprice upward more quickly or in greater quantities than rates paid on interest-bearing liabilities. A “liability sensitive” position refers to when the characteristics of the balance sheet are expected to generate higher NII when interest rates decrease as rates paid on interest-bearing liabilities would reprice downward more quickly or in greater quantities than rates earned on interest-earning assets.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

The Company maintains disclosure controls and procedures that are designed to provide reasonable assurance that information required to be disclosed in reports that it files or submits under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized, and reported within the time period specified in the SEC’s rules and forms. These controls and procedures are also designed to provide reasonable assurance that such information is accumulated and communicated to management, including the principal executive and principal financial officers, as appropriate, to allow timely decisions regarding required disclosures. In designing and evaluating disclosure controls and procedures, the Company has recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. Management is required to apply judgment in evaluating its controls and procedures.

The Company performed an evaluation under the supervision and with the participation of management, including the principal executive and principal financial officers, to assess the effectiveness of the design and operation of its disclosure controls and procedures under the Exchange Act. Based on that evaluation, the principal executive and principal financial officers concluded that the disclosure controls and procedures were effective at a reasonable assurance level as of June 30, 2020.

Changes in Internal Control Over Financial Reporting

There has been no change in the Company’s internal control over financial reporting during the six months ended June 30, 2020 that has materially affected, or is reasonably likely to materially affect, its internal control over financial reporting.

PART II

ITEM 1. LEGAL PROCEEDINGS

Neither we nor any of our subsidiaries are party to any material legal proceedings. From time to time, the Bank is a party to legal actions arising from its normal business activities.

ITEM 1A. RISK FACTORS

There have been no material changes to the risk factors previously disclosed in Part I, Item 1A, of our Annual Report on Form 10-K for the year ended December 31, 2019 (“2019 Form 10-K”), as updated in Part II, Item 1A of our Quarterly Report on Form 10-Q for the three months ended March 31, 2020 (“First Quarter 2020 Form 10-Q”), except as described below. The risk factor set forth below updates, and should be read together with, the risk factors described in our 2019 Form 10-K and First Quarter 2020 Form 10-Q. In addition, the COVID-19 pandemic could exacerbate or trigger other risks discussed in our 2019 Form 10-K and First Quarter 2020 Form 10-Q, any of which could materially affect our business, financial condition and results of operations.

The COVID-19 pandemic is adversely affecting us, our business, customers, employees and third-party service providers, and the ultimate impact on our financial condition, results of operations and prospects will depend on future developments, which are highly uncertain.

Global health concerns related to the ongoing COVID-19 pandemic and related government actions taken to reduce the spread of the virus have had a significant negative impact on the macroeconomic environment and market conditions, including significant disruption of, and volatility in, financial markets, and the pandemic has significantly increased economic uncertainty, reduced economic activity and resulted in lost revenues and increased unemployment throughout the United States, but also specifically in Indiana, where we maintain a significant portion of our operations. Our business is dependent upon the willingness and ability of our customers to conduct banking and other financial transactions. The recent outbreak and continuing effects of the COVID-19 pandemic, or any other highly contagious or infectious disease, could negatively impact the ability of our employees and customers to conduct such transactions and disrupt the business activities and operations in the areas in which we operate. While the spread of the COVID-19 virus has minimally impacted our operations as of June 30, 2020, we could experience temporary closures of our corporate offices and/or suspension of certain services in particular markets. Currently, it is unknown how long the COVID-19 pandemic will last, or when restrictions on individuals and businesses will be fully lifted and when businesses and their employees will be able to resume normal activities in the markets we operate in and serve. Additionally, new information may emerge regarding the severity or spread of COVID-19 and additional actions may be taken by federal, state and local governments to contain COVID-19 or treat its impact. Should there be sustained disruption in our operations, or that of our customers, our financial condition and results of operations could be negatively impacted.

The COVID-19 pandemic has significantly affected the financial markets and has resulted in a number of Federal Reserve actions, which have resulted in a significant decline in market interest rates. Most of our assets and liabilities are financial in nature and are sensitive to movements in market interest rates. A prolonged period of volatile and unstable market conditions will impact both the level of income and expense recorded on our assets and liabilities and the market value of all interest-earning assets and interest-bearing liabilities, which in turn could have an adverse effect on our net interest income, net interest margin and profitability.

Although we have business continuity plans and other safeguards against pandemics or another contagious disease, the spread of COVID-19 could also negatively impact the availability of our employees who are necessary to conduct business operations, as well as potentially impact the business and operations of our third-party service providers. If the response to contain COVID-19, or another highly infectious or contagious disease, is unsuccessful, we could experience a material adverse effect on our business operations, asset valuations, financial condition and results of operations. Material adverse impacts may include all or a combination of valuation impairments on our intangible assets, investments, loans, loan servicing rights, deferred tax assets, or derivatives. The extent to which the COVID-19 pandemic impacts our business, results of operations and financial condition will depend on future developments that are highly uncertain and are difficult to predict, including, but not limited to, the duration and spread of the outbreak, its severity, the actions to contain the virus or treat its impact, and how quickly and to what extent normal economic and operating conditions can resume. After the COVID-19 pandemic has subsided, we may continue to experience materially adverse impacts to our business, financial condition and results of operations as a result of the virus’s global and local economic impact, including the availability of credit, adverse impacts on our liquidity and any recession that has occurred or may occur in the future.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not Applicable.

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS

Exhibit No.

Description

Method of Filing

3.1

Amended and Restated Articles of Incorporation of First Internet Bancorp (incorporated by reference to Exhibit 3.1 to current report on Form 8-K filed May 21, 2020)

Incorporated by Reference

3.2

Amended and Restated Bylaws of First Internet Bancorp (incorporated by reference to Exhibit 3.2 to current report on Form 8-K filed May 21, 2020)

Incorporated by Reference

31.1

Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer

Filed Electronically

31.2

Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer

Filed Electronically

32.1

Section 1350 Certifications

Filed Electronically

101.INS

XBRL Instance Document

Filed Electronically

101.SCH

XBRL Taxonomy Extension Schema

Filed Electronically

101.CAL

XBRL Taxonomy Extension Calculation Linkbase

Filed Electronically

101.DEF

XBRL Taxonomy Extension Definition Linkbase

Filed Electronically

101.LAB

XBRL Taxonomy Extension Label Linkbase

Filed Electronically

101.PRE

XBRL Taxonomy Extension Presentation Linkbase

Filed Electronically

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


		FIRST INTERNET BANCORP

8/6/2020	By	/s/ David B. Becker
		David B. Becker, Chairman, President and Chief Executive Officer (on behalf of Registrant)

8/6/2020	By	/s/ Kenneth J. Lovik
		Kenneth J. Lovik, Executive Vice President and Chief Financial Officer (principal financial officer)

Document

Exhibit 31.1

Certification by the Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, David B. Becker, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of First Internet Bancorp;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with generally accepted accounting principles;

c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function):

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


Date:	August 6, 2020
		/s/ David B. Becker
		David B. Becker, Chief Executive Officer

Document

Exhibit 31.2

Certification by the Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Kenneth J. Lovik, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of First Internet Bancorp;

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


Date:	August 6, 2020
		/s/ Kenneth J. Lovik
		Kenneth J. Lovik, Chief Financial Officer

Document

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of First Internet Bancorp (the “Company") on Form 10-Q for the period ended June 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


/s/ David B. Becker
David B. Becker
Chief Executive Officer
August 6, 2020

/s/ Kenneth J. Lovik
Kenneth J. Lovik
Chief Financial Officer
August 6, 2020

Cover - shares	6 Months Ended
Cover - shares	Jun. 30, 2020	Jul. 31, 2020
Class of Stock [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2020
Document Transition Report	false
Entity File Number	001-35750
Entity Registrant Name	First Internet Bancorp
Entity Incorporation, State or Country Code	IN
Entity Tax Identification Number	20-3489991
Entity Address, Address Line One	11201 USA Parkway
Entity Address, City or Town	Fishers
Entity Address, State or Province	IN
Entity Address, Postal Zip Code	46037
City Area Code	317
Local Phone Number	532-7900
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		9,799,047
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2020
Amendment Flag	false
Entity Central Index Key	0001562463
Current Fiscal Year End Date	--12-31
Common Stock
Class of Stock [Line Items]
Title of 12(b) Security	Common Stock, without par value
Trading Symbol	INBK
Security Exchange Name	NASDAQ
6.0% Fixed to Floating Subordinated Notes due 2026
Class of Stock [Line Items]
Title of 12(b) Security	6.0% Fixed to Floating Subordinated Notes due 2026
Trading Symbol	INBKL
Security Exchange Name	NASDAQ
6.0% Fixed to Floating Subordinated Notes due 2029
Class of Stock [Line Items]
Title of 12(b) Security	6.0% Fixed to Floating Subordinated Notes due 2029
Trading Symbol	INBKZ
Security Exchange Name	NASDAQ

Premises and Equipment

6 Months Ended

Jun. 30, 2020

Property, Plant and Equipment [Abstract]

Premises and Equipment

The following table summarizes premises and equipment at June 30, 2020 and December 31, 2019.


(in thousands)	June 30, 2020		December 31, 2019
Land	$	2,500	$	2,500
Right of use leased asset	1,242		1,602
Building and improvements	19,821		10,004
Furniture and equipment	10,452		9,689
Less: accumulated depreciation	(10,076)		(9,165)
Total	$	23,939	$	14,630

Goodwill	6 Months Ended
Goodwill	Jun. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Goodwill As of June 30, 2020 and December 31, 2019, the carrying amount of goodwill was $4.7 million. There have been no changes in the carrying amount of goodwill for the three months ended June 30, 2020. Goodwill is tested for impairment on an annual basis as of August 31, or whenever events or changes in circumstances indicate the carrying amount of goodwill exceeds its implied fair value. The annual test indicated no impairment existed as of August 31, 2019. Due to the impact of COVID-19 on the economy and the financial markets, the Company evaluated goodwill and determined no triggering event has occurred since the last goodwill impairment test was conducted.

Subordinated Debt

6 Months Ended

Jun. 30, 2020

Debt Disclosure [Abstract]

Subordinated Debt

The following table presents the principal balance and unamortized debt issuance costs for the 2025 Note, the 2026 Notes and the 2029 Notes as of June 30, 2020 and December 31, 2019.


	June 30, 2020						December 31, 2019
(in thousands)	Principal		Unamortized Debt Issuance Costs		Principal		Unamortized Debt Issuance Costs

2025 Note	10,000		(126)		10,000		(138)
2026 Notes	25,000		(777)		25,000		(839)
2029 Notes	37,000		(1,416)		37,000		(1,495)
Total	$	72,000	$	(2,319)	$	72,000	$	(2,472)

Benefit Plans

6 Months Ended

Jun. 30, 2020

Retirement Benefits [Abstract]

Benefit Plans

Employment Agreement

2013 Equity Incentive Plan

The following table summarizes the status of the 2013 Plan awards as of June 30, 2020, and activity for the six months ended June 30, 2020.


	Restricted Stock Units	Weighted-Average Grant Date Fair Value Per Share		Restricted Stock Awards	Weighted-Average Grant Date Fair Value Per Share		Deferred Stock Units	Weighted-Average Grant Date Fair Value Per Share
Nonvested at December 31, 2019	107,244	$	29.03	—	$	—	—	$	—
Granted	66,808	27.56		16,090	25.58		6	19.41
Vested	(48,499)	30.34		(6,808)	26.37		(6)	19.41
Forfeited	—	—		(1,638)	27.56		—	—
Nonvested at June 30, 2020	125,553	$	27.74	7,644	$	24.44	—	$	—

At June 30, 2020, the total unrecognized compensation cost related to nonvested awards was $3.1 million with a weighted-average expense recognition period of 1.9 years.

Directors Deferred Stock Plan

The following table summarizes the status of deferred stock rights related to the Directors Deferred Stock Plan for the six months ended June 30, 2020.


						Deferred Stock Rights
Outstanding, beginning of period						84,505
Granted						428
Exercised						—
Outstanding, end of period						84,933

All deferred stock rights granted during the 2020 period were additional rights issued in lieu of cash dividends payable on outstanding deferred stock rights.

Derivative Financial Instruments

6 Months Ended

Jun. 30, 2020

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Financial Instruments


(in thousands)	Carrying amount of the hedged asset						Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged assets
Line item in the condensed consolidated balance sheets in which the hedged item is included	June 30, 2020		December 31, 2019		June 30, 2020		December 31, 2019
Loans	$	—	$	474,957	$	—	$	21,440
Securities available-for-sale ⁽¹⁾	145,872		151,538		7,095		2,802


(dollars in thousands) June 30, 2020	Notional		Weighted- Average Remaining Maturity			Weighted-Average Ratio
Instruments Associated With	Value		(years)	Fair Value		Receive	Pay

Securities available-for-sale	88,200		3.6	(7,097)		3-month LIBOR	2.54	%
Total at June 30, 2020	$	88,200	3.6	$	(7,097)	3-month LIBOR	2.54	%


(dollars in thousands) December 31, 2019	Notional		Weighted- Average Remaining Maturity			Weighted-Average Ratio
Instruments Associated With	Value		(years)	Fair Value		Receive	Pay
Loans	$	427,446	5.5	$	(21,551)	3-month LIBOR	2.86	%
Securities available-for-sale	88,200		4.1	(2,806)		3-month LIBOR	2.54	%
Total at December 31, 2019	$	515,646	5.3	$	(24,357)	3-month LIBOR	2.80	%


(dollars in thousands) June 30, 2020	Notional		Weighted- Average Remaining Maturity			Weighted-Average Ratio
Cash Flow Hedges	Value		(years)	Fair Value		Receive	Pay
Interest rate swaps	$	110,000	6.6	$	(17,993)	3-month LIBOR	2.88	%
Interest rate swaps	100,000		3.5	(9,404)		1-month LIBOR	2.88	%


(dollars in thousands) December 31, 2019	Notional		Weighted- Average Remaining Maturity			Weighted-Average Ratio
Cash Flow Hedges	Value		(years)	Fair Value		Receive	Pay
Interest rate swaps	$	110,000	7.1	$	(8,390)	3-month LIBOR	2.88	%
Interest rate swaps	100,000		4.0	(5,040)		1-month LIBOR	2.88	%

The following table presents the notional amount and fair value of interest rate swaps, IRLCs and forward contracts utilized by the Company at June 30, 2020 and December 31, 2019.


	June 30, 2020						December 31, 2019
(in thousands)	Notional Amount		Fair Value		Notional Amount		Fair Value
Asset Derivatives




Derivatives not designated as hedging instruments
IRLCs	14,527		282		56,256		910

Total contracts	$	14,527	$	282	$	56,256	$	910
Liability Derivatives
Derivatives designated as hedging instruments
Interest rate swaps associated with loans	$	—	$	—	$	427,446	$	(21,551)
Interest rate swaps associated with securities available-for-sale	88,200		(7,097)		88,200		(2,806)
Interest rate swaps associated with liabilities	210,000		(27,397)		210,000		(13,429)
Derivatives not designated as hedging instruments
Forward contracts	11,710		(17)		115,000		(153)

Total contracts	$	309,910	$	(34,511)	$	840,646	$	(37,939)


	Amount of Loss Recognized in Other Comprehensive Loss in The Three Months Ended						Amount of Loss Recognized in Other Comprehensive Loss in the Six Months Ended
(in thousands)	June 30, 2020		June 30, 2019		June 30, 2020		June 30, 2019

Interest rate swap agreements	$	(509)	$	(5,892)	$	(13,967)	$	(9,464)


	Amount of Gain / (Loss) Recognized in the Three Months Ended						Amount of Gain / (Loss) Recognized in the Six Months Ended
(in thousands)	June 30, 2020		June 30, 2019		June 30, 2020		June 30, 2019
Asset Derivatives
Derivatives not designated as hedging instruments
IRLCs	$	(1,781)	$	428	$	(628)	$	820


Liability Derivatives
Derivatives not designated as hedging instruments

Forward contracts	$	2,281	$	(122)	$	136	$	(189)


(in thousands) Line item in the condensed consolidated statements of income	Three Months Ended									Six Months Ended
			June 30, 2020			June 30, 2019			June 30, 2020			June 30, 2019
Interest income
Loans	$	(1,221)		$	(285)		$	(2,445)		$	(264)
Securities - taxable	(159)			(10)			(250)			(17)
Securities - non-taxable	(164)			27			(230)			72
Total interest income	(1,544)			(268)			(2,925)			(209)
Interest expense
Deposits	593			104			899			194
Other borrowed funds	589			79			911			113
Total interest expense	1,182			183			1,810			307
Net interest income	$	(2,726)		$	(451)		$	(4,735)		$	(516)

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Assets
Cash and due from banks	$ 7,016	$ 5,061
Interest-bearing deposits	491,603	322,300
Total cash and cash equivalents	498,619	327,361
Securities available-for-sale, at fair value (amortized cost of $590,046 and $546,640 in 2020 and 2019, respectively)	589,017	540,852
Securities held-to-maturity, at amortized cost (fair value of $69,152 and $62,560 in 2020 and 2019, respectively)	68,295	61,878
Loans held-for-sale (includes $38,813 and $56,097 at fair value in 2020 and 2019, respectively)	38,813	56,097
Loans	2,973,674	2,963,547
Allowance for loan losses	(24,465)	(21,840)
Net loans	2,949,209	2,941,707
Accrued interest receivable	21,093	18,607
Federal Home Loan Bank of Indianapolis stock	25,650	25,650
Cash surrender value of bank-owned life insurance	37,474	37,002
Premises and equipment, net	23,939	14,630
Goodwill	4,687	4,687
Servicing asset, at fair value	2,522	2,481
Other real estate owned	2,065	2,065
Accrued income and other assets	63,217	67,066
Total assets	4,324,600	4,100,083
Liabilities and Shareholders’ Equity
Noninterest-bearing deposits	82,864	57,115
Interest-bearing deposits	3,297,925	3,096,848
Total deposits	3,380,789	3,153,963
Advances from Federal Home Loan Bank	514,913	514,910
Subordinated debt, net of unamortized debt issuance costs of $2,319 and $2,472 in 2020 and 2019, respectively	69,681	69,528
Accrued interest payable	1,073	3,767
Accrued expenses and other liabilities	50,433	53,002
Total liabilities	4,016,889	3,795,170
Commitments and Contingencies
Shareholders’ Equity
Preferred stock, no par value; 4,913,779 shares authorized; issued and outstanding - none	0	0
Retained earnings	108,431	99,681
Accumulated other comprehensive loss	(21,138)	(14,191)
Total shareholders’ equity	307,711	304,913
Total liabilities and shareholders’ equity	4,324,600	4,100,083
Voting Common Stock
Shareholders’ Equity
Common stock	220,418	219,423
Nonvoting Common Stock
Shareholders’ Equity
Common stock	$ 0	$ 0

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Amortized cost, at fair value	$ 590,046	$ 546,640
Held-to-maturity, at fair value	69,152	62,560
Loans held-for-sale, at fair value	38,813	56,097
Unamortized discounts and debt issuance costs	$ 2,319	$ 2,472
Preferred stock, par value (in dollars per share)	$ 0	$ 0
Preferred stock, shares authorized (in shares)	4,913,779	4,913,779
Preferred stock, shares issued (in shares)	0	0
Preferred stock, share outstanding (in shares)	0	0
Voting Common Stock
Common stock, par value (in dollars per share)	$ 0	$ 0
Common stock, shares authorized (in shares)	45,000,000	45,000,000
Common stock, shares issued (in shares)	9,799,047	9,741,800
Common stock, shares outstanding (in shares)	9,799,047	9,741,800
Nonvoting Common Stock
Common stock, par value (in dollars per share)	$ 0	$ 0
Common stock, shares authorized (in shares)	86,221	86,221
Common stock, shares issued (in shares)	0	0
Common stock, shares outstanding (in shares)	0	0

Condensed Consolidated Statements of Income (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Interest Income
Loans	$ 29,730,000	$ 30,842,000	$ 60,138,000	$ 60,060,000
Securities – taxable	3,276,000	3,540,000	6,895,000	6,864,000
Securities – non-taxable	457,000	668,000	1,029,000	1,352,000
Other earning assets	759,000	1,794,000	2,404,000	3,567,000
Total interest income	34,222,000	36,844,000	70,466,000	71,843,000
Interest Expense
Deposits	15,763,000	17,147,000	32,971,000	32,533,000
Other borrowed funds	4,033,000	3,592,000	8,051,000	6,961,000
Total interest expense	19,796,000	20,739,000	41,022,000	39,494,000
Net Interest Income	14,426,000	16,105,000	29,444,000	32,349,000
Provision for Loan Losses	2,491,000	1,389,000	3,952,000	2,674,000
Net Interest Income After Provision for Loan Losses	11,935,000	14,716,000	25,492,000	29,675,000
Noninterest Income
Gain (loss) on sale of loans	762,000	(66,000)	2,563,000	(170,000)
(Loss) gain on sale of securities	0	(458,000)	41,000	(458,000)
Other	456,000	1,089,000	873,000	1,712,000
Total noninterest income	4,973,000	3,454,000	11,184,000	5,826,000
Noninterest Expense
Salaries and employee benefits	7,789,000	6,642,000	15,563,000	12,963,000
Marketing, advertising and promotion	411,000	466,000	786,000	935,000
Consulting and professional services	932,000	835,000	2,109,000	1,649,000
Data processing	339,000	328,000	714,000	645,000
Loan expenses	399,000	292,000	998,000	606,000
Premises and equipment	1,602,000	1,497,000	3,227,000	2,997,000
Deposit insurance premium	435,000	747,000	920,000	1,302,000
Other	1,337,000	902,000	2,413,000	1,721,000
Total noninterest expense	13,244,000	11,709,000	26,730,000	22,818,000
Income Before Income Taxes	3,664,000	6,461,000	9,946,000	12,683,000
Income Tax (Benefit) Provision	(268,000)	340,000	(5,000)	866,000
Net Income	$ 3,932,000	$ 6,121,000	$ 9,951,000	$ 11,817,000
Income Per Share of Common Stock
Basic (in dollars per share)	$ 0.40	$ 0.60	$ 1.02	$ 1.16
Diluted (in dollars per share)	$ 0.40	$ 0.60	$ 1.02	$ 1.16
Weighted-Average Number of Common Shares Outstanding
Basic (in shares)	9,768,227	10,148,285	9,798,528	10,182,770
Diluted (in shares)	9,768,227	10,148,285	9,802,427	10,186,833
Dividends Declared Per Share (in dollars per share)	$ 0.06	$ 0.06	$ 0.12	$ 0.12
Service charges and fees
Noninterest Income
Noninterest income	$ 182,000	$ 225,000	$ 394,000	$ 461,000
Loan servicing revenue
Noninterest Income
Noninterest income	255,000	0	506,000	0
Loan servicing asset revaluation
Noninterest Income
Noninterest income	(90,000)	0	(269,000)	0
Mortgage banking activities
Noninterest Income
Noninterest income	$ 3,408,000	$ 2,664,000	$ 7,076,000	$ 4,281,000

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Statement of Comprehensive Income [Abstract]
Net income	$ 3,932	$ 6,121	$ 9,951	$ 11,817
Net unrealized holding (losses) gains on securities available-for-sale recorded within other comprehensive (loss) income before income tax	(1,498)	3,667	4,801	10,577
Reclassification adjustment for gains (losses) realized	0	458	(41)	458
Net unrealized holding losses on cash flow hedging derivatives recorded within other comprehensive (loss) income before tax	(509)	(5,892)	(13,967)	(9,464)
Other comprehensive (loss) income before income tax	(2,007)	(1,767)	(9,207)	1,571
Income tax (benefit) provision	(735)	(357)	(2,260)	608
Other comprehensive (loss) income	(1,272)	(1,410)	(6,947)	963
Comprehensive income	$ 2,660	$ 4,711	$ 3,004	$ 12,780

Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock Voting and Nonvoting Common Stock	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss
Balance, beginning of period at Dec. 31, 2018	$ 288,735		$ 227,587	$ 77,689		$ (16,541)
Balance, beginning of period (Accounting Standards Update 2017-08) at Dec. 31, 2018		$ (821)			$ (821)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	11,817			11,817
Other comprehensive income (loss)	963					963
Dividends declared	(1,231)			(1,231)
Recognition of the fair value of share-based compensation	862		862
Repurchase of common stock	(4,133)		(4,133)
Deferred stock rights and restricted stock units issued in lieu of cash dividends payable on outstanding deferred stock rights and restricted stock units	22		22
Common stock redeemed for the net settlement of share-based awards	(94)		(94)
Balance, end of period at Jun. 30, 2019	296,120		224,244	87,454		(15,578)
Balance, beginning of period at Mar. 31, 2019	294,013		226,235	81,946		(14,168)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	6,121			6,121
Other comprehensive income (loss)	(1,410)					(1,410)
Dividends declared	(613)			(613)
Recognition of the fair value of share-based compensation	383		383
Repurchase of common stock	(2,387)		(2,387)
Deferred stock rights and restricted stock units issued in lieu of cash dividends payable on outstanding deferred stock rights and restricted stock units	13		13
Balance, end of period at Jun. 30, 2019	296,120		224,244	87,454		(15,578)
Balance, beginning of period at Dec. 31, 2019	304,913		219,423	99,681		(14,191)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	9,951			9,951
Other comprehensive income (loss)	(6,947)					(6,947)
Dividends declared	(1,201)			(1,201)
Recognition of the fair value of share-based compensation	1,073		1,073
Deferred stock rights and restricted stock units issued in lieu of cash dividends payable on outstanding deferred stock rights and restricted stock units	15		15
Common stock redeemed for the net settlement of share-based awards	(93)		(93)
Balance, end of period at Jun. 30, 2020	307,711		220,418	108,431		(21,138)
Balance, beginning of period at Mar. 31, 2020	305,127		219,893	105,100		(19,866)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	3,932			3,932
Other comprehensive income (loss)	(1,272)					(1,272)
Dividends declared	(601)			(601)
Recognition of the fair value of share-based compensation	517		517
Deferred stock rights and restricted stock units issued in lieu of cash dividends payable on outstanding deferred stock rights and restricted stock units	8		8
Balance, end of period at Jun. 30, 2020	$ 307,711		$ 220,418	$ 108,431		$ (21,138)

Consolidated Statements of Shareholders' Equity (Unaudited) (Parenthetical) - $ / shares	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Statement of Stockholders' Equity [Abstract]
Dividends declared (in dollars per share)	$ 0.06	$ 0.06	$ 0.12	$ 0.12

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Operating Activities
Net income	$ 9,951,000	$ 11,817,000
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization	3,515,000	3,747,000
Increase in cash surrender value of bank-owned life insurance	(472,000)	(468,000)
Provision for loan losses	3,952,000	2,674,000
Share-based compensation expense	1,073,000	862,000
Loss on other-than-temporary impairment of securities	0	0
(Loss) gain on sale of available-for-sale securities	(41,000)	458,000
Loans originated for sale	(427,323,000)	(220,266,000)
Proceeds from sale of loans	454,737,000	211,432,000
Gain on loans sold	(11,069,000)	(3,128,000)
Gain on sale of other real estate owned	0	0
Decrease (increase) in fair value of loans held-for-sale	939,000	(352,000)
Loss (gain) on derivatives	377,000	(553,000)
Settlement of derivatives	(46,109,000)	0
Net change in servicing asset	(41,000)	0
Amortization of operating lease right-of-use assets	360,000	353,000
Net change in accrued income and other assets	(2,221,000)	(44,383,000)
Net change in accrued expenses and other liabilities	(1,840,000)	4,476,000
Net cash used in operating activities	(14,212,000)	(33,331,000)
Investing Activities
Net loan activity, excluding purchases	(18,907,000)	(153,259,000)
Maturities and calls of securities available-for-sale	74,828,000	30,950,000
Proceeds from sale of securities available-for-sale	795,000	30,137,000
Purchase of securities available-for-sale	(116,993,000)	(76,834,000)
Purchase of securities held-to-maturity	(2,000,000)	(13,116,000)
Purchase of Federal Home Loan Bank of Indianapolis stock	0	(2,025,000)
Purchase of premises and equipment	(10,580,000)	(2,852,000)
Loans purchased	(172,250,000)	(159,068,000)
Net proceeds from sale of portfolio loans	205,023,000	184,095,000
Net cash used in investing activities	(40,084,000)	(161,972,000)
Financing Activities
Net increase in deposits	226,826,000	334,912,000
Short-term borrowings	0	0
Cash dividends paid	(1,179,000)	(1,214,000)
Net proceeds from issuance of subordinated debt	0	35,418,000
Repurchase of common stock	0	(4,133,000)
Proceeds from advances from Federal Home Loan Bank	220,000,000	375,000,000
Repayment of advances from Federal Home Loan Bank	(220,000,000)	(385,000,000)
Other, net	(93,000)	(94,000)
Net cash provided by financing activities	225,554,000	354,889,000
Net Increase in Cash and Cash Equivalents	171,258,000	159,586,000
Cash and Cash Equivalents, Beginning of Period	327,361,000	188,712,000
Cash and Cash Equivalents, End of Period	498,619,000	348,298,000
Supplemental Disclosures
Initial recognition of right-of-use asset	0	2,096,000
Initial recognition of operating lease liabilities	0	2,096,000
Cash paid during the period for interest	43,716,000	37,672,000
Income Taxes Paid, Net	91,000	1,793,000
Loans transferred to other real estate owned	0	0
Loans transferred to held-for-sale from portfolio	204,258,000	184,021,000
Cash dividends declared, paid in subsequent period	588,000	601,000
Securities purchased during the period, settled in subsequent period	0	14,247,000
Transfer of available-for-sale municipal securities to held-to-maturity municipal securities	$ 4,479,000	$ 0

Basis of Presentation	6 Months Ended
Basis of Presentation	Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information or footnotes necessary for a complete presentation of financial condition, results of operations, changes in shareholders’ equity, or cash flows in accordance with GAAP. In our opinion, all adjustments (consisting only of normal recurring adjustments) necessary for a fair presentation have been included. The results of operations for the three and six months ended June 30, 2020 are not necessarily indicative of the results expected for the year ending December 31, 2020 or any other period. The June 30, 2020 condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the First Internet Bancorp Annual Report on Form 10-K for the year ended December 31, 2019. The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments, or assumptions that could have a material effect on the carrying value of certain assets and liabilities. These estimates, judgments, and assumptions affect the amounts reported in the condensed consolidated financial statements and the disclosures provided. The determination of the allowance for loan losses, valuations and impairments of investment securities, valuation of the servicing asset and the accounting for income tax expense are highly dependent upon management’s estimates, judgments, and assumptions, and changes in any of these could have a significant impact on the condensed consolidated financial statements. The condensed consolidated financial statements include the accounts of First Internet Bancorp (the “Company”), its wholly owned subsidiary, First Internet Bank of Indiana (the “Bank”), and the Bank’s three wholly owned subsidiaries, First Internet Public Finance Corp., JKH Realty Services, LLC and SPF15, Inc. All significant intercompany accounts and transactions have been eliminated in consolidation. The Company is subject to claims and lawsuits that arise primarily in the ordinary course of business. It is the opinion of management that the disposition or ultimate resolution of such claims and lawsuits will not have a material adverse effect on the consolidated financial position, results of operations, and cash flows of the Company. Certain reclassifications have been made to the 2019 financial statements to conform to the presentation of the 2020 financial statements. These reclassifications had no effect on net income.

Earnings Per Share

6 Months Ended

Jun. 30, 2020

Earnings Per Share [Abstract]

Earnings Per Share

Earnings per share of common stock are based on the weighted-average number of basic shares and dilutive shares outstanding during the period.

The following is a reconciliation of the weighted-average common shares for the basic and diluted earnings per share computations for the three and six months ended June 30, 2020 and 2019.


(dollars in thousands, except per share data)	Three Months Ended June 30,						Six Months Ended June 30,
	2020		2019		2020		2019
Basic earnings per share
Net income	$	3,932	$	6,121	$	9,951	$	11,817
Weighted-average common shares	9,768,227		10,148,285		9,798,528		10,182,770
Basic earnings per common share	$	0.40	$	0.60	$	1.02	$	1.16
Diluted earnings per share
Net income	$	3,932	$	6,121	$	9,951	$	11,817
Weighted-average common shares	9,768,227		10,148,285		9,798,528		10,182,770

Dilutive effect of equity compensation	—		—		3,899		4,063
Weighted-average common and incremental shares	9,768,227		10,148,285		9,802,427		10,186,833
Diluted earnings per common share ⁽¹⁾	$	0.40	$	0.60	$	1.02	$	1.16

Securities

6 Months Ended

Jun. 30, 2020

Investments, Debt and Equity Securities [Abstract]

Securities

The following tables summarize securities available-for-sale and securities held-to-maturity as of June 30, 2020 and December 31, 2019.


	June 30, 2020
	Amortized		Gross Unrealized						Fair
(in thousands)	Cost		Gains		Losses		Value
Securities available-for-sale
U.S. Government-sponsored agencies	$	68,203	$	384	$	(2,043)	$	66,544
Municipal securities	91,906		3,140		(4,484)		90,562
Agency mortgage-backed securities	275,433		6,632		(3,535)		278,530
Private label mortgage-backed securities	101,110		1,044		(229)		101,925
Asset-backed securities	5,000		—		(163)		4,837
Corporate securities	48,394		309		(2,084)		46,619

Total available-for-sale	$	590,046	$	11,509	$	(12,538)	$	589,017


	June 30, 2020
	Amortized		Gross Unrealized						Fair
(in thousands)	Cost		Gains		Losses		Value
Securities held-to-maturity
Municipal securities	$	14,603	$	671	$	—	$	15,274
Corporate securities	53,692		768		(582)		53,878
Total held-to-maturity	$	68,295	$	1,439	$	(582)	$	69,152


	December 31, 2019
	Amortized		Gross Unrealized						Fair
(in thousands)	Cost		Gains		Losses		Value
Securities available-for-sale
U.S. Government-sponsored agencies	$	77,715	$	99	$	(1,942)	$	75,872
Municipal securities	97,447		1,706		(1,501)		97,652
Agency mortgage-backed securities	264,142		1,304		(4,006)		261,440
Private label mortgage-backed securities	63,704		97		(188)		63,613
Asset-backed securities	5,000		—		(45)		4,955
Corporate securities	38,632		220		(1,532)		37,320

Total available-for-sale	$	546,640	$	3,426	$	(9,214)	$	540,852


	December 31, 2019
	Amortized		Gross Unrealized						Fair
(in thousands)	Cost		Gains		Losses		Value
Securities held-to-maturity
Municipal securities	$	10,142	$	226	$	—	$	10,368
Corporate securities	51,736		588		(132)		52,192
Total held-to-maturity	$	61,878	$	814	$	(132)	$	62,560


	Available-for-Sale
(in thousands)	Amortized Cost		Fair Value
Within one year	$	15	$	15
One to five years	30,141		25,364
Five to ten years	82,174		79,991
After ten years	96,173		98,355
	208,503		203,725
Agency mortgage-backed securities	275,433		278,530
Private label mortgage-backed securities	101,110		101,925
Asset-backed securities	5,000		4,837

Total	$	590,046	$	589,017


	Held-to-Maturity
(in thousands)	Amortized Cost		Fair Value

One to five years	$	1,505	$	1,557
Five to ten years	54,272		54,642
After ten years	12,518		12,953
Total	$	68,295	$	69,152

six months ended June 30, 2020. There were $0.5 million of gross losses resulting from sales of available-for-sale securities during the three and six months ended June 30, 2019.

U. S. Government-Sponsored Agencies, Municipal Securities and Corporate Securities

Agency Mortgage-Backed, Private Label Mortgage-Backed and Asset-Backed Securities


	June 30, 2020
	Less Than 12 Months						12 Months or Longer						Total
(in thousands)	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Securities available-for-sale
U.S. Government-sponsored agencies	$	1,195	$	(15)	$	56,494	$	(2,028)	$	57,689	$	(2,043)
Municipal securities	61,167		(4,484)		—		—		61,167		(4,484)
Agency mortgage-backed securities	22,419		(391)		10,727		(3,144)		33,146		(3,535)
Private label mortgage-backed securities	21,781		(160)		2,777		(69)		24,558		(229)
Asset-backed securities	—		—		4,837		(163)		4,837		(163)
Corporate securities	12,512		(122)		20,038		(1,962)		32,550		(2,084)

Total	$	119,074	$	(5,172)	$	94,873	$	(7,366)	$	213,947	$	(12,538)


	June 30, 2020
	Less Than 12 Months						12 Months or Longer						Total
(in thousands)	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Securities held-to-maturity

Corporate securities	$	23,527	$	(582)	$	—	$	—	$	23,527	$	(582)
Total	$	23,527	$	(582)	$	—	$	—	$	23,527	$	(582)


	December 31, 2019
	Less Than 12 Months						12 Months or Longer						Total
(in thousands)	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Securities available-for-sale
U.S. Government-sponsored agencies	$	4,820	$	(61)	$	62,182	$	(1,881)	$	67,002	$	(1,942)
Municipal securities	1,279		(1,501)		—		—		1,279		(1,501)
Agency mortgage-backed securities	91,159		(829)		83,212		(3,177)		174,371		(4,006)
Private label mortgage-backed securities	30,077		(180)		2,884		(8)		32,961		(188)
Asset-backed securities	—		—		4,955		(45)		4,955		(45)
Corporate securities	—		—		22,985		(1,532)		22,985		(1,532)

Total	$	127,335	$	(2,571)	$	176,218	$	(6,643)	$	303,553	$	(9,214)


	December 31, 2019
	Less Than 12 Months						12 Months or Longer						Total
(in thousands)	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Securities held-to-maturity

Corporate securities	13,977		(132)		—		—		13,977		(132)
Total	$	13,977	$	(132)	$	—	$	—	$	13,977	$	(132)


(in thousands) Details About Accumulated Other Comprehensive Loss Components														Affected Line Item in the Statements of Income
			Three Months Ended June 30, 2020			Six Months Ended June 30, 2020			Three Months Ended June 30, 2019			Six Months Ended June 30, 2019
Realized gains (losses) on securities available-for-sale
Gain (loss) realized in earnings	$	—		$	41		$	(458)		$	(458)		Gain (loss) on sale of securities

Total reclassified amount before tax	—			41			(458)			(458)			Income Before Income Taxes
Tax expense (benefit)	—			11			(124)			(124)			Income Tax Provision (Benefit)
Total reclassifications out of accumulated other comprehensive loss	$	—		$	30		$	(334)		$	(334)		Net Income

Loans

6 Months Ended

Jun. 30, 2020

Receivables [Abstract]

Loans

Loan balances as of June 30, 2020 and December 31, 2019 are summarized in the table below. Categories of loans include:


(in thousands)	June 30, 2020		December 31, 2019
Commercial loans
Commercial and industrial	$	81,687	$	96,420
Owner-occupied commercial real estate⁽¹⁾	86,897		86,726
Investor commercial real estate	13,286		12,567
Construction	77,591		60,274
Single tenant lease financing	980,292		995,879
Public finance	647,107		687,094
Healthcare finance	380,956		300,612
Small business lending⁽¹⁾	118,526		46,945
Total commercial loans	2,386,342		2,286,517
Consumer loans
Residential mortgage	208,728		313,849
Home equity	22,640		24,306
Other consumer	291,632		295,309
Total consumer loans	523,000		633,464
Total commercial and consumer loans	2,909,342		2,919,981
Net deferred loan origination costs and premiums and discounts on purchased loans and other⁽²⁾	64,332		43,566
Total loans	2,973,674		2,963,547
Allowance for loan losses	(24,465)		(21,840)
Net loans	$	2,949,209	$	2,941,707

⁽¹⁾ As of June 30, 2020, $13.3 million of commercial real estate loan balances were reclassified from small business lending to owner-occupied commercial real estate.

The risk characteristics of each loan portfolio segment are as follows:

Allowance for Loan Losses Methodology

Provision for Loan Losses

Policy for Charging Off Loans

The following tables present changes in the balance of the ALLL during the three and six months ended June 30, 2020 and 2019.


(in thousands)	Three Months Ended June 30, 2020
Allowance for loan losses:	Balance, Beginning of Period		Provision (Credit) Charged to Expense		Losses Charged Off		Recoveries		Balance, End of Period
Commercial and industrial	$	1,670	$	(141)	$	(57)	$	5	$	1,477
Owner-occupied commercial real estate	645		201		—		—		846
Investor commercial real estate	128		2		—		—		130
Construction	460		261		—		—		721
Single tenant lease financing	10,755		563		—		—		11,318
Public finance	1,483		59		—		—		1,542
Healthcare finance	4,318		1,187		(743)		—		4,762
Small business lending	265		(20)		—		6		251
Residential mortgage	500		36		—		3		539
Home equity	53		(4)		—		2		51
Other consumer	2,580		347		(216)		117		2,828
Total	$	22,857	$	2,491	$	(1,016)	$	133	$	24,465


	Six Months Ended June 30, 2020
Allowance for loan losses:	Balance, Beginning of Period		Provision (Credit) Charged to Expense		Losses Charged Off		Recoveries		Balance, End of Period
Commercial and industrial	$	1,521	$	205	$	(254)	$	5	$	1,477
Owner-occupied commercial real estate	561		285		—		—		846
Investor commercial real estate	109		21		—		—		130
Construction	380		341		—		—		721
Single tenant lease financing	11,175		143		—		—		11,318
Public finance	1,580		(38)		—		—		1,542
Healthcare finance	3,247		2,258		(743)		—		4,762
Small business lending	54		183		—		14		251
Residential mortgage	657		(107)		(15)		4		539
Home equity	46		—		—		5		51
Other consumer	2,510		661		(502)		159		2,828
Total	$	21,840	$	3,952	$	(1,514)	$	187	$	24,465


(in thousands)	Three Months Ended June 30, 2019
Allowance for loan losses:	Balance, Beginning of Period		Provision (Credit) Charged to Expense		Losses Charged Off		Recoveries		Balance, End of Period
Commercial and industrial	$	1,351	$	444	$	—	$	—	$	1,795
Owner-occupied commercial real estate	847		(223)		—		—		624
Investor commercial real estate	103		66		—		—		169
Construction	267		35		—		—		302
Single tenant lease financing	9,368		293		—		—		9,661
Public finance	1,650		113		—		—		1,763
Healthcare finance	1,731		562		—		—		2,293
Small business lending	93		36		—		—		129
Residential mortgage	1,044		(383)		—		1		662
Home equity	49		(5)		—		4		48
Other consumer	2,338		451		(337)		78		2,530
Total	$	18,841	$	1,389	$	(337)	$	83	$	19,976


	Six Months Ended June 30, 2019
Allowance for loan losses:	Balance, Beginning of Period		Provision (Credit) Charged to Expense		Losses Charged Off		Recoveries		Balance, End of Period
Commercial and industrial	$	1,384	$	523	$	(112)	$	—	$	1,795
Owner-occupied commercial real estate	891		(267)		—		—		624
Investor commercial real estate	61		108		—		—		169
Construction	251		51		—		—		302
Single tenant lease financing	8,827		834		—		—		9,661
Public finance	1,670		93		—		—		1,763
Healthcare finance	1,264		1,029		—		—		2,293
Small business lending	95		34		—		—		129
Residential mortgage	1,079		(419)		—		2		662
Home equity	53		(11)		—		6		48
Other consumer	2,321		699		(654)		164		2,530
Total	$	17,896	$	2,674	$	(766)	$	172	$	19,976

The following tables present the recorded investment in loans based on portfolio segment and impairment method as of June 30, 2020 and December 31, 2019.


(in thousands)	Loans										Allowance for Loan Losses
June 30, 2020	Ending Balance: Collectively Evaluated for Impairment		Ending Balance: Individually Evaluated for Impairment		Ending Balance		Ending Balance: Collectively Evaluated for Impairment		Ending Balance: Individually Evaluated for Impairment		Ending Balance
Commercial and industrial	$	80,871	$	816	$	81,687	$	1,368	$	109	$	1,477
Owner-occupied commercial real estate	82,974		3,922		86,897		846		—		846
Investor commercial real estate	13,286		—		13,286		130		—		130
Construction	77,591		—		77,591		721		—		721
Single tenant lease financing	975,612		4,680		980,292		9,658		1,660		11,318
Public finance	647,107		—		647,107		1,542		—		1,542
Healthcare finance	380,956		—		380,956		4,762		—		4,762
Small business lending	118,526		—		118,526		251				251
Residential mortgage	207,320		1,408		208,728		539		—		539
Home equity	22,640		—		22,640		51		—		51
Other consumer	291,518		115		291,632		2,828		—		2,828
Total	$	2,898,401	$	10,941	$	2,909,342	$	22,696	$	1,769	$	24,465


(in thousands)	Loans										Allowance for Loan Losses
December 31, 2019	Ending Balance: Collectively Evaluated for Impairment		Ending Balance: Individually Evaluated for Impairment		Ending Balance		Ending Balance: Collectively Evaluated for Impairment		Ending Balance: Individually Evaluated for Impairment		Ending Balance
Commercial and industrial	$	93,520	$	2,900	$	96,420	$	1,412	$	109	$	1,521
Owner-occupied commercial real estate	81,063		5,663		86,726		561		—		561
Investor commercial real estate	12,567		—		12,567		109		—		109
Construction	60,274		—		60,274		380		—		380
Single tenant lease financing	991,199		4,680		995,879		9,515		1,660		11,175
Public finance	687,094		—		687,094		1,580		—		1,580
Healthcare finance	300,612		—		300,612		3,247		—		3,247
Small business lending	46,945		—		46,945		54		—		54
Residential mortgage	312,714		1,135		313,849		657		—		657
Home equity	24,306		—		24,306		46		—		46
Other consumer	295,266		43		295,309		2,510		—		2,510
Total	$	2,905,560	$	14,421	$	2,919,981	$	20,071	$	1,769	$	21,840

The Company utilizes a risk grading matrix to assign a risk grade to each of its commercial loans. A description of the general characteristics of the risk grades is as follows:

•“Pass” - Higher quality loans that do not fit any of the other categories described below.

•“Special Mention” - Loans that possess some credit deficiency or potential weakness, which deserve close attention.

•“Loss” - Loans that are considered uncollectible and of such little value that continuing to carry them as assets is not warranted.

Nonaccrual Loans


	June 30, 2020
(in thousands)	Pass		Special Mention		Substandard		Total
Commercial and industrial	$	77,447	$	3,465	$	775	$	81,687
Owner-occupied commercial real estate	80,389		2,585		3,923		86,897
Investor commercial real estate	13,286		—		—		13,286
Construction	77,591		—		—		77,591
Single tenant lease financing	966,782		8,830		4,680		980,292
Public finance	647,107		—		—		647,107
Healthcare finance	379,899		1,057		—		380,956
Small business lending	118,526		—		—		118,526
Total commercial loans	$	2,361,027	$	15,937	$	9,378	$	2,386,342


	June 30, 2020
(in thousands)	Performing		Nonaccrual		Total
Residential mortgage	$	207,686	$	1,042	$	208,728
Home equity	22,640		—		22,640
Other consumer	291,524		108		291,632
Total consumer loans	$	521,850	$	1,150	$	523,000


	December 31, 2019
(in thousands)	Pass		Special Mention		Substandard		Total
Commercial and industrial	$	89,818	$	3,973	$	2,629	$	96,420
Owner-occupied commercial real estate	79,329		3,462		3,935		86,726
Investor commercial real estate	12,567		—		—		12,567
Construction	60,274		—		—		60,274
Single tenant lease financing	983,448		7,751		4,680		995,879
Public finance	687,094		—		—		687,094
Healthcare finance	300,612		—		—		300,612
Small business lending	46,945		—		—		46,945
Total commercial loans	$	2,260,087	$	15,186	$	11,244	$	2,286,517


	December 31, 2019
(in thousands)	Performing		Nonaccrual		Total
Residential mortgage	$	313,088	$	761	$	313,849
Home equity	24,306		—		24,306
Other consumer	295,276		33		295,309
Total consumer loans	$	632,670	$	794	$	633,464

The following tables present the Company’s loan portfolio delinquency analysis as of June 30, 2020 and December 31, 2019.


	June 30, 2020
(in thousands)	30-59 Days Past Due		60-89 Days Past Due		90 Days or More Past Due		Total Past Due		Current		Total Loans		Non- accrual Loans		Total Loans 90 Days or More Past Due and Accruing
Commercial and industrial	$	80	$	—	$	212	$	292	$	81,395	$	81,687	$	299	$	—
Owner-occupied commercial real estate	—		—		2,066		2,066		84,831		86,897		2,066		—
Investor commercial real estate	—		—		—		—		13,286		13,286		—		—
Construction	—		—		—		—		77,591		77,591		—		—
Single tenant lease financing	—		—		4,680		4,680		975,612		980,292		4,680		—
Public finance	—		—		—		—		647,107		647,107		—		—
Healthcare finance	—		—		—		—		380,956		380,956		—		—
Small business lending	—		—		—		—		118,526		118,526		—		—
Residential mortgage	—		—		281		281		208,447		208,728		1,042		—
Home equity	—		—		—		—		22,640		22,640		—		—
Other consumer	80		56		25		161		291,471		291,632		108		—
Total	$	160	$	56	$	7,264	$	7,480	$	2,901,862	$	2,909,342	$	8,195	$	—


	December 31, 2019
(in thousands)	30-59 Days Past Due		60-89 Days Past Due		90 Days or More Past Due		Total Past Due		Current		Total Loans		Non- accrual Loans		Total Loans 90 Days or More Past Due and Accruing
Commercial and industrial	$	15	$	96	$	122	$	233	$	96,187	$	96,420	$	226	$	—
Owner-occupied commercial real estate	—		—		464		464		86,262		86,726		464		—
Investor commercial real estate	—		—		—		—		12,567		12,567		—		—
Construction	—		—		—		—		60,274		60,274		—		—
Single tenant lease financing	—		4,680		—		4,680		991,199		995,879		4,680		—
Public finance	—		—		—		—		687,094		687,094		—		—
Healthcare finance	—		—		—		—		300,612		300,612		—		—
Small business lending	54				—		54		46,891		46,945		—		—
Residential mortgage	—		—		1,177		1,177		312,672		313,849		761		416
Home equity	—		—		—		—		24,306		24,306		—		—
Other consumer	240		107		—		347		294,962		295,309		33		—
Total	$	309	$	4,883	$	1,763	$	6,955	$	2,913,026	$	2,919,981	$	6,164	$	416

Impaired Loans

The following table presents the Company’s impaired loans as of June 30, 2020 and December 31, 2019.


	June 30, 2020										December 31, 2019
(in thousands)	Recorded Balance		Unpaid Principal Balance		Specific Allowance		Recorded Balance		Unpaid Principal Balance		Specific Allowance
Loans without a specific valuation allowance
Commercial and industrial	$	613	$	672	$	—	$	2,693	$	2,694	$	—
Owner-occupied commercial real estate	3,922		3,925		—		5,663		5,665		—





Residential mortgage	1,408		1,498		—		1,135		1,209		—

Other consumer	115		215		—		43		107		—
Total	6,058		6,310		—		9,534		9,675		—
Loans with a specific valuation allowance
Commercial and industrial	203		240		109		207		244		109



Single tenant lease financing	4,680		4,680		1,660		4,680		4,680		1,660





Total	4,883		4,920		1,769		4,887		4,924		1,769
Total impaired loans	$	10,941	$	11,230	$	1,769	$	14,421	$	14,599	$	1,769

The table below presents average balances and interest income recognized for impaired loans during the three and six months ended June 30, 2020 and 2019.


	Three Months Ended														Six Months Ended
	June 30, 2020						June 30, 2019						June 30, 2020				June 30, 2019
(in thousands)	Average Balance		Interest Income		Average Balance		Interest Income		Average Balance		Interest Income		Average Balance		Interest Income
Loans without a specific valuation allowance
Commercial and industrial	$	594	$	18	$	4,053	$	86	$	1,330	$	36	$	4,376	$	167
Owner-occupied commercial real estate	3,923		29		2,723		66		4,573		31		2,464		93




Small business lending	—		—		—		—
Residential mortgage	1,352		—		3,538		—		1,313		—		2,796		—
Home equity	—		—		—		—		—		—		21		—
Other consumer	75		—		83		—		60		—		79		—
Total	5,944		47		10,397		152		7,276		67		9,736		260
Loans with a specific valuation allowance
Commercial and industrial	204		—		353		—		204		—		177		—



Single tenant lease financing	4,680		—		—		—		4,680		—		—		—





Total	4,884		—		353		—		4,884		—		177		—
Total impaired loans	$	10,828	$	47	$	10,750	$	152	$	12,160	$	67	$	9,913	$	260

Troubled Debt Restructurings

considering the borrower’s sustained repayment performance for a reasonable period, generally not less than six consecutive months.

Non-TDR Loan Modifications due to COVID-19

Leases

6 Months Ended

Jun. 30, 2020

Leases [Abstract]

Leases

The following table shows the components of lease expense.


(in thousands)	Three Months Ended								Six Months Ended
	June 30, 2020		June 30, 2019		June 30, 2020		June 30, 2019
Operating lease cost	$	251	$	187	$	466	$	368

The following table shows supplemental cash flow information related to leases.


(in thousands)	Six Months Ended
	June 30, 2020		June 30, 2019
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	497	$	394


(dollars in thousands)
	June 30, 2020			December 31, 2019
Operating lease right-of-use assets	$	1,242		$	1,602
Operating lease liabilities	1,242			1,602

Weighted-average remaining lease term (years)
Operating leases	2.1			2.4

Weighted-average discount rate
Operating leases	2.0		%	2.0		%

The following table shows the future minimum payments of operating leases with initial or remaining terms of one year or more as of June 30, 2020.


(in thousands)
Twelve months ended June 30,
2021	$	691
2022	290
2023	232
2024	—
2025	—
Thereafter	—
Total lease payments	1,213
Less: imputed interest	(30)
Total	$	1,183

Servicing Asset

6 Months Ended

Jun. 30, 2020

Transfers and Servicing [Abstract]

Servicing Asset

Activity for the servicing asset and the related changes in fair value for the six months ended June 30, 2020 and 2019 are shown in the table below.


(in thousands)	Six Months Ended
	June 30, 2020		June 30, 2019
Beginning balance	$	2,481	$	—
Additions	310		—
Changes in fair value	(269)		—
Ending balance	$	2,522	$	—


(in thousands)
	June 30, 2020		December 31, 2019
Loan portfolios serviced for:
SBA guaranteed loans	$	113,927	$	103,981

Total	$	113,927	$	103,981

Commitments and Credit Risk	6 Months Ended
Commitments and Credit Risk	Jun. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Credit Risk	Commitments and Credit Risk In the normal course of business, the Company makes various commitments to extend credit which are not reflected in the accompanying condensed consolidated financial statements. At June 30, 2020 and December 31, 2019, the Company had outstanding loan commitments totaling approximately $267.4 million and $254.4 million, respectively. In addition, the Company is a limited partner in a Small Business Investment Company fund (the “SBIC Fund”). As of June 30, 2020, the Company has committed to contribute up to $1.7 million of capital to the SBIC Fund. Capital Commitments Capital expenditures contracted to at the balance sheet date but not yet recognized in the financial statements are associated with the construction of premises intended to house our future corporate headquarters. The Company has entered into construction-related contracts in the amount of $65.1 million. As of June 30, 2020, $51.6 million of such contract commitments had not yet been incurred. These commitments are due within two years.

Fair Value of Financial Instruments

6 Months Ended

Jun. 30, 2020

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

Level 1 Quoted prices in active markets for identical assets or liabilities

Level 3 Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities

Available-for-Sale Securities

Loans Held-for-Sale (mandatory pricing agreements)

The fair value of loans held-for-sale is determined using quoted prices for similar assets, adjusted for specific attributes of that loan (Level 2).

Servicing Asset

Interest Rate Swap Agreements

Forward Contracts

The fair values of forward contracts on to-be-announced securities are determined using quoted prices in active markets or benchmarked thereto (Level 1).

Interest Rate Lock Commitments


			June 30, 2020 Fair Value Measurements Using
(in thousands)	Fair Value		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
U.S. Government-sponsored agencies	$	66,544	$	—	$	66,544	$	—
Municipal securities	90,562		—		90,562		—
Agency mortgage-backed securities	278,530		—		278,530		—
Private label mortgage-backed securities	101,925				101,925		—
Asset-backed securities	4,837		—		4,837		—
Corporate securities	46,619		—		46,619		—

Total available-for-sale securities	589,017		—		589,017		—
Servicing asset	2,522		—		—		2,522

Interest rate swap liabilities	(34,494)		—		(34,494)		—
Loans held-for-sale (mandatory pricing agreements)	2,001		—		2,001		—
Forward contracts	(17)		(17)		—		—
IRLCs	282		—		—		282


			December 31, 2019 Fair Value Measurements Using
(in thousands)	Fair Value		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
U.S. Government-sponsored agencies	$	75,872	$	—	$	75,872	$	—
Municipal securities	97,652		—		97,652		—
Agency mortgage-backed securities	261,440		—		261,440		—
Private label mortgage-backed securities	63,613		—		63,613		—
Asset-backed securities	4,955		—		4,955		—
Corporate securities	37,320		—		37,320		—

Total available-for-sale securities	540,852		—		540,852		—
Servicing asset	2,481		—		—		2,481

Interest rate swap liabilities	(37,786)		—		(37,786)		—
Loans held-for-sale (mandatory pricing agreements)	56,097		—		56,097		—
Forward contracts	(153)		(153)		—		—
IRLCs	910		—		—		910


	Three Months Ended
(in thousands)	Servicing Asset		Interest Rate Lock Commitments
Balance, April 1, 2020	$	2,415	$	2,064
Total realized gains (losses)
Additions	197		—
Change in fair value	(90)		(1,782)

Balance, June 30, 2020	2,522		282

Balance as of April 1, 2019	$	—	$	781
Total realized gains

Change in fair value	—		428

Balance, June 30, 2019	$	—	$	1,209



(in thousands)	Six Months Ended
	Servicing Asset		Interest Rate Lock Commitments
Balance January 1, 2020	$	2,481	$	910
Total realized gains (losses)
Additions	310		—
Change in fair value	(269)		(628)

Balance, June 30, 2020	$	2,522	282

Balance as of January 1, 2019	$	—	$	389
Total realized gains
Change in fair value	—		820

Balance, June 30, 2019	$	—	$	1,209

Impaired Loans (Collateral Dependent)

Impaired loans with a specific valuation allowance based on the value of the underlying collateral or a discounted cash flow analysis are classified as Level 3 assets.

hierarchy in which the fair value measurement falls at December 31, 2019. The Company did not have any measurements on a nonrecurring basis at June 30, 2020.


			December 31, 2019
(in thousands)			Fair Value Measurements Using
	Fair Value		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Impaired loans	$	3,019	$	—	$	—	$	3,019

Significant Unobservable (Level 3) Inputs

The following tables present quantitative information about unobservable inputs used in recurring and nonrecurring Level 3 fair value measurements.

(dollars in thousands)

Fair Value at
June 30, 2020

Valuation
Technique

Significant Unobservable
Inputs

Range

Weighted-Average Range

IRLCs

282

Discounted cash flow

Loan closing rates

63% - 100%

73%

Servicing asset

2,522

Discounted cash flow

Prepayment speeds

0% - 25%

13.0%

Expected weighted-average loan life

3.6 - 5.6 years

4.8 years

(dollars in thousands)

Fair Value at
December 31, 2019

Valuation
Technique

Significant Unobservable
Inputs

Range

Weighted-Average Range

Impaired loans

3,019

Fair value of collateral

Discount for type of property and current market conditions

10%

IRLCs

910

Discounted cash flow

Loan closing rates

50% - 100%

84%

Servicing asset

2,481

Discounted cash flow

Prepayment speeds

0% - 25%

13.5%

Expected weighted-average loan life

3.2 - 5.7 years

5.0 years

The following methods were used to estimate the fair value of all other financial instruments recognized in the accompanying condensed consolidated balance sheets at amounts other than fair value.

Cash and Cash Equivalents

For these instruments, the carrying amount is a reasonable estimate of fair value.

Securities Held-to-Maturity

Loans Held-for-Sale (best efforts pricing agreements)

The fair value of these loans approximates carrying value.

Loans

The fair value of loans is estimated on an exit price basis incorporating discounts for credit, liquidity and marketability factors.

Accrued Interest Receivable

The fair value of these financial instruments approximates carrying value.

Federal Home Loan Bank of Indianapolis Stock

The fair value approximates carrying value.

Deposits

Advances from Federal Home Loan Bank

Subordinated Debt

Accrued Interest Payable

The fair value of these financial instruments approximates carrying value.

Commitments

The following tables present the carrying value and estimated fair value of all financial assets and liabilities at June 30, 2020 and December 31, 2019.


	June 30, 2020 Fair Value Measurements Using
(in thousands)	Carrying Amount		Fair Value		Quoted Prices In Active Market for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Cash and cash equivalents	$	498,619	$	498,619	$	498,619	$	—	$	—

Securities held-to-maturity	68,295		69,152		—		69,152		—
Loans held-for-sale (best efforts pricing agreements)	23,493		23,493		—		23,493		—
Net loans	2,949,209		3,006,369		—		—		3,006,369
Accrued interest receivable	21,093		21,093		21,093		—		—
Federal Home Loan Bank of Indianapolis stock	25,650		25,650		—		25,650		—
Deposits	3,380,789		3,428,960		1,520,495		—		1,908,465
Advances from Federal Home Loan Bank	514,913		548,015		—		548,015		—
Subordinated debt	69,681		65,349		55,154		10,195		—
Accrued interest payable	1,073		1,073		1,073		—		—


	December 31, 2019 Fair Value Measurements Using
(in thousands)	Carrying Amount		Fair Value		Quoted Prices In Active Market for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Cash and cash equivalents	$	327,361	$	327,361	$	327,361	$	—	$	—

Securities held-to-maturity	61,878		62,560		—		62,560		—

Net loans	2,941,707		2,876,688		—		—		2,876,688
Accrued interest receivable	18,607		18,607		18,607		—		—
Federal Home Loan Bank of Indianapolis stock	25,650		25,650		—		25,650		—
Deposits	3,153,963		3,232,065		1,002,141		—		2,229,924
Advances from Federal Home Loan Bank	514,910		520,950		—		520,950		—
Subordinated debt	69,528		75,206		64,996		10,210		—
Accrued interest payable	3,767		3,767		3,767		—		—

Mortgage Banking Activities

6 Months Ended

Jun. 30, 2020

Mortgage Banking [Abstract]

Mortgage Banking Activities

Mortgage Banking ActivitiesThe Company’s residential real estate lending business originates mortgage loans for customers and typically sells a majority of the originated loans into the secondary market. For most of the mortgages it sells in the secondary market, the Company hedges its mortgage banking pipeline by entering into forward contracts for the future delivery of mortgage loans to third party investors and entering into IRLCs with potential borrowers to fund specific mortgage loans that will be sold into the secondary market. To facilitate the hedging of the loans, the Company has elected the fair value option for loans originated and intended for sale in the secondary market under mandatory pricing agreements. Changes in the fair value of loans held-for-sale, IRLCs and forward contracts are recorded in the mortgage banking activities line item within noninterest income. Refer to Note 14 for further information on derivative financial instruments.

The following table presents the components of income from mortgage banking activities for the three and six months ended June 30, 2020 and 2019.


	Three Months Ended June 30,						Six Months Ended June 30,
(in thousands)	2020		2019		2020		2019
Gain on loans sold	$	4,164	$	1,825	$	8,507	$	3,298
(Loss) gain resulting from the change in fair value of loans held-for-sale	(1,255)		534		(939)		352
Gain (loss) resulting from the change in fair value of derivatives	499		305		(492)		631
Net revenue from mortgage banking activities	$	3,408	$	2,664	$	7,076	$	4,281

Accumulated Other Comprehensive Loss

6 Months Ended

Jun. 30, 2020

Stockholders' Equity Note [Abstract]

Accumulated Other Comprehensive Loss

The components of accumulated other comprehensive loss, included in stockholders' equity, for the six months ended June 30, 2020 and 2019, respectively, are presented in the table below.


(in thousands)	Available-For-Sale Securities		Cash Flow Hedges		Total
Balance, January 1, 2020	$	(4,388)	$	(9,803)	$	(14,191)
Net change in unrealized gain (loss)	4,801		(13,967)		(9,166)
Reclassification of gain realized and included in earnings	(41)		—		(41)
Accumulated other comprehensive income (loss) before income tax	372		(23,770)		(23,398)
Income tax provision (benefit)	1,760		(4,020)		(2,260)
Balance, June 30, 2020	$	(1,388)	$	(19,750)	$	(21,138)

Balance, January 1, 2019	$	(13,360)	$	(3,181)	$	(16,541)
Net change in unrealized gain (loss)	10,577		(9,464)		1,113
Reclassification of net loss realized and included in earnings	458		—		458
Accumulated other comprehensive loss before income tax	(2,325)		(12,645)		(14,970)
Income tax provision (benefit)	3,163		(2,555)		608
Balance, June 30, 2019	$	(5,488)	$	(10,090)	$	(15,578)

The components of accumulated other comprehensive loss, included in stockholders' equity, for the three months ended June 30, 2020 and 2019, respectively, are presented in the table below.


(in thousands)	Available-For-Sale Securities		Cash Flow Hedges		Total
Balance, April 1, 2020	$	(239)	$	(19,627)	$	(19,866)
Net change in unrealized loss	(1,498)		(509)		(2,007)

Accumulated other comprehensive loss before income tax	(1,737)		(20,136)		(21,873)
Income tax benefit	(349)		(386)		(735)
Balance, June 30, 2020	$	(1,388)	$	(19,750)	$	(21,138)

Balance, April 1, 2019	$	(8,380)	$	(5,788)	$	(14,168)
Net change in unrealized gain (loss)	3,667		(5,892)		(2,225)
Reclassification of net loss realized and included in earnings	458		—		458
Accumulated other comprehensive loss before income tax	(4,255)		(11,680)		(15,935)
Income tax provision (benefit)	1,233		(1,590)		(357)
Balance, June 30, 2019	$	(5,488)	$	(10,090)	$	(15,578)

Recent Accounting Pronouncements	6 Months Ended
Recent Accounting Pronouncements	Jun. 30, 2020
Accounting Standards Update and Change in Accounting Principle [Abstract]
Recent Accounting Pronouncements	Recent Accounting Pronouncements ASU 2016-13 - Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (June 2016) The main objective of this update is to provide financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date. To achieve this objective, the amendments in this update replace the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The amendments affect entities holding financial assets that are not accounted for at fair value through net income. The amendments affect loans, debt securities, off-balance-sheet credit exposures, and any other financial assets not excluded from the scope that have the contractual right to receive cash. The amendments in this update affect an entity to varying degrees depending on the credit quality of the assets held by the entity, their duration, and how the entity applies current GAAP. There is diversity in practice in applying the incurred loss methodology, which means that before transition some entities may be more aligned under current GAAP than others to the new measure of expected credit losses. The following describes the main provisions of this update. •Assets Measured at Amortized Cost: The amendments in this update require a financial asset (or a group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset(s) to present the net carrying value at the amount expected to be collected on the financial asset. The statements of income reflect the measurement of credit losses for newly recognized financial assets, as well as the expected increase or decrease of credit losses that have taken place during the period. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. An entity must use judgment in determining the relevant information and estimation methods that are appropriate in its circumstances. •Available-for-Sale Debt Securities: Credit losses relating to available-for-sale debt securities should be recorded through an allowance for credit losses. Available-for-sale accounting recognizes that value may be realized either through collection of contractual cash flows or through sale of the security. Therefore, the amendments limit the amount of the allowance for credit losses to the amount by which fair value is below amortized cost because the classification as available-for-sale is premised on an investment strategy that recognizes that the investment could be sold at fair value if cash collection would result in the realization of an amount less than fair value. •In May 2019, the FASB issued ASU 2019-05 - Financial Instruments - Credit Losses (Topic 326) - Targeted Transition Relief. This ASU allows an option for preparers to irrevocably elect the fair value option, on an instrument-by-instrument basis, for eligible financial assets measured at amortized cost basis upon adoption of the credit losses standard. This increases the comparability of financial statement information provided by institutions that otherwise would have reported similar financial instruments using different measurement methodologies, potentially decreasing costs for financial statement preparers while providing more useful information to investors and other users. For public business entities that are SEC filers, the amendments in this update are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. All entities may early adopt the amendments in this update as of the fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. In October 2019, the FASB voted to delay the effective date for smaller reporting companies to fiscal years beginning after December 15, 2022. An entity will apply the amendments in this update through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective (that is, a modified-retrospective approach). A prospective transition approach is required for debt securities for which an OTTI had been recognized before the effective date. The effect of a prospective transition approach is to maintain the same amortized cost basis before and after the effective date of this update. The Company does not expect to early adopt and is currently evaluating the impact of the amendments on the Company’s condensed consolidated financial statements. The Company currently cannot determine or reasonably quantify the impact of the adoption of the amendments due to the complexity and extensive changes. The Company intends to develop processes and procedures prior to the effective date to ensure it is fully compliant with the amendments at the adoption date. The Company has formed an implementation committee and has engaged a third-party consultant to assist in developing current expected credit losses (“CECL”) models using appropriate methodologies. ASU 2017-04 - Intangibles - Goodwill and other (Topic 350) - Simplifying the Test for Goodwill Impairment” (January 2017) The amendments in this update simplify the goodwill impairment test by eliminating Step 2 of the goodwill impairment process, which requires an entity to determine the implied fair value of its goodwill by assigning fair value to all its assets and liabilities. Under the new guidance, an entity will record an impairment charge if a reporting unit’s carrying amount exceeds its fair value. Entities still have the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment is necessary. The amendments in this ASU are effective for smaller reporting companies for annual and interim impairment tests performed in periods beginning after December 15, 2022. Early adoption is permitted. The Company adopted this guidance effective July 1, 2020 and it did not have a material impact on the condensed consolidated financial statements. ASU 2018-13 - Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement (August 2018) The amendments in this update modify the disclosure requirements on fair value measurements in ASC Topic 820. This ASU eliminates the requirements to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels and the valuation processes for Level 3 fair value measurements. In addition, this ASU requires entities that calculate net asset value to disclose the timing of liquidation of an investee’s assets and the date when restrictions from redemption might lapse only if the investee has communicated the timing to the entity or announced the timing publicly. This ASU also adds new requirements, which include the disclosure of the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. The amendments in this ASU are effective for public companies for fiscal years, and interim fiscal periods within those fiscal years, beginning after December 15, 2019. The Company adopted this guidance and it did not have a material impact on the condensed consolidated financial statements. ASU 2019-04 - Codification Improvements to Topic 326, Financial Instruments - Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments (April 2019) The amendments in this ASU clarify or correct the guidance in ASC Topic 326, Topic 815 and Topic 825. With respect to Topic 326, ASU 2019-04 addresses a number of issues as it relates to the CECL standard including consideration of accrued interest, recoveries, variable-rate financial instruments, prepayments, extension and renewal options, among other things, in the measurement of expected credit losses. The amendments to Topic 326 have the same effective dates as ASU 2016-13 and the Company is currently evaluating the potential impact of these amendments on the condensed consolidated financial statements. With respect to Topic 815, ASU 2019-04 clarifies issues related to partial-term hedges, hedged debt securities, and transitioning from a quantitative method of assessing hedge effectiveness to a more simplified method. The amendments to Topic 815 are effective for interim and annual reporting periods beginning after December 15, 2019 and are not expected to have a material impact on the condensed consolidated financial statements. With respect to Topic 825, ASU 2019-04 addresses the scope of the guidance, the requirement for remeasurement under ASC Topic 820 when using the measurement alternative, certain disclosure requirements, and which equity securities must be remeasured at historical exchanges rates. The amendments to Topic 825 are effective for interim and annual reporting periods beginning after December 15, 2019 and are not expected to have a material impact on the condensed consolidated financial statements. Coronavirus Aid, Relief and Economic Security Act (“CARES Act”) In March 2020 in connection with the implementation of the CARES Act and related provisions, the Company elected the temporary relief in the CARES Act not to apply the guidance in ASC 310-40 on accounting for TDRs to loan modifications related to COVID-19. Section 4013 of the CARES Act further provides that loan modifications due to the impact of COVID-19 that would otherwise be classified as TDRs under GAAP will not be so classified. Modifications within the scope of this relief are in effect from the period beginning March 1, 2020 until the earlier of December 31, 2020 or 60 days after the date on which the national emergency related to the COVID-19 pandemic formally terminates. See the “Non-TDR Loan Modifications due to COVID-19” section of Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations for more information.

Basis of Presentation (Policies)	6 Months Ended
Basis of Presentation (Policies)	Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Recent Accounting Pronouncements	Recent Accounting Pronouncements ASU 2016-13 - Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (June 2016) The main objective of this update is to provide financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date. To achieve this objective, the amendments in this update replace the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The amendments affect entities holding financial assets that are not accounted for at fair value through net income. The amendments affect loans, debt securities, off-balance-sheet credit exposures, and any other financial assets not excluded from the scope that have the contractual right to receive cash. The amendments in this update affect an entity to varying degrees depending on the credit quality of the assets held by the entity, their duration, and how the entity applies current GAAP. There is diversity in practice in applying the incurred loss methodology, which means that before transition some entities may be more aligned under current GAAP than others to the new measure of expected credit losses. The following describes the main provisions of this update. •Assets Measured at Amortized Cost: The amendments in this update require a financial asset (or a group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset(s) to present the net carrying value at the amount expected to be collected on the financial asset. The statements of income reflect the measurement of credit losses for newly recognized financial assets, as well as the expected increase or decrease of credit losses that have taken place during the period. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. An entity must use judgment in determining the relevant information and estimation methods that are appropriate in its circumstances. •Available-for-Sale Debt Securities: Credit losses relating to available-for-sale debt securities should be recorded through an allowance for credit losses. Available-for-sale accounting recognizes that value may be realized either through collection of contractual cash flows or through sale of the security. Therefore, the amendments limit the amount of the allowance for credit losses to the amount by which fair value is below amortized cost because the classification as available-for-sale is premised on an investment strategy that recognizes that the investment could be sold at fair value if cash collection would result in the realization of an amount less than fair value. •In May 2019, the FASB issued ASU 2019-05 - Financial Instruments - Credit Losses (Topic 326) - Targeted Transition Relief. This ASU allows an option for preparers to irrevocably elect the fair value option, on an instrument-by-instrument basis, for eligible financial assets measured at amortized cost basis upon adoption of the credit losses standard. This increases the comparability of financial statement information provided by institutions that otherwise would have reported similar financial instruments using different measurement methodologies, potentially decreasing costs for financial statement preparers while providing more useful information to investors and other users. For public business entities that are SEC filers, the amendments in this update are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. All entities may early adopt the amendments in this update as of the fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. In October 2019, the FASB voted to delay the effective date for smaller reporting companies to fiscal years beginning after December 15, 2022. An entity will apply the amendments in this update through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective (that is, a modified-retrospective approach). A prospective transition approach is required for debt securities for which an OTTI had been recognized before the effective date. The effect of a prospective transition approach is to maintain the same amortized cost basis before and after the effective date of this update. The Company does not expect to early adopt and is currently evaluating the impact of the amendments on the Company’s condensed consolidated financial statements. The Company currently cannot determine or reasonably quantify the impact of the adoption of the amendments due to the complexity and extensive changes. The Company intends to develop processes and procedures prior to the effective date to ensure it is fully compliant with the amendments at the adoption date. The Company has formed an implementation committee and has engaged a third-party consultant to assist in developing current expected credit losses (“CECL”) models using appropriate methodologies. ASU 2017-04 - Intangibles - Goodwill and other (Topic 350) - Simplifying the Test for Goodwill Impairment” (January 2017) The amendments in this update simplify the goodwill impairment test by eliminating Step 2 of the goodwill impairment process, which requires an entity to determine the implied fair value of its goodwill by assigning fair value to all its assets and liabilities. Under the new guidance, an entity will record an impairment charge if a reporting unit’s carrying amount exceeds its fair value. Entities still have the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment is necessary. The amendments in this ASU are effective for smaller reporting companies for annual and interim impairment tests performed in periods beginning after December 15, 2022. Early adoption is permitted. The Company adopted this guidance effective July 1, 2020 and it did not have a material impact on the condensed consolidated financial statements. ASU 2018-13 - Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement (August 2018) The amendments in this update modify the disclosure requirements on fair value measurements in ASC Topic 820. This ASU eliminates the requirements to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels and the valuation processes for Level 3 fair value measurements. In addition, this ASU requires entities that calculate net asset value to disclose the timing of liquidation of an investee’s assets and the date when restrictions from redemption might lapse only if the investee has communicated the timing to the entity or announced the timing publicly. This ASU also adds new requirements, which include the disclosure of the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. The amendments in this ASU are effective for public companies for fiscal years, and interim fiscal periods within those fiscal years, beginning after December 15, 2019. The Company adopted this guidance and it did not have a material impact on the condensed consolidated financial statements. ASU 2019-04 - Codification Improvements to Topic 326, Financial Instruments - Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments (April 2019) The amendments in this ASU clarify or correct the guidance in ASC Topic 326, Topic 815 and Topic 825. With respect to Topic 326, ASU 2019-04 addresses a number of issues as it relates to the CECL standard including consideration of accrued interest, recoveries, variable-rate financial instruments, prepayments, extension and renewal options, among other things, in the measurement of expected credit losses. The amendments to Topic 326 have the same effective dates as ASU 2016-13 and the Company is currently evaluating the potential impact of these amendments on the condensed consolidated financial statements. With respect to Topic 815, ASU 2019-04 clarifies issues related to partial-term hedges, hedged debt securities, and transitioning from a quantitative method of assessing hedge effectiveness to a more simplified method. The amendments to Topic 815 are effective for interim and annual reporting periods beginning after December 15, 2019 and are not expected to have a material impact on the condensed consolidated financial statements. With respect to Topic 825, ASU 2019-04 addresses the scope of the guidance, the requirement for remeasurement under ASC Topic 820 when using the measurement alternative, certain disclosure requirements, and which equity securities must be remeasured at historical exchanges rates. The amendments to Topic 825 are effective for interim and annual reporting periods beginning after December 15, 2019 and are not expected to have a material impact on the condensed consolidated financial statements. Coronavirus Aid, Relief and Economic Security Act (“CARES Act”) In March 2020 in connection with the implementation of the CARES Act and related provisions, the Company elected the temporary relief in the CARES Act not to apply the guidance in ASC 310-40 on accounting for TDRs to loan modifications related to COVID-19. Section 4013 of the CARES Act further provides that loan modifications due to the impact of COVID-19 that would otherwise be classified as TDRs under GAAP will not be so classified. Modifications within the scope of this relief are in effect from the period beginning March 1, 2020 until the earlier of December 31, 2020 or 60 days after the date on which the national emergency related to the COVID-19 pandemic formally terminates. See the “Non-TDR Loan Modifications due to COVID-19” section of Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations for more information.

Earnings Per Share (Tables)

6 Months Ended

Jun. 30, 2020

Earnings Per Share [Abstract]

Schedule of Weighted Average Number of Shares

The following is a reconciliation of the weighted-average common shares for the basic and diluted earnings per share computations for the three and six months ended June 30, 2020 and 2019.


(dollars in thousands, except per share data)	Three Months Ended June 30,						Six Months Ended June 30,
	2020		2019		2020		2019
Basic earnings per share
Net income	$	3,932	$	6,121	$	9,951	$	11,817
Weighted-average common shares	9,768,227		10,148,285		9,798,528		10,182,770
Basic earnings per common share	$	0.40	$	0.60	$	1.02	$	1.16
Diluted earnings per share
Net income	$	3,932	$	6,121	$	9,951	$	11,817
Weighted-average common shares	9,768,227		10,148,285		9,798,528		10,182,770

Dilutive effect of equity compensation	—		—		3,899		4,063
Weighted-average common and incremental shares	9,768,227		10,148,285		9,802,427		10,186,833
Diluted earnings per common share ⁽¹⁾	$	0.40	$	0.60	$	1.02	$	1.16

(1) Potential dilutive common shares are excluded from the computation of diluted EPS in the periods where the effect would be antidilutive. Excluded from the computation of diluted EPS were weighted-average antidilutive shares totaling 79,893 and 29,606 for the three and six months ended June 30, 2020, respectively and 30,250 and 23,305 for the three and six months ended June 30, 2019, respectively

Securities (Tables)

6 Months Ended

Jun. 30, 2020

Investments, Debt and Equity Securities [Abstract]

Schedule of Available-for-sale Securities Reconciliation

The following tables summarize securities available-for-sale and securities held-to-maturity as of June 30, 2020 and December 31, 2019.


	June 30, 2020
	Amortized		Gross Unrealized						Fair
(in thousands)	Cost		Gains		Losses		Value
Securities available-for-sale
U.S. Government-sponsored agencies	$	68,203	$	384	$	(2,043)	$	66,544
Municipal securities	91,906		3,140		(4,484)		90,562
Agency mortgage-backed securities	275,433		6,632		(3,535)		278,530
Private label mortgage-backed securities	101,110		1,044		(229)		101,925
Asset-backed securities	5,000		—		(163)		4,837
Corporate securities	48,394		309		(2,084)		46,619

Total available-for-sale	$	590,046	$	11,509	$	(12,538)	$	589,017


	December 31, 2019
	Amortized		Gross Unrealized						Fair
(in thousands)	Cost		Gains		Losses		Value
Securities available-for-sale
U.S. Government-sponsored agencies	$	77,715	$	99	$	(1,942)	$	75,872
Municipal securities	97,447		1,706		(1,501)		97,652
Agency mortgage-backed securities	264,142		1,304		(4,006)		261,440
Private label mortgage-backed securities	63,704		97		(188)		63,613
Asset-backed securities	5,000		—		(45)		4,955
Corporate securities	38,632		220		(1,532)		37,320

Total available-for-sale	$	546,640	$	3,426	$	(9,214)	$	540,852

Schedule Of Held-To-Maturity Securities Reconciliation


	June 30, 2020
	Amortized		Gross Unrealized						Fair
(in thousands)	Cost		Gains		Losses		Value
Securities held-to-maturity
Municipal securities	$	14,603	$	671	$	—	$	15,274
Corporate securities	53,692		768		(582)		53,878
Total held-to-maturity	$	68,295	$	1,439	$	(582)	$	69,152


	December 31, 2019
	Amortized		Gross Unrealized						Fair
(in thousands)	Cost		Gains		Losses		Value
Securities held-to-maturity
Municipal securities	$	10,142	$	226	$	—	$	10,368
Corporate securities	51,736		588		(132)		52,192
Total held-to-maturity	$	61,878	$	814	$	(132)	$	62,560

Available-for-sale Securities


	Available-for-Sale
(in thousands)	Amortized Cost		Fair Value
Within one year	$	15	$	15
One to five years	30,141		25,364
Five to ten years	82,174		79,991
After ten years	96,173		98,355
	208,503		203,725
Agency mortgage-backed securities	275,433		278,530
Private label mortgage-backed securities	101,110		101,925
Asset-backed securities	5,000		4,837

Total	$	590,046	$	589,017

Held-to-maturity Securities


	Held-to-Maturity
(in thousands)	Amortized Cost		Fair Value

One to five years	$	1,505	$	1,557
Five to ten years	54,272		54,642
After ten years	12,518		12,953
Total	$	68,295	$	69,152

Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value


	June 30, 2020
	Less Than 12 Months						12 Months or Longer						Total
(in thousands)	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Securities available-for-sale
U.S. Government-sponsored agencies	$	1,195	$	(15)	$	56,494	$	(2,028)	$	57,689	$	(2,043)
Municipal securities	61,167		(4,484)		—		—		61,167		(4,484)
Agency mortgage-backed securities	22,419		(391)		10,727		(3,144)		33,146		(3,535)
Private label mortgage-backed securities	21,781		(160)		2,777		(69)		24,558		(229)
Asset-backed securities	—		—		4,837		(163)		4,837		(163)
Corporate securities	12,512		(122)		20,038		(1,962)		32,550		(2,084)

Total	$	119,074	$	(5,172)	$	94,873	$	(7,366)	$	213,947	$	(12,538)


	June 30, 2020
	Less Than 12 Months						12 Months or Longer						Total
(in thousands)	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Securities held-to-maturity

Corporate securities	$	23,527	$	(582)	$	—	$	—	$	23,527	$	(582)
Total	$	23,527	$	(582)	$	—	$	—	$	23,527	$	(582)


	December 31, 2019
	Less Than 12 Months						12 Months or Longer						Total
(in thousands)	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Securities available-for-sale
U.S. Government-sponsored agencies	$	4,820	$	(61)	$	62,182	$	(1,881)	$	67,002	$	(1,942)
Municipal securities	1,279		(1,501)		—		—		1,279		(1,501)
Agency mortgage-backed securities	91,159		(829)		83,212		(3,177)		174,371		(4,006)
Private label mortgage-backed securities	30,077		(180)		2,884		(8)		32,961		(188)
Asset-backed securities	—		—		4,955		(45)		4,955		(45)
Corporate securities	—		—		22,985		(1,532)		22,985		(1,532)

Total	$	127,335	$	(2,571)	$	176,218	$	(6,643)	$	303,553	$	(9,214)

Held to Maturity, Continuous Unrealized Loss Position, Fair Value


	December 31, 2019
	Less Than 12 Months						12 Months or Longer						Total
(in thousands)	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Securities held-to-maturity

Corporate securities	13,977		(132)		—		—		13,977		(132)
Total	$	13,977	$	(132)	$	—	$	—	$	13,977	$	(132)

Schedule of Accumulated Other Comprehensive Income (Loss)


(in thousands) Details About Accumulated Other Comprehensive Loss Components														Affected Line Item in the Statements of Income
			Three Months Ended June 30, 2020			Six Months Ended June 30, 2020			Three Months Ended June 30, 2019			Six Months Ended June 30, 2019
Realized gains (losses) on securities available-for-sale
Gain (loss) realized in earnings	$	—		$	41		$	(458)		$	(458)		Gain (loss) on sale of securities

Total reclassified amount before tax	—			41			(458)			(458)			Income Before Income Taxes
Tax expense (benefit)	—			11			(124)			(124)			Income Tax Provision (Benefit)
Total reclassifications out of accumulated other comprehensive loss	$	—		$	30		$	(334)		$	(334)		Net Income

The components of accumulated other comprehensive loss, included in stockholders' equity, for the six months ended June 30, 2020 and 2019, respectively, are presented in the table below.


(in thousands)	Available-For-Sale Securities		Cash Flow Hedges		Total
Balance, January 1, 2020	$	(4,388)	$	(9,803)	$	(14,191)
Net change in unrealized gain (loss)	4,801		(13,967)		(9,166)
Reclassification of gain realized and included in earnings	(41)		—		(41)
Accumulated other comprehensive income (loss) before income tax	372		(23,770)		(23,398)
Income tax provision (benefit)	1,760		(4,020)		(2,260)
Balance, June 30, 2020	$	(1,388)	$	(19,750)	$	(21,138)

Balance, January 1, 2019	$	(13,360)	$	(3,181)	$	(16,541)
Net change in unrealized gain (loss)	10,577		(9,464)		1,113
Reclassification of net loss realized and included in earnings	458		—		458
Accumulated other comprehensive loss before income tax	(2,325)		(12,645)		(14,970)
Income tax provision (benefit)	3,163		(2,555)		608
Balance, June 30, 2019	$	(5,488)	$	(10,090)	$	(15,578)

The components of accumulated other comprehensive loss, included in stockholders' equity, for the three months ended June 30, 2020 and 2019, respectively, are presented in the table below.


(in thousands)	Available-For-Sale Securities		Cash Flow Hedges		Total
Balance, April 1, 2020	$	(239)	$	(19,627)	$	(19,866)
Net change in unrealized loss	(1,498)		(509)		(2,007)

Accumulated other comprehensive loss before income tax	(1,737)		(20,136)		(21,873)
Income tax benefit	(349)		(386)		(735)
Balance, June 30, 2020	$	(1,388)	$	(19,750)	$	(21,138)

Balance, April 1, 2019	$	(8,380)	$	(5,788)	$	(14,168)
Net change in unrealized gain (loss)	3,667		(5,892)		(2,225)
Reclassification of net loss realized and included in earnings	458		—		458
Accumulated other comprehensive loss before income tax	(4,255)		(11,680)		(15,935)
Income tax provision (benefit)	1,233		(1,590)		(357)
Balance, June 30, 2019	$	(5,488)	$	(10,090)	$	(15,578)

Loans (Tables)

6 Months Ended

Jun. 30, 2020

Receivables [Abstract]

Schedule of Accounts, Notes, Loans and Financing Receivable

Loan balances as of June 30, 2020 and December 31, 2019 are summarized in the table below. Categories of loans include:


(in thousands)	June 30, 2020		December 31, 2019
Commercial loans
Commercial and industrial	$	81,687	$	96,420
Owner-occupied commercial real estate⁽¹⁾	86,897		86,726
Investor commercial real estate	13,286		12,567
Construction	77,591		60,274
Single tenant lease financing	980,292		995,879
Public finance	647,107		687,094
Healthcare finance	380,956		300,612
Small business lending⁽¹⁾	118,526		46,945
Total commercial loans	2,386,342		2,286,517
Consumer loans
Residential mortgage	208,728		313,849
Home equity	22,640		24,306
Other consumer	291,632		295,309
Total consumer loans	523,000		633,464
Total commercial and consumer loans	2,909,342		2,919,981
Net deferred loan origination costs and premiums and discounts on purchased loans and other⁽²⁾	64,332		43,566
Total loans	2,973,674		2,963,547
Allowance for loan losses	(24,465)		(21,840)
Net loans	$	2,949,209	$	2,941,707

⁽¹⁾ As of June 30, 2020, $13.3 million of commercial real estate loan balances were reclassified from small business lending to owner-occupied commercial real estate.

(2) Includes carrying value adjustments of $46.0 million related to terminated interest rate swaps associated with public finance loans as of June 30, 2020 and $21.4 million related to interest rate swaps associated with public finance loans as of December 31, 2019.

Allowance for Credit Losses on Financing Receivables

The following tables present changes in the balance of the ALLL during the three and six months ended June 30, 2020 and 2019.


(in thousands)	Three Months Ended June 30, 2020
Allowance for loan losses:	Balance, Beginning of Period		Provision (Credit) Charged to Expense		Losses Charged Off		Recoveries		Balance, End of Period
Commercial and industrial	$	1,670	$	(141)	$	(57)	$	5	$	1,477
Owner-occupied commercial real estate	645		201		—		—		846
Investor commercial real estate	128		2		—		—		130
Construction	460		261		—		—		721
Single tenant lease financing	10,755		563		—		—		11,318
Public finance	1,483		59		—		—		1,542
Healthcare finance	4,318		1,187		(743)		—		4,762
Small business lending	265		(20)		—		6		251
Residential mortgage	500		36		—		3		539
Home equity	53		(4)		—		2		51
Other consumer	2,580		347		(216)		117		2,828
Total	$	22,857	$	2,491	$	(1,016)	$	133	$	24,465


	Six Months Ended June 30, 2020
Allowance for loan losses:	Balance, Beginning of Period		Provision (Credit) Charged to Expense		Losses Charged Off		Recoveries		Balance, End of Period
Commercial and industrial	$	1,521	$	205	$	(254)	$	5	$	1,477
Owner-occupied commercial real estate	561		285		—		—		846
Investor commercial real estate	109		21		—		—		130
Construction	380		341		—		—		721
Single tenant lease financing	11,175		143		—		—		11,318
Public finance	1,580		(38)		—		—		1,542
Healthcare finance	3,247		2,258		(743)		—		4,762
Small business lending	54		183		—		14		251
Residential mortgage	657		(107)		(15)		4		539
Home equity	46		—		—		5		51
Other consumer	2,510		661		(502)		159		2,828
Total	$	21,840	$	3,952	$	(1,514)	$	187	$	24,465


(in thousands)	Three Months Ended June 30, 2019
Allowance for loan losses:	Balance, Beginning of Period		Provision (Credit) Charged to Expense		Losses Charged Off		Recoveries		Balance, End of Period
Commercial and industrial	$	1,351	$	444	$	—	$	—	$	1,795
Owner-occupied commercial real estate	847		(223)		—		—		624
Investor commercial real estate	103		66		—		—		169
Construction	267		35		—		—		302
Single tenant lease financing	9,368		293		—		—		9,661
Public finance	1,650		113		—		—		1,763
Healthcare finance	1,731		562		—		—		2,293
Small business lending	93		36		—		—		129
Residential mortgage	1,044		(383)		—		1		662
Home equity	49		(5)		—		4		48
Other consumer	2,338		451		(337)		78		2,530
Total	$	18,841	$	1,389	$	(337)	$	83	$	19,976


	Six Months Ended June 30, 2019
Allowance for loan losses:	Balance, Beginning of Period		Provision (Credit) Charged to Expense		Losses Charged Off		Recoveries		Balance, End of Period
Commercial and industrial	$	1,384	$	523	$	(112)	$	—	$	1,795
Owner-occupied commercial real estate	891		(267)		—		—		624
Investor commercial real estate	61		108		—		—		169
Construction	251		51		—		—		302
Single tenant lease financing	8,827		834		—		—		9,661
Public finance	1,670		93		—		—		1,763
Healthcare finance	1,264		1,029		—		—		2,293
Small business lending	95		34		—		—		129
Residential mortgage	1,079		(419)		—		2		662
Home equity	53		(11)		—		6		48
Other consumer	2,321		699		(654)		164		2,530
Total	$	17,896	$	2,674	$	(766)	$	172	$	19,976

Allowance For Credit Losses On Financing Receivables Portfolio Segment

The following tables present the recorded investment in loans based on portfolio segment and impairment method as of June 30, 2020 and December 31, 2019.


(in thousands)	Loans										Allowance for Loan Losses
June 30, 2020	Ending Balance: Collectively Evaluated for Impairment		Ending Balance: Individually Evaluated for Impairment		Ending Balance		Ending Balance: Collectively Evaluated for Impairment		Ending Balance: Individually Evaluated for Impairment		Ending Balance
Commercial and industrial	$	80,871	$	816	$	81,687	$	1,368	$	109	$	1,477
Owner-occupied commercial real estate	82,974		3,922		86,897		846		—		846
Investor commercial real estate	13,286		—		13,286		130		—		130
Construction	77,591		—		77,591		721		—		721
Single tenant lease financing	975,612		4,680		980,292		9,658		1,660		11,318
Public finance	647,107		—		647,107		1,542		—		1,542
Healthcare finance	380,956		—		380,956		4,762		—		4,762
Small business lending	118,526		—		118,526		251				251
Residential mortgage	207,320		1,408		208,728		539		—		539
Home equity	22,640		—		22,640		51		—		51
Other consumer	291,518		115		291,632		2,828		—		2,828
Total	$	2,898,401	$	10,941	$	2,909,342	$	22,696	$	1,769	$	24,465


(in thousands)	Loans										Allowance for Loan Losses
December 31, 2019	Ending Balance: Collectively Evaluated for Impairment		Ending Balance: Individually Evaluated for Impairment		Ending Balance		Ending Balance: Collectively Evaluated for Impairment		Ending Balance: Individually Evaluated for Impairment		Ending Balance
Commercial and industrial	$	93,520	$	2,900	$	96,420	$	1,412	$	109	$	1,521
Owner-occupied commercial real estate	81,063		5,663		86,726		561		—		561
Investor commercial real estate	12,567		—		12,567		109		—		109
Construction	60,274		—		60,274		380		—		380
Single tenant lease financing	991,199		4,680		995,879		9,515		1,660		11,175
Public finance	687,094		—		687,094		1,580		—		1,580
Healthcare finance	300,612		—		300,612		3,247		—		3,247
Small business lending	46,945		—		46,945		54		—		54
Residential mortgage	312,714		1,135		313,849		657		—		657
Home equity	24,306		—		24,306		46		—		46
Other consumer	295,266		43		295,309		2,510		—		2,510
Total	$	2,905,560	$	14,421	$	2,919,981	$	20,071	$	1,769	$	21,840

Financing Receivable Credit Quality Indicators


	June 30, 2020
(in thousands)	Pass		Special Mention		Substandard		Total
Commercial and industrial	$	77,447	$	3,465	$	775	$	81,687
Owner-occupied commercial real estate	80,389		2,585		3,923		86,897
Investor commercial real estate	13,286		—		—		13,286
Construction	77,591		—		—		77,591
Single tenant lease financing	966,782		8,830		4,680		980,292
Public finance	647,107		—		—		647,107
Healthcare finance	379,899		1,057		—		380,956
Small business lending	118,526		—		—		118,526
Total commercial loans	$	2,361,027	$	15,937	$	9,378	$	2,386,342


	June 30, 2020
(in thousands)	Performing		Nonaccrual		Total
Residential mortgage	$	207,686	$	1,042	$	208,728
Home equity	22,640		—		22,640
Other consumer	291,524		108		291,632
Total consumer loans	$	521,850	$	1,150	$	523,000


	December 31, 2019
(in thousands)	Pass		Special Mention		Substandard		Total
Commercial and industrial	$	89,818	$	3,973	$	2,629	$	96,420
Owner-occupied commercial real estate	79,329		3,462		3,935		86,726
Investor commercial real estate	12,567		—		—		12,567
Construction	60,274		—		—		60,274
Single tenant lease financing	983,448		7,751		4,680		995,879
Public finance	687,094		—		—		687,094
Healthcare finance	300,612		—		—		300,612
Small business lending	46,945		—		—		46,945
Total commercial loans	$	2,260,087	$	15,186	$	11,244	$	2,286,517


	December 31, 2019
(in thousands)	Performing		Nonaccrual		Total
Residential mortgage	$	313,088	$	761	$	313,849
Home equity	24,306		—		24,306
Other consumer	295,276		33		295,309
Total consumer loans	$	632,670	$	794	$	633,464

Past Due Financing Receivables

The following tables present the Company’s loan portfolio delinquency analysis as of June 30, 2020 and December 31, 2019.


	June 30, 2020
(in thousands)	30-59 Days Past Due		60-89 Days Past Due		90 Days or More Past Due		Total Past Due		Current		Total Loans		Non- accrual Loans		Total Loans 90 Days or More Past Due and Accruing
Commercial and industrial	$	80	$	—	$	212	$	292	$	81,395	$	81,687	$	299	$	—
Owner-occupied commercial real estate	—		—		2,066		2,066		84,831		86,897		2,066		—
Investor commercial real estate	—		—		—		—		13,286		13,286		—		—
Construction	—		—		—		—		77,591		77,591		—		—
Single tenant lease financing	—		—		4,680		4,680		975,612		980,292		4,680		—
Public finance	—		—		—		—		647,107		647,107		—		—
Healthcare finance	—		—		—		—		380,956		380,956		—		—
Small business lending	—		—		—		—		118,526		118,526		—		—
Residential mortgage	—		—		281		281		208,447		208,728		1,042		—
Home equity	—		—		—		—		22,640		22,640		—		—
Other consumer	80		56		25		161		291,471		291,632		108		—
Total	$	160	$	56	$	7,264	$	7,480	$	2,901,862	$	2,909,342	$	8,195	$	—


	December 31, 2019
(in thousands)	30-59 Days Past Due		60-89 Days Past Due		90 Days or More Past Due		Total Past Due		Current		Total Loans		Non- accrual Loans		Total Loans 90 Days or More Past Due and Accruing
Commercial and industrial	$	15	$	96	$	122	$	233	$	96,187	$	96,420	$	226	$	—
Owner-occupied commercial real estate	—		—		464		464		86,262		86,726		464		—
Investor commercial real estate	—		—		—		—		12,567		12,567		—		—
Construction	—		—		—		—		60,274		60,274		—		—
Single tenant lease financing	—		4,680		—		4,680		991,199		995,879		4,680		—
Public finance	—		—		—		—		687,094		687,094		—		—
Healthcare finance	—		—		—		—		300,612		300,612		—		—
Small business lending	54				—		54		46,891		46,945		—		—
Residential mortgage	—		—		1,177		1,177		312,672		313,849		761		416
Home equity	—		—		—		—		24,306		24,306		—		—
Other consumer	240		107		—		347		294,962		295,309		33		—
Total	$	309	$	4,883	$	1,763	$	6,955	$	2,913,026	$	2,919,981	$	6,164	$	416

Impaired Financing Receivables

The following table presents the Company’s impaired loans as of June 30, 2020 and December 31, 2019.


	June 30, 2020										December 31, 2019
(in thousands)	Recorded Balance		Unpaid Principal Balance		Specific Allowance		Recorded Balance		Unpaid Principal Balance		Specific Allowance
Loans without a specific valuation allowance
Commercial and industrial	$	613	$	672	$	—	$	2,693	$	2,694	$	—
Owner-occupied commercial real estate	3,922		3,925		—		5,663		5,665		—





Residential mortgage	1,408		1,498		—		1,135		1,209		—

Other consumer	115		215		—		43		107		—
Total	6,058		6,310		—		9,534		9,675		—
Loans with a specific valuation allowance
Commercial and industrial	203		240		109		207		244		109



Single tenant lease financing	4,680		4,680		1,660		4,680		4,680		1,660





Total	4,883		4,920		1,769		4,887		4,924		1,769
Total impaired loans	$	10,941	$	11,230	$	1,769	$	14,421	$	14,599	$	1,769

The table below presents average balances and interest income recognized for impaired loans during the three and six months ended June 30, 2020 and 2019.


	Three Months Ended														Six Months Ended
	June 30, 2020						June 30, 2019						June 30, 2020				June 30, 2019
(in thousands)	Average Balance		Interest Income		Average Balance		Interest Income		Average Balance		Interest Income		Average Balance		Interest Income
Loans without a specific valuation allowance
Commercial and industrial	$	594	$	18	$	4,053	$	86	$	1,330	$	36	$	4,376	$	167
Owner-occupied commercial real estate	3,923		29		2,723		66		4,573		31		2,464		93




Small business lending	—		—		—		—
Residential mortgage	1,352		—		3,538		—		1,313		—		2,796		—
Home equity	—		—		—		—		—		—		21		—
Other consumer	75		—		83		—		60		—		79		—
Total	5,944		47		10,397		152		7,276		67		9,736		260
Loans with a specific valuation allowance
Commercial and industrial	204		—		353		—		204		—		177		—



Single tenant lease financing	4,680		—		—		—		4,680		—		—		—





Total	4,884		—		353		—		4,884		—		177		—
Total impaired loans	$	10,828	$	47	$	10,750	$	152	$	12,160	$	67	$	9,913	$	260

Premises and Equipment (Tables)

6 Months Ended

Jun. 30, 2020

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment

The following table summarizes premises and equipment at June 30, 2020 and December 31, 2019.


(in thousands)	June 30, 2020		December 31, 2019
Land	$	2,500	$	2,500
Right of use leased asset	1,242		1,602
Building and improvements	19,821		10,004
Furniture and equipment	10,452		9,689
Less: accumulated depreciation	(10,076)		(9,165)
Total	$	23,939	$	14,630

Leases (Tables)

6 Months Ended

Jun. 30, 2020

Leases [Abstract]

Lease, Cost

The following table shows the components of lease expense.


(in thousands)	Three Months Ended								Six Months Ended
	June 30, 2020		June 30, 2019		June 30, 2020		June 30, 2019
Operating lease cost	$	251	$	187	$	466	$	368

Lessee, Supplemental Cash Flow

The following table shows supplemental cash flow information related to leases.


(in thousands)	Six Months Ended
	June 30, 2020		June 30, 2019
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	497	$	394

Lessee, Supplemental Balance Sheet


(dollars in thousands)
	June 30, 2020			December 31, 2019
Operating lease right-of-use assets	$	1,242		$	1,602
Operating lease liabilities	1,242			1,602

Weighted-average remaining lease term (years)
Operating leases	2.1			2.4

Weighted-average discount rate
Operating leases	2.0		%	2.0		%

Lessee, Operating Lease, Liability, Maturity

The following table shows the future minimum payments of operating leases with initial or remaining terms of one year or more as of June 30, 2020.


(in thousands)
Twelve months ended June 30,
2021	$	691
2022	290
2023	232
2024	—
2025	—
Thereafter	—
Total lease payments	1,213
Less: imputed interest	(30)
Total	$	1,183

Servicing Asset (Tables)

6 Months Ended

Jun. 30, 2020

Transfers and Servicing [Abstract]

Schedule of Servicing Assets at Fair Value

Activity for the servicing asset and the related changes in fair value for the six months ended June 30, 2020 and 2019 are shown in the table below.


(in thousands)	Six Months Ended
	June 30, 2020		June 30, 2019
Beginning balance	$	2,481	$	—
Additions	310		—
Changes in fair value	(269)		—
Ending balance	$	2,522	$	—

Schedule Of Unpaid Principal Balances Of Loans Serviced For Others

The unpaid principal balances of these loans serviced for others as of June 30, 2020 and December 31, 2019 are shown in the table below.


(in thousands)
	June 30, 2020		December 31, 2019
Loan portfolios serviced for:
SBA guaranteed loans	$	113,927	$	103,981

Total	$	113,927	$	103,981

Subordinated Debt (Tables)

6 Months Ended

Jun. 30, 2020

Debt Disclosure [Abstract]

Schedule of Subordinated Borrowing


	June 30, 2020						December 31, 2019
(in thousands)	Principal		Unamortized Debt Issuance Costs		Principal		Unamortized Debt Issuance Costs

2025 Note	10,000		(126)		10,000		(138)
2026 Notes	25,000		(777)		25,000		(839)
2029 Notes	37,000		(1,416)		37,000		(1,495)
Total	$	72,000	$	(2,319)	$	72,000	$	(2,472)

Benefit Plans (Tables)

6 Months Ended

Jun. 30, 2020

Retirement Benefits [Abstract]

Nonvested Restricted Stock Shares Activity

The following table summarizes the status of the 2013 Plan awards as of June 30, 2020, and activity for the six months ended June 30, 2020.


	Restricted Stock Units	Weighted-Average Grant Date Fair Value Per Share		Restricted Stock Awards	Weighted-Average Grant Date Fair Value Per Share		Deferred Stock Units	Weighted-Average Grant Date Fair Value Per Share
Nonvested at December 31, 2019	107,244	$	29.03	—	$	—	—	$	—
Granted	66,808	27.56		16,090	25.58		6	19.41
Vested	(48,499)	30.34		(6,808)	26.37		(6)	19.41
Forfeited	—	—		(1,638)	27.56		—	—
Nonvested at June 30, 2020	125,553	$	27.74	7,644	$	24.44	—	$	—

Schedule Of Deferred Stock Option Plan

The following table summarizes the status of deferred stock rights related to the Directors Deferred Stock Plan for the six months ended June 30, 2020.


						Deferred Stock Rights
Outstanding, beginning of period						84,505
Granted						428
Exercised						—
Outstanding, end of period						84,933

Fair Value of Financial Instruments (Tables)

6 Months Ended

Jun. 30, 2020

Fair Value Disclosures [Abstract]

Fair Value, Assets Measured on Recurring Basis


			June 30, 2020 Fair Value Measurements Using
(in thousands)	Fair Value		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
U.S. Government-sponsored agencies	$	66,544	$	—	$	66,544	$	—
Municipal securities	90,562		—		90,562		—
Agency mortgage-backed securities	278,530		—		278,530		—
Private label mortgage-backed securities	101,925				101,925		—
Asset-backed securities	4,837		—		4,837		—
Corporate securities	46,619		—		46,619		—

Total available-for-sale securities	589,017		—		589,017		—
Servicing asset	2,522		—		—		2,522

Interest rate swap liabilities	(34,494)		—		(34,494)		—
Loans held-for-sale (mandatory pricing agreements)	2,001		—		2,001		—
Forward contracts	(17)		(17)		—		—
IRLCs	282		—		—		282


			December 31, 2019 Fair Value Measurements Using
(in thousands)	Fair Value		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
U.S. Government-sponsored agencies	$	75,872	$	—	$	75,872	$	—
Municipal securities	97,652		—		97,652		—
Agency mortgage-backed securities	261,440		—		261,440		—
Private label mortgage-backed securities	63,613		—		63,613		—
Asset-backed securities	4,955		—		4,955		—
Corporate securities	37,320		—		37,320		—

Total available-for-sale securities	540,852		—		540,852		—
Servicing asset	2,481		—		—		2,481

Interest rate swap liabilities	(37,786)		—		(37,786)		—
Loans held-for-sale (mandatory pricing agreements)	56,097		—		56,097		—
Forward contracts	(153)		(153)		—		—
IRLCs	910		—		—		910

Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation


	Three Months Ended
(in thousands)	Servicing Asset		Interest Rate Lock Commitments
Balance, April 1, 2020	$	2,415	$	2,064
Total realized gains (losses)
Additions	197		—
Change in fair value	(90)		(1,782)

Balance, June 30, 2020	2,522		282

Balance as of April 1, 2019	$	—	$	781
Total realized gains

Change in fair value	—		428

Balance, June 30, 2019	$	—	$	1,209



(in thousands)	Six Months Ended
	Servicing Asset		Interest Rate Lock Commitments
Balance January 1, 2020	$	2,481	$	910
Total realized gains (losses)
Additions	310		—
Change in fair value	(269)		(628)

Balance, June 30, 2020	$	2,522	282

Balance as of January 1, 2019	$	—	$	389
Total realized gains
Change in fair value	—		820

Balance, June 30, 2019	$	—	$	1,209

Schedule Of Impaired Loans, Including Valuation Allowance, Fair Value, Unobservable Inputs Reconciliation

hierarchy in which the fair value measurement falls at December 31, 2019. The Company did not have any measurements on a nonrecurring basis at June 30, 2020.


			December 31, 2019
(in thousands)			Fair Value Measurements Using
	Fair Value		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Impaired loans	$	3,019	$	—	$	—	$	3,019

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques

The following tables present quantitative information about unobservable inputs used in recurring and nonrecurring Level 3 fair value measurements.

(dollars in thousands)

Fair Value at
June 30, 2020

Valuation
Technique

Significant Unobservable
Inputs

Range

Weighted-Average Range

IRLCs

282

Discounted cash flow

Loan closing rates

63% - 100%

73%

Servicing asset

2,522

Discounted cash flow

Prepayment speeds

0% - 25%

13.0%

Expected weighted-average loan life

3.6 - 5.6 years

4.8 years

(dollars in thousands)

Fair Value at
December 31, 2019

Valuation
Technique

Significant Unobservable
Inputs

Range

Weighted-Average Range

Impaired loans

3,019

Fair value of collateral

Discount for type of property and current market conditions

10%

IRLCs

910

Discounted cash flow

Loan closing rates

50% - 100%

84%

Servicing asset

2,481

Discounted cash flow

Prepayment speeds

0% - 25%

13.5%

Expected weighted-average loan life

3.2 - 5.7 years

5.0 years

Fair Value, by Balance Sheet Grouping

The following tables present the carrying value and estimated fair value of all financial assets and liabilities at June 30, 2020 and December 31, 2019.


	June 30, 2020 Fair Value Measurements Using
(in thousands)	Carrying Amount		Fair Value		Quoted Prices In Active Market for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Cash and cash equivalents	$	498,619	$	498,619	$	498,619	$	—	$	—

Securities held-to-maturity	68,295		69,152		—		69,152		—
Loans held-for-sale (best efforts pricing agreements)	23,493		23,493		—		23,493		—
Net loans	2,949,209		3,006,369		—		—		3,006,369
Accrued interest receivable	21,093		21,093		21,093		—		—
Federal Home Loan Bank of Indianapolis stock	25,650		25,650		—		25,650		—
Deposits	3,380,789		3,428,960		1,520,495		—		1,908,465
Advances from Federal Home Loan Bank	514,913		548,015		—		548,015		—
Subordinated debt	69,681		65,349		55,154		10,195		—
Accrued interest payable	1,073		1,073		1,073		—		—


	December 31, 2019 Fair Value Measurements Using
(in thousands)	Carrying Amount		Fair Value		Quoted Prices In Active Market for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Cash and cash equivalents	$	327,361	$	327,361	$	327,361	$	—	$	—

Securities held-to-maturity	61,878		62,560		—		62,560		—

Net loans	2,941,707		2,876,688		—		—		2,876,688
Accrued interest receivable	18,607		18,607		18,607		—		—
Federal Home Loan Bank of Indianapolis stock	25,650		25,650		—		25,650		—
Deposits	3,153,963		3,232,065		1,002,141		—		2,229,924
Advances from Federal Home Loan Bank	514,910		520,950		—		520,950		—
Subordinated debt	69,528		75,206		64,996		10,210		—
Accrued interest payable	3,767		3,767		3,767		—		—

Mortgage Banking Activities (Tables)

6 Months Ended

Jun. 30, 2020

Mortgage Banking [Abstract]

Schedule of Participating Mortgage Loans

The following table presents the components of income from mortgage banking activities for the three and six months ended June 30, 2020 and 2019.


	Three Months Ended June 30,						Six Months Ended June 30,
(in thousands)	2020		2019		2020		2019
Gain on loans sold	$	4,164	$	1,825	$	8,507	$	3,298
(Loss) gain resulting from the change in fair value of loans held-for-sale	(1,255)		534		(939)		352
Gain (loss) resulting from the change in fair value of derivatives	499		305		(492)		631
Net revenue from mortgage banking activities	$	3,408	$	2,664	$	7,076	$	4,281

Derivative Financial Instruments (Tables)

6 Months Ended

Jun. 30, 2020

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule Of Derivative Instruments, Cumulative Basis Adjustments


(in thousands)	Carrying amount of the hedged asset						Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged assets
Line item in the condensed consolidated balance sheets in which the hedged item is included	June 30, 2020		December 31, 2019		June 30, 2020		December 31, 2019
Loans	$	—	$	474,957	$	—	$	21,440
Securities available-for-sale ⁽¹⁾	145,872		151,538		7,095		2,802

Schedule Of Derivative Instruments Of Fixed Rate Receivables


(dollars in thousands) June 30, 2020	Notional		Weighted- Average Remaining Maturity			Weighted-Average Ratio
Instruments Associated With	Value		(years)	Fair Value		Receive	Pay

Securities available-for-sale	88,200		3.6	(7,097)		3-month LIBOR	2.54	%
Total at June 30, 2020	$	88,200	3.6	$	(7,097)	3-month LIBOR	2.54	%


(dollars in thousands) December 31, 2019	Notional		Weighted- Average Remaining Maturity			Weighted-Average Ratio
Instruments Associated With	Value		(years)	Fair Value		Receive	Pay
Loans	$	427,446	5.5	$	(21,551)	3-month LIBOR	2.86	%
Securities available-for-sale	88,200		4.1	(2,806)		3-month LIBOR	2.54	%
Total at December 31, 2019	$	515,646	5.3	$	(24,357)	3-month LIBOR	2.80	%

Schedule Of Derivative Instruments Of Variable Rate Liabilities


(dollars in thousands) June 30, 2020	Notional		Weighted- Average Remaining Maturity			Weighted-Average Ratio
Cash Flow Hedges	Value		(years)	Fair Value		Receive	Pay
Interest rate swaps	$	110,000	6.6	$	(17,993)	3-month LIBOR	2.88	%
Interest rate swaps	100,000		3.5	(9,404)		1-month LIBOR	2.88	%


(dollars in thousands) December 31, 2019	Notional		Weighted- Average Remaining Maturity			Weighted-Average Ratio
Cash Flow Hedges	Value		(years)	Fair Value		Receive	Pay
Interest rate swaps	$	110,000	7.1	$	(8,390)	3-month LIBOR	2.88	%
Interest rate swaps	100,000		4.0	(5,040)		1-month LIBOR	2.88	%

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value

The following table presents the notional amount and fair value of interest rate swaps, IRLCs and forward contracts utilized by the Company at June 30, 2020 and December 31, 2019.


	June 30, 2020						December 31, 2019
(in thousands)	Notional Amount		Fair Value		Notional Amount		Fair Value
Asset Derivatives




Derivatives not designated as hedging instruments
IRLCs	14,527		282		56,256		910

Total contracts	$	14,527	$	282	$	56,256	$	910
Liability Derivatives
Derivatives designated as hedging instruments
Interest rate swaps associated with loans	$	—	$	—	$	427,446	$	(21,551)
Interest rate swaps associated with securities available-for-sale	88,200		(7,097)		88,200		(2,806)
Interest rate swaps associated with liabilities	210,000		(27,397)		210,000		(13,429)
Derivatives not designated as hedging instruments
Forward contracts	11,710		(17)		115,000		(153)

Total contracts	$	309,910	$	(34,511)	$	840,646	$	(37,939)

Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)


	Amount of Loss Recognized in Other Comprehensive Loss in The Three Months Ended						Amount of Loss Recognized in Other Comprehensive Loss in the Six Months Ended
(in thousands)	June 30, 2020		June 30, 2019		June 30, 2020		June 30, 2019

Interest rate swap agreements	$	(509)	$	(5,892)	$	(13,967)	$	(9,464)

Schedule of Derivative Instruments in Statements of Income Fair Value


	Amount of Gain / (Loss) Recognized in the Three Months Ended						Amount of Gain / (Loss) Recognized in the Six Months Ended
(in thousands)	June 30, 2020		June 30, 2019		June 30, 2020		June 30, 2019
Asset Derivatives
Derivatives not designated as hedging instruments
IRLCs	$	(1,781)	$	428	$	(628)	$	820


Liability Derivatives
Derivatives not designated as hedging instruments

Forward contracts	$	2,281	$	(122)	$	136	$	(189)

Schedule Of Effects Of Interest Rate Swap Agreements On Statements Of Income


(in thousands) Line item in the condensed consolidated statements of income	Three Months Ended									Six Months Ended
			June 30, 2020			June 30, 2019			June 30, 2020			June 30, 2019
Interest income
Loans	$	(1,221)		$	(285)		$	(2,445)		$	(264)
Securities - taxable	(159)			(10)			(250)			(17)
Securities - non-taxable	(164)			27			(230)			72
Total interest income	(1,544)			(268)			(2,925)			(209)
Interest expense
Deposits	593			104			899			194
Other borrowed funds	589			79			911			113
Total interest expense	1,182			183			1,810			307
Net interest income	$	(2,726)		$	(451)		$	(4,735)		$	(516)

Accumulated Other Comprehensive Loss (Tables)

6 Months Ended

Jun. 30, 2020

Stockholders' Equity Note [Abstract]

Schedule of Accumulated Other Comprehensive Income (Loss)


(in thousands) Details About Accumulated Other Comprehensive Loss Components														Affected Line Item in the Statements of Income
			Three Months Ended June 30, 2020			Six Months Ended June 30, 2020			Three Months Ended June 30, 2019			Six Months Ended June 30, 2019
Realized gains (losses) on securities available-for-sale
Gain (loss) realized in earnings	$	—		$	41		$	(458)		$	(458)		Gain (loss) on sale of securities

Total reclassified amount before tax	—			41			(458)			(458)			Income Before Income Taxes
Tax expense (benefit)	—			11			(124)			(124)			Income Tax Provision (Benefit)
Total reclassifications out of accumulated other comprehensive loss	$	—		$	30		$	(334)		$	(334)		Net Income

The components of accumulated other comprehensive loss, included in stockholders' equity, for the six months ended June 30, 2020 and 2019, respectively, are presented in the table below.


(in thousands)	Available-For-Sale Securities		Cash Flow Hedges		Total
Balance, January 1, 2020	$	(4,388)	$	(9,803)	$	(14,191)
Net change in unrealized gain (loss)	4,801		(13,967)		(9,166)
Reclassification of gain realized and included in earnings	(41)		—		(41)
Accumulated other comprehensive income (loss) before income tax	372		(23,770)		(23,398)
Income tax provision (benefit)	1,760		(4,020)		(2,260)
Balance, June 30, 2020	$	(1,388)	$	(19,750)	$	(21,138)

Balance, January 1, 2019	$	(13,360)	$	(3,181)	$	(16,541)
Net change in unrealized gain (loss)	10,577		(9,464)		1,113
Reclassification of net loss realized and included in earnings	458		—		458
Accumulated other comprehensive loss before income tax	(2,325)		(12,645)		(14,970)
Income tax provision (benefit)	3,163		(2,555)		608
Balance, June 30, 2019	$	(5,488)	$	(10,090)	$	(15,578)

The components of accumulated other comprehensive loss, included in stockholders' equity, for the three months ended June 30, 2020 and 2019, respectively, are presented in the table below.


(in thousands)	Available-For-Sale Securities		Cash Flow Hedges		Total
Balance, April 1, 2020	$	(239)	$	(19,627)	$	(19,866)
Net change in unrealized loss	(1,498)		(509)		(2,007)

Accumulated other comprehensive loss before income tax	(1,737)		(20,136)		(21,873)
Income tax benefit	(349)		(386)		(735)
Balance, June 30, 2020	$	(1,388)	$	(19,750)	$	(21,138)

Balance, April 1, 2019	$	(8,380)	$	(5,788)	$	(14,168)
Net change in unrealized gain (loss)	3,667		(5,892)		(2,225)
Reclassification of net loss realized and included in earnings	458		—		458
Accumulated other comprehensive loss before income tax	(4,255)		(11,680)		(15,935)
Income tax provision (benefit)	1,233		(1,590)		(357)
Balance, June 30, 2019	$	(5,488)	$	(10,090)	$	(15,578)

Basis of Presentation (Details)	Jun. 30, 2020 subsidiary
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of wholly-owned subsidiaries	3

Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Basic earnings per share
Net income	$ 3,932	$ 6,121	$ 9,951	$ 11,817
Weighted-average common shares (in shares)	9,768,227	10,148,285	9,798,528	10,182,770
Basic earnings per common share ( in dollars per share)	$ 0.40	$ 0.60	$ 1.02	$ 1.16
Diluted earnings per share
Net income	$ 3,932	$ 6,121	$ 9,951	$ 11,817
Weighted-average common shares (in shares)	9,768,227	10,148,285	9,798,528	10,182,770
Dilutive effect of equity compensation (in shares)	0	0	3,899	4,063
Weighted-average common and incremental shares (in shares)	9,768,227	10,148,285	9,802,427	10,186,833
Diluted earnings per common share (in dollars per share)	$ 0.40	$ 0.60	$ 1.02	$ 1.16
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	79,893	29,606

Securities (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Available-for-sale Securities [Abstract]
Amortized cost	$ 590,046	$ 546,640
Gross Unrealized Gains	11,509	3,426
Gross Unrealized Losses	(12,538)	(9,214)
Fair Value	589,017	540,852
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Held-to-maturity securities, amortized cost	68,295	61,878
Held-to-maturity securities, Gross Unrealized Gains	1,439	814
Held-to-maturity securities, Gross Unrealized Losses	(582)	(132)
Held-to-maturity, at fair value	69,152	62,560
U.S. Government-sponsored agencies
Available-for-sale Securities [Abstract]
Amortized cost	68,203	77,715
Gross Unrealized Gains	384	99
Gross Unrealized Losses	(2,043)	(1,942)
Fair Value	66,544	75,872
Municipal securities
Available-for-sale Securities [Abstract]
Amortized cost	91,906	97,447
Gross Unrealized Gains	3,140	1,706
Gross Unrealized Losses	(4,484)	(1,501)
Fair Value	90,562	97,652
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Held-to-maturity securities, amortized cost	14,603	10,142
Held-to-maturity securities, Gross Unrealized Gains	671	226
Held-to-maturity securities, Gross Unrealized Losses	0	0
Held-to-maturity, at fair value	15,274	10,368
Agency mortgage-backed securities
Available-for-sale Securities [Abstract]
Amortized cost	275,433	264,142
Gross Unrealized Gains	6,632	1,304
Gross Unrealized Losses	(3,535)	(4,006)
Fair Value	278,530	261,440
Private label mortgage-backed securities
Available-for-sale Securities [Abstract]
Amortized cost	101,110	63,704
Gross Unrealized Gains	1,044	97
Gross Unrealized Losses	(229)	(188)
Fair Value	101,925	63,613
Asset-backed securities
Available-for-sale Securities [Abstract]
Amortized cost	5,000	5,000
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(163)	(45)
Fair Value	4,837	4,955
Corporate securities
Available-for-sale Securities [Abstract]
Amortized cost	48,394	38,632
Gross Unrealized Gains	309	220
Gross Unrealized Losses	(2,084)	(1,532)
Fair Value	46,619	37,320
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Held-to-maturity securities, amortized cost	53,692	51,736
Held-to-maturity securities, Gross Unrealized Gains	768	588
Held-to-maturity securities, Gross Unrealized Losses	(582)	(132)
Held-to-maturity, at fair value	$ 53,878	$ 52,192

Securities (Details Textual)		3 Months Ended			6 Months Ended
Securities (Details Textual)	Mar. 01, 2020 USD ($) security	Jun. 30, 2020 USD ($)	Jun. 30, 2019 USD ($)	Mar. 31, 2019	Jun. 30, 2020 USD ($)	Jun. 30, 2019 USD ($)	Dec. 31, 2019 USD ($)
Investments, Debt and Equity Securities [Abstract]
Number of available for sale securities transferred to held for sale \| security	10
Available for sale securities transferred to held to maturity	$ 4,500,000
Unrealized holding gain, net of tax, retained in accumulated other comprehensive income	$ 100,000
Available-for-sale securities, gross realized gain (loss)		$ 0	$ (458,000)		$ 41,000	$ (458,000)
Continuous unrealized loss position, fair value		$ 237,500,000			$ 237,500,000		$ 317,500,000
Continuous unrealized loss position, fair value (as a percent)				53.00%	36.00%

Securities - Carrying Value (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Amortized Cost
Within one year	$ 15
One to five years	30,141
Five to ten years	82,174
After ten years	96,173
Amortized Cost	208,503
Amortized cost	590,046	$ 546,640
Held-to-maturity securities, One to five years	1,505
Held-to-maturity securities, Five to ten years	54,272
Held-to-maturity securities, After ten years	12,518
Held-to-maturity securities, Amortized Cost	68,295
Fair Value
Within one year	15
One to five years	25,364
Five to ten years	79,991
After ten years	98,355
Fair Value	203,725
Fair Value	589,017	540,852
Held-to-maturity securities, One to five years	1,557
Held-to-maturity securities, Five to ten years	54,642
Held-to-maturity securities, After ten years	12,953
Held-to-maturity securities, Fair Value	69,152
Agency mortgage-backed securities
Amortized Cost
Amortized cost	275,433	264,142
Fair Value
Fair Value	278,530	261,440
Private label mortgage-backed securities
Amortized Cost
Amortized cost	101,110	63,704
Fair Value
Fair Value	101,925	63,613
Asset-backed securities
Amortized Cost
Amortized cost	5,000	5,000
Fair Value
Fair Value	$ 4,837	$ 4,955

Securities - Gross Unrealized Losses and Fair Value (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Less Than 12 Months, Fair Value	$ 119,074	$ 127,335
Less Than 12 Months, Unrealized Losses	(5,172)	(2,571)
12 Months or Longer, Fair Value	94,873	176,218
12 Months or Longer, Unrealized Losses	(7,366)	(6,643)
Total, Fair Value	213,947	303,553
Total, Unrealized Losses	(12,538)	(9,214)
Held-to-maturity securities, Less Than 12 Months, Fair Value	23,527	13,977
Held-to-maturity securities, Less Than 12 Months, Unrealized Losses	(582)	(132)
Held-to-maturity securities, 12 Months or Longer, Fair Value	0	0
Held-to-maturity securities, 12 Months or Longer, Unrealized Losses	0	0
Held-to-maturity securities, Total, Fair Value	23,527	13,977
Held-to-maturity securities, Total, Unrealized Losses	(582)	(132)
U.S. Government-sponsored agencies
Less Than 12 Months, Fair Value	1,195	4,820
Less Than 12 Months, Unrealized Losses	(15)	(61)
12 Months or Longer, Fair Value	56,494	62,182
12 Months or Longer, Unrealized Losses	(2,028)	(1,881)
Total, Fair Value	57,689	67,002
Total, Unrealized Losses	(2,043)	(1,942)
Municipal securities
Less Than 12 Months, Fair Value	61,167	1,279
Less Than 12 Months, Unrealized Losses	(4,484)	(1,501)
12 Months or Longer, Fair Value	0	0
12 Months or Longer, Unrealized Losses	0	0
Total, Fair Value	61,167	1,279
Total, Unrealized Losses	(4,484)	(1,501)
Agency mortgage-backed securities
Less Than 12 Months, Fair Value	22,419	91,159
Less Than 12 Months, Unrealized Losses	(391)	(829)
12 Months or Longer, Fair Value	10,727	83,212
12 Months or Longer, Unrealized Losses	(3,144)	(3,177)
Total, Fair Value	33,146	174,371
Total, Unrealized Losses	(3,535)	(4,006)
Private label mortgage-backed securities
Less Than 12 Months, Fair Value	21,781	30,077
Less Than 12 Months, Unrealized Losses	(160)	(180)
12 Months or Longer, Fair Value	2,777	2,884
12 Months or Longer, Unrealized Losses	(69)	(8)
Total, Fair Value	24,558	32,961
Total, Unrealized Losses	(229)	(188)
Asset-backed securities
Less Than 12 Months, Fair Value	0	0
Less Than 12 Months, Unrealized Losses	0	0
12 Months or Longer, Fair Value	4,837	4,955
12 Months or Longer, Unrealized Losses	(163)	(45)
Total, Fair Value	4,837	4,955
Total, Unrealized Losses	(163)	(45)
Corporate securities
Less Than 12 Months, Fair Value	12,512	0
Less Than 12 Months, Unrealized Losses	(122)	0
12 Months or Longer, Fair Value	20,038	22,985
12 Months or Longer, Unrealized Losses	(1,962)	(1,532)
Total, Fair Value	32,550	22,985
Total, Unrealized Losses	(2,084)	(1,532)
Held-to-maturity securities, Less Than 12 Months, Fair Value	23,527	13,977
Held-to-maturity securities, Less Than 12 Months, Unrealized Losses	(582)	(132)
Held-to-maturity securities, 12 Months or Longer, Fair Value	0	0
Held-to-maturity securities, 12 Months or Longer, Unrealized Losses	0	0
Held-to-maturity securities, Total, Fair Value	23,527	13,977
Held-to-maturity securities, Total, Unrealized Losses	$ (582)	$ (132)

Securities Securities - Amounts Reclassified from Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Investments, Debt and Equity Securities [Abstract]
Gain (loss) realized in earnings	$ 0	$ (458,000)	$ 41,000	$ (458,000)
Total reclassified amount before tax	0	(458,000)	41,000	(458,000)
Tax expense (benefit)	0	(124,000)	11,000	(124,000)
Total reclassifications out of accumulated other comprehensive loss	$ 0	$ (334,000)	$ 30,000	$ (334,000)

Loans - Categories (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial loans	$ 2,909,342		$ 2,919,981
Net deferred loan origination costs and premiums and discounts on purchased loans and other	64,332		43,566
Total loans	2,973,674		2,963,547
Allowance for loan losses	(24,465)	$ (22,857)	(21,840)	$ (19,976)	$ (18,841)	$ (17,896)
Net loans	2,949,209		2,941,707
Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses	(1,477)	(1,670)	(1,521)	(1,795)	(1,351)	(1,384)
Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses	(846)	(645)	(561)	(624)	(847)	(891)
Investor commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses	(130)	(128)	(109)	(169)	(103)	(61)
Construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses	(721)	(460)	(380)	(302)	(267)	(251)
Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses	(11,318)	(10,755)	(11,175)	(9,661)	(9,368)	(8,827)
Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses	(1,542)	(1,483)	(1,580)	(1,763)	(1,650)	(1,670)
Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses	(4,762)	(4,318)	(3,247)	(2,293)	(1,731)	(1,264)
Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses	(251)	(265)	(54)	(129)	(93)	(95)
Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses	(539)	(500)	(657)	(662)	(1,044)	(1,079)
Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses	(51)	(53)	(46)	(48)	(49)	(53)
Other consumer
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses	(2,828)	$ (2,580)	(2,510)	$ (2,530)	$ (2,338)	$ (2,321)
Commercial Portfolio Segment
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial loans	2,386,342		2,286,517
Commercial Portfolio Segment \| Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial loans	81,687		96,420
Commercial Portfolio Segment \| Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial loans	86,897		86,726
Loans reclassified	13,300
Commercial Portfolio Segment \| Investor commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial loans	13,286		12,567
Commercial Portfolio Segment \| Construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial loans	77,591		60,274
Commercial Portfolio Segment \| Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial loans	980,292		995,879
Commercial Portfolio Segment \| Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial loans	647,107		687,094
Commercial Portfolio Segment \| Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial loans	380,956		300,612
Commercial Portfolio Segment \| Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial loans	118,526		46,945
Consumer Portfolio
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial loans	523,000		633,464
Consumer Portfolio \| Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial loans	208,728		313,849
Consumer Portfolio \| Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial loans	22,640		24,306
Consumer Portfolio \| Other consumer
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial loans	291,632		295,309
Interest rate swaps \| Commercial Portfolio Segment \| Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial loans	$ 46,000		$ 21,400

Loans - Change in the Balances of the ALLL (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Allowance for loan losses:
Balance, beginning of period	$ 22,857	$ 18,841	$ 21,840	$ 17,896
Provision (credit) charged to expense	2,491	1,389	3,952	2,674
Losses charged off	(1,016)	(337)	(1,514)	(766)
Recoveries	133	83	187	172
Balance, end of period	24,465	19,976	24,465	19,976
Commercial and industrial
Allowance for loan losses:
Balance, beginning of period	1,670	1,351	1,521	1,384
Provision (credit) charged to expense	(141)	444	205	523
Losses charged off	(57)	0	(254)	(112)
Recoveries	5	0	5	0
Balance, end of period	1,477	1,795	1,477	1,795
Owner-occupied commercial real estate
Allowance for loan losses:
Balance, beginning of period	645	847	561	891
Provision (credit) charged to expense	201	(223)	285	(267)
Losses charged off	0	0	0	0
Recoveries	0	0	0	0
Balance, end of period	846	624	846	624
Investor commercial real estate
Allowance for loan losses:
Balance, beginning of period	128	103	109	61
Provision (credit) charged to expense	2	66	21	108
Losses charged off	0	0	0	0
Recoveries	0	0	0	0
Balance, end of period	130	169	130	169
Construction
Allowance for loan losses:
Balance, beginning of period	460	267	380	251
Provision (credit) charged to expense	261	35	341	51
Losses charged off	0	0	0	0
Recoveries	0	0	0	0
Balance, end of period	721	302	721	302
Single tenant lease financing
Allowance for loan losses:
Balance, beginning of period	10,755	9,368	11,175	8,827
Provision (credit) charged to expense	563	293	143	834
Losses charged off	0	0	0	0
Recoveries	0	0	0	0
Balance, end of period	11,318	9,661	11,318	9,661
Public finance
Allowance for loan losses:
Balance, beginning of period	1,483	1,650	1,580	1,670
Provision (credit) charged to expense	59	113	(38)	93
Losses charged off	0	0	0	0
Recoveries	0	0	0	0
Balance, end of period	1,542	1,763	1,542	1,763
Healthcare finance
Allowance for loan losses:
Balance, beginning of period	4,318	1,731	3,247	1,264
Provision (credit) charged to expense	1,187	562	2,258	1,029
Losses charged off	(743)	0	(743)	0
Recoveries	0	0	0	0
Balance, end of period	4,762	2,293	4,762	2,293
Small business lending
Allowance for loan losses:
Balance, beginning of period	265	93	54	95
Provision (credit) charged to expense	(20)	36	183	34
Losses charged off	0	0	0	0
Recoveries	6	0	14	0
Balance, end of period	251	129	251	129
Residential mortgage
Allowance for loan losses:
Balance, beginning of period	500	1,044	657	1,079
Provision (credit) charged to expense	36	(383)	(107)	(419)
Losses charged off	0	0	(15)	0
Recoveries	3	1	4	2
Balance, end of period	539	662	539	662
Home equity
Allowance for loan losses:
Balance, beginning of period	53	49	46	53
Provision (credit) charged to expense	(4)	(5)	0	(11)
Losses charged off	0	0	0	0
Recoveries	2	4	5	6
Balance, end of period	51	48	51	48
Other consumer
Allowance for loan losses:
Balance, beginning of period	2,580	2,338	2,510	2,321
Provision (credit) charged to expense	347	451	661	699
Losses charged off	(216)	(337)	(502)	(654)
Recoveries	117	78	159	164
Balance, end of period	$ 2,828	$ 2,530	$ 2,828	$ 2,530

Loans - Recorded Investments in Loans (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018
Loans:
Ending balance: collectively evaluated for impairment	$ 2,898,401		$ 2,905,560
Ending balance: individually evaluated for impairment	10,941		14,421
Total Loans Receivable	2,909,342		2,919,981
Allowance for loan losses:
Ending balance: collectively evaluated for impairment	22,696		20,071
Ending balance: individually evaluated for impairment	1,769		1,769
Ending balance	24,465	$ 22,857	21,840	$ 19,976	$ 18,841	$ 17,896
Commercial and industrial
Loans:
Ending balance: collectively evaluated for impairment	80,871		93,520
Ending balance: individually evaluated for impairment	816		2,900
Allowance for loan losses:
Ending balance: collectively evaluated for impairment	1,368		1,412
Ending balance: individually evaluated for impairment	109		109
Ending balance	1,477	1,670	1,521	1,795	1,351	1,384
Owner-occupied commercial real estate
Loans:
Ending balance: collectively evaluated for impairment	82,974		81,063
Ending balance: individually evaluated for impairment	3,922		5,663
Allowance for loan losses:
Ending balance: collectively evaluated for impairment	846		561
Ending balance: individually evaluated for impairment	0		0
Ending balance	846	645	561	624	847	891
Investor commercial real estate
Loans:
Ending balance: collectively evaluated for impairment	13,286		12,567
Ending balance: individually evaluated for impairment	0		0
Allowance for loan losses:
Ending balance: collectively evaluated for impairment	130		109
Ending balance: individually evaluated for impairment	0		0
Ending balance	130	128	109	169	103	61
Construction
Loans:
Ending balance: collectively evaluated for impairment	77,591		60,274
Ending balance: individually evaluated for impairment	0		0
Allowance for loan losses:
Ending balance: collectively evaluated for impairment	721		380
Ending balance: individually evaluated for impairment	0		0
Ending balance	721	460	380	302	267	251
Single tenant lease financing
Loans:
Ending balance: collectively evaluated for impairment	975,612		991,199
Ending balance: individually evaluated for impairment	4,680		4,680
Allowance for loan losses:
Ending balance: collectively evaluated for impairment	9,658		9,515
Ending balance: individually evaluated for impairment	1,660		1,660
Ending balance	11,318	10,755	11,175	9,661	9,368	8,827
Public finance
Loans:
Ending balance: collectively evaluated for impairment	647,107		687,094
Ending balance: individually evaluated for impairment	0		0
Allowance for loan losses:
Ending balance: collectively evaluated for impairment	1,542		1,580
Ending balance: individually evaluated for impairment	0		0
Ending balance	1,542	1,483	1,580	1,763	1,650	1,670
Healthcare finance
Loans:
Ending balance: collectively evaluated for impairment	380,956		300,612
Ending balance: individually evaluated for impairment	0		0
Allowance for loan losses:
Ending balance: collectively evaluated for impairment	4,762		3,247
Ending balance: individually evaluated for impairment	0		0
Ending balance	4,762	4,318	3,247	2,293	1,731	1,264
Small business lending
Loans:
Ending balance: collectively evaluated for impairment	118,526		46,945
Ending balance: individually evaluated for impairment	0		0
Allowance for loan losses:
Ending balance: collectively evaluated for impairment	251		54
Ending balance	251	265	54	129	93	95
Residential mortgage
Loans:
Ending balance: collectively evaluated for impairment	207,320		312,714
Ending balance: individually evaluated for impairment	1,408		1,135
Allowance for loan losses:
Ending balance: collectively evaluated for impairment	539		657
Ending balance: individually evaluated for impairment	0		0
Ending balance	539	500	657	662	1,044	1,079
Home equity
Loans:
Ending balance: collectively evaluated for impairment	22,640		24,306
Ending balance: individually evaluated for impairment	0		0
Allowance for loan losses:
Ending balance: collectively evaluated for impairment	51		46
Ending balance: individually evaluated for impairment	0		0
Ending balance	51	53	46	48	49	53
Other consumer
Loans:
Ending balance: collectively evaluated for impairment	291,518		295,266
Ending balance: individually evaluated for impairment	115		43
Allowance for loan losses:
Ending balance: collectively evaluated for impairment	2,828		2,510
Ending balance: individually evaluated for impairment	0		0
Ending balance	2,828	$ 2,580	2,510	$ 2,530	$ 2,338	$ 2,321
Commercial Portfolio Segment
Loans:
Total Loans Receivable	2,386,342		2,286,517
Commercial Portfolio Segment \| Commercial and industrial
Loans:
Total Loans Receivable	81,687		96,420
Commercial Portfolio Segment \| Owner-occupied commercial real estate
Loans:
Total Loans Receivable	86,897		86,726
Commercial Portfolio Segment \| Investor commercial real estate
Loans:
Total Loans Receivable	13,286		12,567
Commercial Portfolio Segment \| Construction
Loans:
Total Loans Receivable	77,591		60,274
Commercial Portfolio Segment \| Single tenant lease financing
Loans:
Total Loans Receivable	980,292		995,879
Commercial Portfolio Segment \| Public finance
Loans:
Total Loans Receivable	647,107		687,094
Commercial Portfolio Segment \| Healthcare finance
Loans:
Total Loans Receivable	380,956		300,612
Commercial Portfolio Segment \| Small business lending
Loans:
Total Loans Receivable	$ 118,526		$ 46,945

Loans - Nonaccrual Loans (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	$ 2,909,342	$ 2,919,981
Commercial Portfolio Segment
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	2,386,342	2,286,517
Commercial Portfolio Segment \| Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	2,361,027	2,260,087
Commercial Portfolio Segment \| Special Mention
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	15,937	15,186
Commercial Portfolio Segment \| Substandard
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	9,378	11,244
Commercial Portfolio Segment \| Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	81,687	96,420
Commercial Portfolio Segment \| Commercial and industrial \| Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	77,447	89,818
Commercial Portfolio Segment \| Commercial and industrial \| Special Mention
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	3,465	3,973
Commercial Portfolio Segment \| Commercial and industrial \| Substandard
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	775	2,629
Commercial Portfolio Segment \| Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	86,897	86,726
Commercial Portfolio Segment \| Owner-occupied commercial real estate \| Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	80,389	79,329
Commercial Portfolio Segment \| Owner-occupied commercial real estate \| Special Mention
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	2,585	3,462
Commercial Portfolio Segment \| Owner-occupied commercial real estate \| Substandard
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	3,923	3,935
Commercial Portfolio Segment \| Investor commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	13,286	12,567
Commercial Portfolio Segment \| Investor commercial real estate \| Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	13,286	12,567
Commercial Portfolio Segment \| Investor commercial real estate \| Special Mention
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	0	0
Commercial Portfolio Segment \| Investor commercial real estate \| Substandard
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	0	0
Commercial Portfolio Segment \| Construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	77,591	60,274
Commercial Portfolio Segment \| Construction \| Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	77,591	60,274
Commercial Portfolio Segment \| Construction \| Special Mention
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	0	0
Commercial Portfolio Segment \| Construction \| Substandard
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	0	0
Commercial Portfolio Segment \| Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	980,292	995,879
Commercial Portfolio Segment \| Single tenant lease financing \| Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	966,782	983,448
Commercial Portfolio Segment \| Single tenant lease financing \| Special Mention
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	8,830	7,751
Commercial Portfolio Segment \| Single tenant lease financing \| Substandard
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	4,680	4,680
Commercial Portfolio Segment \| Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	647,107	687,094
Commercial Portfolio Segment \| Public finance \| Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	647,107	687,094
Commercial Portfolio Segment \| Public finance \| Special Mention
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	0	0
Commercial Portfolio Segment \| Public finance \| Substandard
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	0	0
Commercial Portfolio Segment \| Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	380,956	300,612
Commercial Portfolio Segment \| Healthcare finance \| Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	379,899	300,612
Commercial Portfolio Segment \| Healthcare finance \| Special Mention
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	1,057	0
Commercial Portfolio Segment \| Healthcare finance \| Substandard
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	0	0
Commercial Portfolio Segment \| Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	118,526	46,945
Commercial Portfolio Segment \| Small business lending \| Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	118,526	46,945
Commercial Portfolio Segment \| Small business lending \| Special Mention
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	0	0
Commercial Portfolio Segment \| Small business lending \| Substandard
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	$ 0	$ 0

Loans Loans - Internal Credit Assessment (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Financing Receivable, Credit Quality Indicator [Line Items]
Total Loans Receivable	$ 2,909,342	$ 2,919,981
Nonaccrual
Financing Receivable, Credit Quality Indicator [Line Items]
Total Loans Receivable	8,195	6,164
Consumer Portfolio
Financing Receivable, Credit Quality Indicator [Line Items]
Total Loans Receivable	523,000	633,464
Consumer Portfolio \| Performing
Financing Receivable, Credit Quality Indicator [Line Items]
Total Loans Receivable	521,850	632,670
Consumer Portfolio \| Nonaccrual
Financing Receivable, Credit Quality Indicator [Line Items]
Total Loans Receivable	1,150	794
Consumer Portfolio \| Residential mortgage
Financing Receivable, Credit Quality Indicator [Line Items]
Total Loans Receivable	208,728	313,849
Consumer Portfolio \| Residential mortgage \| Performing
Financing Receivable, Credit Quality Indicator [Line Items]
Total Loans Receivable	207,686	313,088
Consumer Portfolio \| Residential mortgage \| Nonaccrual
Financing Receivable, Credit Quality Indicator [Line Items]
Total Loans Receivable	1,042	761
Consumer Portfolio \| Home equity
Financing Receivable, Credit Quality Indicator [Line Items]
Total Loans Receivable	22,640	24,306
Consumer Portfolio \| Home equity \| Performing
Financing Receivable, Credit Quality Indicator [Line Items]
Total Loans Receivable	22,640	24,306
Consumer Portfolio \| Home equity \| Nonaccrual
Financing Receivable, Credit Quality Indicator [Line Items]
Total Loans Receivable	0	0
Consumer Portfolio \| Other consumer
Financing Receivable, Credit Quality Indicator [Line Items]
Total Loans Receivable	291,632	295,309
Consumer Portfolio \| Other consumer \| Performing
Financing Receivable, Credit Quality Indicator [Line Items]
Total Loans Receivable	291,524	295,276
Consumer Portfolio \| Other consumer \| Nonaccrual
Financing Receivable, Credit Quality Indicator [Line Items]
Total Loans Receivable	$ 108	$ 33

Loans - Loan Portfolio Aging (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	$ 7,480	$ 6,955
Current	2,901,862	2,913,026
Total Loans Receivable	2,909,342	2,919,981
Total Loans 90 Days or More Past Due and Accruing	0	416
Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans 90 Days or More Past Due and Accruing	0	0
Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans 90 Days or More Past Due and Accruing	0	0
Investor commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans 90 Days or More Past Due and Accruing	0	0
Construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans 90 Days or More Past Due and Accruing	0	0
Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans 90 Days or More Past Due and Accruing	0	0
Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans 90 Days or More Past Due and Accruing	0	0
Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans 90 Days or More Past Due and Accruing	0	0
Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans 90 Days or More Past Due and Accruing	0	0
Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans 90 Days or More Past Due and Accruing	0	416
Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans 90 Days or More Past Due and Accruing	0	0
Other consumer
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans 90 Days or More Past Due and Accruing	0	0
30-59 Days Past Due
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	160	309
60-89 Days Past Due
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	56	4,883
90 Days or More Past Due
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	7,264	1,763
Commercial Portfolio Segment
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	2,386,342	2,286,517
Commercial Portfolio Segment \| Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	292	233
Current	81,395	96,187
Total Loans Receivable	81,687	96,420
Commercial Portfolio Segment \| Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	2,066	464
Current	84,831	86,262
Total Loans Receivable	86,897	86,726
Commercial Portfolio Segment \| Investor commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	0	0
Current	13,286	12,567
Total Loans Receivable	13,286	12,567
Commercial Portfolio Segment \| Construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	0	0
Current	77,591	60,274
Total Loans Receivable	77,591	60,274
Commercial Portfolio Segment \| Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	4,680	4,680
Current	975,612	991,199
Total Loans Receivable	980,292	995,879
Commercial Portfolio Segment \| Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	0	0
Current	647,107	687,094
Total Loans Receivable	647,107	687,094
Commercial Portfolio Segment \| Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	0	0
Current	380,956	300,612
Total Loans Receivable	380,956	300,612
Commercial Portfolio Segment \| Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	0	54
Current	118,526	46,891
Total Loans Receivable	118,526	46,945
Commercial Portfolio Segment \| 30-59 Days Past Due \| Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	80	15
Commercial Portfolio Segment \| 30-59 Days Past Due \| Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	0	0
Commercial Portfolio Segment \| 30-59 Days Past Due \| Investor commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	0	0
Commercial Portfolio Segment \| 30-59 Days Past Due \| Construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	0	0
Commercial Portfolio Segment \| 30-59 Days Past Due \| Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	0	0
Commercial Portfolio Segment \| 30-59 Days Past Due \| Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	0	0
Commercial Portfolio Segment \| 30-59 Days Past Due \| Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	0	0
Commercial Portfolio Segment \| 30-59 Days Past Due \| Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	0	54
Commercial Portfolio Segment \| 60-89 Days Past Due \| Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	0	96
Commercial Portfolio Segment \| 60-89 Days Past Due \| Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	0	0
Commercial Portfolio Segment \| 60-89 Days Past Due \| Investor commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	0	0
Commercial Portfolio Segment \| 60-89 Days Past Due \| Construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	0	0
Commercial Portfolio Segment \| 60-89 Days Past Due \| Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	0	4,680
Commercial Portfolio Segment \| 60-89 Days Past Due \| Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	0	0
Commercial Portfolio Segment \| 60-89 Days Past Due \| Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	0	0
Commercial Portfolio Segment \| 60-89 Days Past Due \| Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	0
Commercial Portfolio Segment \| 90 Days or More Past Due \| Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	212	122
Commercial Portfolio Segment \| 90 Days or More Past Due \| Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	2,066	464
Commercial Portfolio Segment \| 90 Days or More Past Due \| Investor commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	0	0
Commercial Portfolio Segment \| 90 Days or More Past Due \| Construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	0	0
Commercial Portfolio Segment \| 90 Days or More Past Due \| Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	4,680	0
Commercial Portfolio Segment \| 90 Days or More Past Due \| Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	0	0
Commercial Portfolio Segment \| 90 Days or More Past Due \| Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	0	0
Commercial Portfolio Segment \| 90 Days or More Past Due \| Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	0	0
Consumer Portfolio
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	523,000	633,464
Consumer Portfolio \| Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	281	1,177
Current	208,447	312,672
Total Loans Receivable	208,728	313,849
Consumer Portfolio \| Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	0	0
Current	22,640	24,306
Total Loans Receivable	22,640	24,306
Consumer Portfolio \| Other consumer
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	161	347
Current	291,471	294,962
Total Loans Receivable	291,632	295,309
Consumer Portfolio \| 30-59 Days Past Due \| Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	0	0
Consumer Portfolio \| 30-59 Days Past Due \| Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	0	0
Consumer Portfolio \| 30-59 Days Past Due \| Other consumer
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	80	240
Consumer Portfolio \| 60-89 Days Past Due \| Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	0	0
Consumer Portfolio \| 60-89 Days Past Due \| Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	0	0
Consumer Portfolio \| 60-89 Days Past Due \| Other consumer
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	56	107
Consumer Portfolio \| 90 Days or More Past Due \| Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	281	1,177
Consumer Portfolio \| 90 Days or More Past Due \| Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	0	0
Consumer Portfolio \| 90 Days or More Past Due \| Other consumer
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Past Due	25	0
Nonaccrual
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	8,195	6,164
Nonaccrual \| Commercial Portfolio Segment \| Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	299	226
Nonaccrual \| Commercial Portfolio Segment \| Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	2,066	464
Nonaccrual \| Commercial Portfolio Segment \| Investor commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	0	0
Nonaccrual \| Commercial Portfolio Segment \| Construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	0	0
Nonaccrual \| Commercial Portfolio Segment \| Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	4,680	4,680
Nonaccrual \| Commercial Portfolio Segment \| Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	0	0
Nonaccrual \| Commercial Portfolio Segment \| Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	0	0
Nonaccrual \| Commercial Portfolio Segment \| Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	0	0
Nonaccrual \| Consumer Portfolio
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	1,150	794
Nonaccrual \| Consumer Portfolio \| Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	1,042	761
Nonaccrual \| Consumer Portfolio \| Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	0	0
Nonaccrual \| Consumer Portfolio \| Other consumer
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	$ 108	$ 33

Loans - Impaired Loans (Details)	3 Months Ended		6 Months Ended
Loans - Impaired Loans (Details)	Jun. 30, 2020 USD ($) loan	Jun. 30, 2019 USD ($) loan	Jun. 30, 2020 USD ($) loan	Jun. 30, 2019 USD ($) loan	Dec. 31, 2019 USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans without a specific valuation allowance - Recorded Balance	$ 6,058,000		$ 6,058,000		$ 9,534,000
Loans without a specific valuation allowance - Unpaid Principal Balance	6,310,000		6,310,000		9,675,000
Loans without a specific valuation allowance	0		0		0
Impaired loans	4,883,000		4,883,000		4,887,000
Loans with a specific valuation allowance - Unpaid Principal Balance	4,920,000		4,920,000		4,924,000
Loans with a specific valuation allowance	1,769,000		1,769,000		1,769,000
Impaired Financing Receivable, Recorded Investment	10,941,000		10,941,000		14,421,000
Impaired Financing Receivable, Unpaid Principal Balance	11,230,000		11,230,000		14,599,000
Impaired Financing Receivable, Related Allowance	1,769,000		1,769,000		1,769,000
Loans without a specific valuation allowance - Average Balance	5,944,000	$ 10,397,000	7,276,000	$ 9,736,000
Loans without a specific valuation allowance - Interest Income	47,000	152,000	67,000	260,000
Loans with a specific valuation allowance - Average Balance	4,884,000	353,000	4,884,000	177,000
Loans with a specific valuation allowance - Interest Income	0	0	0	0
Impaired Financing Receivable, Average Recorded Investment	10,828,000	10,750,000	12,160,000	9,913,000
Impaired Financing Receivable, Interest Income, Accrual Method	47,000	152,000	67,000	260,000
Other real estate owned	$ 2,065,000		$ 2,065,000		2,065,000
Mortgage loans in process of foreclosure, number of loans \| loan	1		1
Mortgage loans in process of foreclosure, amount	$ 100,000		$ 100,000		0
Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans without a specific valuation allowance - Recorded Balance	613,000		613,000		2,693,000
Loans without a specific valuation allowance - Unpaid Principal Balance	672,000		672,000		2,694,000
Loans without a specific valuation allowance	0		0		0
Impaired loans	203,000		203,000		207,000
Loans with a specific valuation allowance - Unpaid Principal Balance	240,000		240,000		244,000
Loans with a specific valuation allowance	109,000		109,000		109,000
Loans without a specific valuation allowance - Average Balance	594,000	4,053,000	1,330,000	4,376,000
Loans without a specific valuation allowance - Interest Income	18,000	86,000	36,000	167,000
Loans with a specific valuation allowance - Average Balance	204,000	353,000	204,000	177,000
Loans with a specific valuation allowance - Interest Income	0	$ 0	0	$ 0
Number of contracts classified as TDRs \| loan		4		4
Financing receivable, troubled debt restructuring		$ 2,000,000.0		$ 2,000,000.0
Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans without a specific valuation allowance - Recorded Balance	3,922,000		3,922,000		5,663,000
Loans without a specific valuation allowance - Unpaid Principal Balance	3,925,000		3,925,000		5,665,000
Loans without a specific valuation allowance	0		0		0
Loans without a specific valuation allowance - Average Balance	3,923,000	2,723,000	4,573,000	2,464,000
Loans without a specific valuation allowance - Interest Income	29,000	66,000	31,000	93,000
Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans without a specific valuation allowance - Average Balance	0	0
Loans without a specific valuation allowance - Interest Income	0	0
Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans without a specific valuation allowance - Recorded Balance	1,408,000		1,408,000		1,135,000
Loans without a specific valuation allowance - Unpaid Principal Balance	1,498,000		1,498,000		1,209,000
Loans without a specific valuation allowance	0		0		0
Loans without a specific valuation allowance - Average Balance	1,352,000	3,538,000	1,313,000	2,796,000
Loans without a specific valuation allowance - Interest Income	0	0	0	0
Other real estate owned	$ 0		$ 0		0
Number of contracts classified as TDRs \| loan	1		1
Financing receivable, troubled debt restructuring	$ 800,000		$ 800,000
Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans without a specific valuation allowance - Average Balance	0	0	0	21,000
Loans without a specific valuation allowance - Interest Income	0	0	0	0
Other consumer
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans without a specific valuation allowance - Recorded Balance	115,000		115,000		43,000
Loans without a specific valuation allowance - Unpaid Principal Balance	215,000		215,000		107,000
Loans without a specific valuation allowance	0		0		0
Loans without a specific valuation allowance - Average Balance	75,000	83,000	60,000	79,000
Loans without a specific valuation allowance - Interest Income	0	0	0	0
Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Impaired loans	4,680,000		4,680,000		4,680,000
Loans with a specific valuation allowance - Unpaid Principal Balance	4,680,000		4,680,000		4,680,000
Loans with a specific valuation allowance	1,660,000		1,660,000		$ 1,660,000
Loans with a specific valuation allowance - Average Balance	4,680,000	0	4,680,000	0
Loans with a specific valuation allowance - Interest Income	0	$ 0	0	$ 0
COVID-19 \| Commercial Portfolio Segment \| Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, troubled debt restructuring	$ 392,400,000		$ 392,400,000

- Summary (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Property, Plant and Equipment [Line Items]
Less: accumulated depreciation	$ (10,076)	$ (9,165)
Premises and equipment, net	23,939	14,630
Land
Property, Plant and Equipment [Line Items]
Premises and equipment, gross	2,500	2,500
Right of use leased asset
Property, Plant and Equipment [Line Items]
Premises and equipment, gross	1,242	1,602
Building and improvements
Property, Plant and Equipment [Line Items]
Premises and equipment, gross	19,821	10,004
Furniture and equipment
Property, Plant and Equipment [Line Items]
Premises and equipment, gross	$ 10,452	$ 9,689

Premises and Equipment - Narrative (Details) - Land Acquisition - SPF15, Inc. $ in Millions		3 Months Ended
	Oct. 25, 2019 USD ($)	Mar. 31, 2019 USD ($) parcel	Dec. 31, 2018 a
Property, Plant and Equipment [Line Items]
Area of land			3.3
Payments to acquire land \| $		$ 10.2
Number of additional parcels of land transferred \| parcel		2
Proceeds from purchase price reimbursement \| $	$ 11.1
Fishers Town Hall Building Corporation
Property, Plant and Equipment [Line Items]
Area of land			0.75
Third Parties
Property, Plant and Equipment [Line Items]
Area of land			1.65

Leases (Details) $ in Thousands	3 Months Ended		6 Months Ended
Leases (Details) $ in Thousands	Jun. 30, 2020 USD ($) lease	Jun. 30, 2019 USD ($)	Jun. 30, 2020 USD ($) lease	Jun. 30, 2019 USD ($)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Number of leases \| lease	3		3
Operating lease cost	$ 251	$ 187	$ 466	$ 368
Operating cash flows from operating leases		$ 394	$ 497
Minimum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Remaining term of contract			2 years
Maximum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Remaining term of contract			4 years

Leases - Balance Sheet Amounts (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Leases [Abstract]
Operating lease right-of-use assets	$ 1,242	$ 1,602
Operating lease liabilities	$ 1,242	$ 1,602
Weighted-average remaining lease term (years)	2 years 1 month 6 days	2 years 4 months 24 days
Weighted-average discount rate	2.00%	2.00%

Leases - Maturity (Details) $ in Thousands	Jun. 30, 2020 USD ($)
Leases [Abstract]
2021	$ 691
2022	290
2023	232
2024	0
2025	0
Thereafter	0
Total lease payments	1,213
Less: imputed interest	(30)
Operating lease liabilities	$ 1,183

Goodwill (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 4,687	$ 4,687

Servicing Asset (Details) - USD ($) $ in Thousands	6 Months Ended
Servicing Asset (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Jun. 30, 2019
Servicing Asset at Fair Value, Amount [Roll Forward]
Beginning balance	$ 2,481	$ 0
Additions	310	0
Changes in fair value	(269)	0
Ending balance	$ 2,522	$ 0

Servicing Asset - Unpaid principal balance (Details) - Loan servicing - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Servicing Assets at Fair Value [Line Items]
Loans serviced for others	$ 113,927	$ 103,981
SBA guaranteed loans
Servicing Assets at Fair Value [Line Items]
Loans serviced for others	$ 113,927	$ 103,981

Servicing Asset - Narrative (Details) - USD ($)	3 Months Ended		6 Months Ended
Servicing Asset - Narrative (Details) - USD ($)	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Servicing Assets at Fair Value [Line Items]
Changes in fair value			$ (269,000)	$ 0
Loan servicing
Servicing Assets at Fair Value [Line Items]
Loan servicing revenue	$ 255,000	$ 0	506,000	0
Changes in fair value	$ 100,000	$ 0	$ (300,000)	$ 0

Subordinated Debt (Details Textual) - Subordinated Debt - USD ($)	1 Months Ended	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2020	Oct. 20, 2015
2025 Note
Debt Instrument [Line Items]
Subordinated debenture, principal amount			$ 10,000,000.0
Fixed annual interest rate (as a percent)			6.4375%
2026 Notes
Debt Instrument [Line Items]
Subordinated debenture, principal amount		$ 25,000,000.0
Fixed annual interest rate (as a percent)		6.00%
2029 Notes
Debt Instrument [Line Items]
Subordinated debenture, principal amount		$ 37,000,000.0
Fixed annual interest rate (as a percent)		6.00%
LIBOR \| 2026 Notes
Debt Instrument [Line Items]
Basis spread on variable rate		485.00%
LIBOR \| 2029 Notes
Debt Instrument [Line Items]
Basis spread on variable rate	411.00%

Subordinated Debt - Schedule of Subordinated Debt (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Unamortized Debt Issuance Costs	$ (2,319)	$ (2,472)
Subordinated Debt
Debt Instrument [Line Items]
Principal	72,000	72,000
Unamortized Debt Issuance Costs	(2,319)	(2,472)
Subordinated Debt \| 2025 Note
Debt Instrument [Line Items]
Principal	10,000	10,000
Unamortized Debt Issuance Costs	(126)	(138)
Subordinated Debt \| 2026 Notes
Debt Instrument [Line Items]
Principal	25,000	25,000
Unamortized Debt Issuance Costs	(777)	(839)
Subordinated Debt \| 2029 Notes
Debt Instrument [Line Items]
Principal	37,000	37,000
Unamortized Debt Issuance Costs	$ (1,416)	$ (1,495)

Benefit Plans - Activity (Details)	6 Months Ended
Benefit Plans - Activity (Details)	Jun. 30, 2020 $ / shares shares
Restricted Stock Awards
Awards/Units Outstanding (in shares)
Balance at beginning of period \| shares	0
Granted \| shares	16,090
Vested \| shares	(6,808)
Vested \| shares	(1,638)
Balance at end of period \| shares	7,644
Weighted-Average Grant Date Fair Value Per Share (in dollars per share)
Balance at beginning of period \| $ / shares	$ 0
Granted \| $ / shares	25.58
Vested \| $ / shares	26.37
Vested \| $ / shares	27.56
Balance at end of period \| $ / shares	$ 24.44
Deferred Stock Units
Awards/Units Outstanding (in shares)
Balance at beginning of period \| shares	0
Granted \| shares	6
Vested \| shares	(6)
Vested \| shares	0
Balance at end of period \| shares	0
Weighted-Average Grant Date Fair Value Per Share (in dollars per share)
Balance at beginning of period \| $ / shares	$ 0
Granted \| $ / shares	19.41
Vested \| $ / shares	19.41
Vested \| $ / shares	0
Balance at end of period \| $ / shares	$ 0
Restricted Stock Units
Awards/Units Outstanding (in shares)
Balance at beginning of period \| shares	107,244
Granted \| shares	66,808
Vested \| shares	(48,499)
Vested \| shares	0
Balance at end of period \| shares	125,553
Weighted-Average Grant Date Fair Value Per Share (in dollars per share)
Balance at beginning of period \| $ / shares	$ 29.03
Granted \| $ / shares	27.56
Vested \| $ / shares	30.34
Vested \| $ / shares	0
Balance at end of period \| $ / shares	$ 27.74

Benefit Plans - Deferred Stock Rights (Details)	6 Months Ended
Benefit Plans - Deferred Stock Rights (Details)	Jun. 30, 2020 shares
Deferred Stock Rights
Outstanding, beginning of period	84,505
Granted	428
Exercised	0
Outstanding, end of period	84,933

Benefit Plans (Details Textual) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
Benefit Plans (Details Textual) - USD ($) $ in Thousands	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019
Allocated share-based compensation expense	$ 517	$ 383	$ 1,073	$ 862
Compensation cost not yet recognized	3,100		$ 3,100
Period for recognition			1 year 10 months 24 days
Percentage of annual retainer received in either common stock or deferred stock rights			100.00%
Plan 2013
Number of shares authorized (in shares)					750,000
Director
Common stock shares reserved for future grants (in shares)			180,000
Voting and Nonvoting Common Stock \| Voting and Nonvoting Common Stock
Allocated share-based compensation expense	$ 517	$ 383	$ 1,073	$ 862

Commitments and Credit Risk (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2020	Dec. 31, 2019
Other Commitments [Line Items]
Loan commitments	$ 267.4	$ 254.4
Capital committed to Small Business Investment Company fund, not contributed	1.7
Capital Addition Purchase Commitments
Other Commitments [Line Items]
Construction related contract commitment	65.1
Construction related contract commitment, not yet incurred	$ 51.6
Construction related contract commitment, term	2 years

Fair Value of Financial Instruments - Fair Value Hierarchy (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Total available-for-sale securities	$ 589,017	$ 540,852
Servicing asset	2,522	2,481
Loans held-for-sale (mandatory pricing agreements)	38,813	56,097
Derivative, fair value	(34,511)	(37,939)
Loans held-for-sale (mandatory pricing agreements)
Loans held-for-sale (mandatory pricing agreements)	2,001	56,097
Quoted Prices in Active Markets for Identical Assets (Level 1)
Total available-for-sale securities	0	0
Servicing asset	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) \| Loans held-for-sale (mandatory pricing agreements)
Loans held-for-sale (mandatory pricing agreements)	0	0
Significant Other Observable Inputs (Level 2)
Total available-for-sale securities	589,017	540,852
Servicing asset	0	0
Significant Other Observable Inputs (Level 2) \| Loans held-for-sale (mandatory pricing agreements)
Loans held-for-sale (mandatory pricing agreements)	2,001	56,097
Significant Unobservable Inputs (Level 3)
Total available-for-sale securities	0	0
Servicing asset	2,522	2,481
Significant Unobservable Inputs (Level 3) \| Loans held-for-sale (mandatory pricing agreements)
Loans held-for-sale (mandatory pricing agreements)	0	0
U.S. Government-sponsored agencies
Total available-for-sale securities	66,544	75,872
U.S. Government-sponsored agencies \| Quoted Prices in Active Markets for Identical Assets (Level 1)
Total available-for-sale securities	0	0
U.S. Government-sponsored agencies \| Significant Other Observable Inputs (Level 2)
Total available-for-sale securities	66,544	75,872
U.S. Government-sponsored agencies \| Significant Unobservable Inputs (Level 3)
Total available-for-sale securities	0	0
Municipal securities
Total available-for-sale securities	90,562	97,652
Municipal securities \| Quoted Prices in Active Markets for Identical Assets (Level 1)
Total available-for-sale securities	0	0
Municipal securities \| Significant Other Observable Inputs (Level 2)
Total available-for-sale securities	90,562	97,652
Municipal securities \| Significant Unobservable Inputs (Level 3)
Total available-for-sale securities	0	0
Agency mortgage-backed securities
Total available-for-sale securities	278,530	261,440
Agency mortgage-backed securities \| Quoted Prices in Active Markets for Identical Assets (Level 1)
Total available-for-sale securities	0	0
Agency mortgage-backed securities \| Significant Other Observable Inputs (Level 2)
Total available-for-sale securities		261,440
Agency mortgage-backed securities \| Significant Unobservable Inputs (Level 3)
Total available-for-sale securities	0	0
Private label mortgage-backed securities
Total available-for-sale securities	101,925	63,613
Private label mortgage-backed securities \| Quoted Prices in Active Markets for Identical Assets (Level 1)
Total available-for-sale securities		0
Private label mortgage-backed securities \| Significant Unobservable Inputs (Level 3)
Total available-for-sale securities	0	0
Asset-backed securities
Total available-for-sale securities	4,837	4,955
Asset-backed securities \| Quoted Prices in Active Markets for Identical Assets (Level 1)
Total available-for-sale securities	0	0
Asset-backed securities \| Significant Other Observable Inputs (Level 2)
Total available-for-sale securities	4,837	4,955
Asset-backed securities \| Significant Unobservable Inputs (Level 3)
Total available-for-sale securities	0	0
Corporate securities
Total available-for-sale securities	46,619	37,320
Corporate securities \| Quoted Prices in Active Markets for Identical Assets (Level 1)
Total available-for-sale securities	0	0
Corporate securities \| Significant Other Observable Inputs (Level 2)
Total available-for-sale securities	46,619	37,320
Corporate securities \| Significant Unobservable Inputs (Level 3)
Total available-for-sale securities	0	0
IRLCs
Derivative, fair value	282	910
IRLCs \| Quoted Prices in Active Markets for Identical Assets (Level 1)
Derivative, fair value	0	0
IRLCs \| Significant Other Observable Inputs (Level 2)
Derivative, fair value	0	0
IRLCs \| Significant Unobservable Inputs (Level 3)
Derivative, fair value	282	910
Interest rate swaps \| Interest rate swaps
Derivative liability, fair value	(34,494)	(37,786)
Interest rate swaps \| Quoted Prices in Active Markets for Identical Assets (Level 1) \| Interest rate swaps
Derivative liability, fair value	0	0
Interest rate swaps \| Significant Other Observable Inputs (Level 2) \| Interest rate swaps
Derivative liability, fair value	(34,494)	(37,786)
Interest rate swaps \| Significant Unobservable Inputs (Level 3) \| Interest rate swaps
Derivative liability, fair value	0	0
Forward contracts \| Forward contracts
Derivative, fair value	(17)	(153)
Forward contracts \| Quoted Prices in Active Markets for Identical Assets (Level 1) \| Forward contracts
Derivative, fair value	(17)	(153)
Forward contracts \| Significant Other Observable Inputs (Level 2) \| Forward contracts
Derivative, fair value	0	0
Forward contracts \| Significant Unobservable Inputs (Level 3) \| Forward contracts
Derivative, fair value	$ 0	$ 0

Fair Value of Financial Instruments - Fair Value Roll Forward (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Interest Rate Lock Commitments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ 2,064	$ 781	$ 910	$ 389
Additions	0		0
Included in net income	(1,782)	428	(628)	820
Ending balance	282	1,209	282	1,209
Servicing asset
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	2,415	0	2,481	0
Additions	197		310
Included in net income	(90)	0	(269)	0
Ending balance	$ 2,522	$ 0	$ 2,522	$ 0

Fair Value of Financial Instruments - Quantative Information About Unobservable Inputs (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Mar. 31, 2020	Jun. 30, 2020	Dec. 31, 2019
Impaired loans		$ 4,883	$ 4,887
Impaired loans		2,065	2,065
Servicing asset		2,522	2,481
Quoted Prices in Active Markets for Identical Assets (Level 1)
Servicing asset		0	0
Significant Other Observable Inputs (Level 2)
Servicing asset		0	0
Significant Unobservable Inputs (Level 3)
Servicing asset		2,522	2,481
Other Real Estate Owned \| Significant Unobservable Inputs (Level 3)
Impaired loans			3,019
Other securities Valuation Technique	Fair value of collateral
Other securities Unobservable Inputs	Discount for type of property and current market conditions
IRLCs \| Significant Unobservable Inputs (Level 3)
IRLCs Fair Value		$ 282	910
Other securities Valuation Technique	Discounted cash flow	Discounted cash flow
Other securities Unobservable Inputs	Loan closing rates	Loan closing rates
Servicing asset \| Significant Unobservable Inputs (Level 3)
Other securities Valuation Technique	Discounted cash flow	Discounted cash flow
Other securities Unobservable Inputs	Prepayment speeds	Prepayment speeds
Servicing asset		$ 2,522	$ 2,481
Discount for type of property and current market conditions \| Fair value of collateral \| Impaired Loans \| Significant Unobservable Inputs (Level 3)
Other real estate owned, discount rate			10.00%
Discount for type of property and current market conditions \| Fair value of collateral \| Impaired Loans \| Significant Unobservable Inputs (Level 3) \| Weighted-Average Range
Other real estate owned, discount rate			10.00%
Loan closing rates \| Discounted cash flow \| IRLCs \| Significant Unobservable Inputs (Level 3) \| Minimum
IRLC - Loan closing rates	50.00%	36.00%
Loan closing rates \| Discounted cash flow \| IRLCs \| Significant Unobservable Inputs (Level 3) \| Maximum
IRLC - Loan closing rates	100.00%	100.00%
Loan closing rates \| Discounted cash flow \| IRLCs \| Significant Unobservable Inputs (Level 3) \| Weighted-Average Range
IRLC - Loan closing rates	84.00%	73.00%
Prepayment speeds \| Discounted cash flow \| Servicing asset \| Significant Unobservable Inputs (Level 3) \| Minimum
Servicing asset, discount rate	0.00%	0.00%
Prepayment speeds \| Discounted cash flow \| Servicing asset \| Significant Unobservable Inputs (Level 3) \| Maximum
Servicing asset, discount rate	25.00%	25.00%
Prepayment speeds \| Discounted cash flow \| Servicing asset \| Significant Unobservable Inputs (Level 3) \| Weighted-Average Range
Servicing asset, discount rate	13.50%	13.00%
Expected weighted-average loan life \| Significant Unobservable Inputs (Level 3) \| Minimum
Loan life term	3 years 2 months 12 days	3 years 7 months 6 days
Expected weighted-average loan life \| Significant Unobservable Inputs (Level 3) \| Maximum
Loan life term	5 years 8 months 12 days	5 years 3 months 18 days
Expected weighted-average loan life \| Significant Unobservable Inputs (Level 3) \| Weighted-Average Range
Loan life term	5 years	4 years 9 months 18 days

Fair Value of Financial Instruments - Carrying Value and Estimated Fair Value (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Cash and cash equivalents, Carrying Amount	$ 498,619	$ 327,361
Debt Securities, Held-to-maturity	68,295	61,878
Held-to-maturity, at fair value	69,152	62,560
Loans held for sale, Fair Value	38,813	56,097
Loans receivable	2,949,209	2,941,707
Accrued interest receivable, Carrying Amount	21,093	18,607
FHLB stock, Carrying Amount	25,650	25,650
Deposits, Carrying Amount	3,380,789	3,153,963
Accrued interest payable, Carrying Amount	1,073	3,767
Reported Value Measurement
Cash and cash equivalents, Carrying Amount	498,619	327,361
Debt Securities, Held-to-maturity	68,295	61,878
Loans receivable	2,949,209	2,941,707
Accrued interest receivable, Carrying Amount	21,093	18,607
FHLB stock, Carrying Amount	25,650	25,650
Deposits, Carrying Amount	3,380,789	3,153,963
Advances from Federal Home Loan Bank, Fair Value	514,913	514,910
Subordinated debt, Carrying Value	1,073	69,528
Accrued interest payable, Carrying Amount	69,681
Fair Value
Cash and cash equivalents, Fair Value	498,619	327,361
Held-to-maturity, at fair value	69,152	62,560
Loans receivable, fair value	3,006,369	2,876,688
Accrued interest receivable, Fair Value	21,093	18,607
FHLB stock, Fair Value	25,650	25,650
Deposits, Fair Value	3,428,960	3,232,065
Advances from Federal Home Loan Bank, Fair Value	548,015	520,950
Subordinated debt, Fair Value	65,349	75,206
Accrued interest payable, Fair Value	1,073	3,767
Fair Value \| Quoted Prices in Active Markets for Identical Assets (Level 1)
Cash and cash equivalents, Fair Value	498,619	327,361
Held-to-maturity, at fair value	0	0
Loans receivable, fair value	0	0
Accrued interest receivable, Fair Value	21,093	18,607
FHLB stock, Fair Value	0	0
Deposits, Fair Value	1,520,495	1,002,141
Advances from Federal Home Loan Bank, Fair Value	0	0
Subordinated debt, Fair Value	55,154	64,996
Accrued interest payable, Fair Value	1,073	3,767
Fair Value \| Significant Other Observable Inputs (Level 2)
Cash and cash equivalents, Fair Value	0	0
Held-to-maturity, at fair value	69,152	62,560
Loans receivable, fair value	0	0
Accrued interest receivable, Fair Value	0	0
FHLB stock, Fair Value	25,650	25,650
Deposits, Fair Value	0	0
Advances from Federal Home Loan Bank, Fair Value	548,015	520,950
Subordinated debt, Fair Value	10,195	10,210
Accrued interest payable, Fair Value	0	0
Fair Value \| Significant Unobservable Inputs (Level 3)
Cash and cash equivalents, Fair Value	0	0
Held-to-maturity, at fair value	0	0
Loans receivable, fair value	3,006,369	2,876,688
Accrued interest receivable, Fair Value	0	0
FHLB stock, Fair Value	0	0
Deposits, Fair Value	1,908,465	2,229,924
Advances from Federal Home Loan Bank, Fair Value	0	0
Subordinated debt, Fair Value	0	0
Accrued interest payable, Fair Value	$ 0	$ 0

Mortgage Banking Activities (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Principal Transaction Revenue [Line Items]
Loans originated for sale	$ 211,900	$ 145,000	$ 427,323	$ 220,266
Proceeds from sale of loans	229,200	130,400	454,737	211,432
Mortgage banking activities
Principal Transaction Revenue [Line Items]
Gain on loans sold	4,164	1,825	8,507	3,298
(Loss) gain resulting from the change in fair value of loans held-for-sale	(1,255)	534	(939)	352
Gain (loss) resulting from the change in fair value of derivatives	499	305	(492)	631
Net revenue from mortgage banking activities	$ 3,408	$ 2,664	$ 7,076	$ 4,281

Derivative Financial Instruments - Carrying Amount and Adjustment (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Mar. 31, 2020	Jun. 30, 2020	Dec. 31, 2019
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amortized cost, at fair value		$ 590,046	$ 546,640
Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amortized cost, at fair value		88,200
Loans \| Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Carrying amount of the hedged assets		0	474,957
Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged assets	$ 21,440	0
Securities available-for-sale \| Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Carrying amount of the hedged assets		145,872	$ 151,538
Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged assets	$ 2,802	$ 7,095

Derivative Financial Instruments - Interest Swap Derivatives (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended
	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Value	$ 309,910			$ 309,910		$ 840,646
Fair Value	(34,511)			(34,511)		(37,939)
Interest expense	19,796		$ 20,739	41,022	$ 39,494
Interest rate swaps \| Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Value	$ 88,200			$ 88,200		$ 515,646
Weighted Average Remaining Maturity (years)		5 years 3 months 18 days		3 years 7 months 6 days
Fair Value		$ (24,357)		$ (7,097)
Weighted-Average Rate	2.54%			2.54%		2.80%
Cash collateral received						$ 34,600
Cash collateral pledged						42,300
Loans \| Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Fair Value		$ 21,440		$ 0
Loans \| Interest rate swaps \| Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Value						$ 427,446
Weighted Average Remaining Maturity (years)		5 years 6 months
Fair Value		$ (21,551)
Weighted-Average Rate						2.86%
Securities available-for-sale \| Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Fair Value		$ 2,802		7,095
Securities available-for-sale \| Interest rate swaps \| Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Value	$ 88,200			$ 88,200		$ 88,200
Weighted Average Remaining Maturity (years)		4 years 1 month 6 days		3 years 7 months 6 days
Fair Value		$ (2,806)		$ (7,097)
Weighted-Average Rate	2.54%			2.54%		2.54%
3-month LIBOR \| Interest rate swaps \| Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Value	$ 110,000			$ 110,000		$ 110,000
Weighted Average Remaining Maturity (years)		7 years 1 month 6 days		6 years 7 months 6 days
Fair Value	$ (17,993)			$ (17,993)		$ (8,390)
Derivative, variable interest rate	2.88%			2.88%		2.88%
1-month LIBOR \| Interest rate swaps \| Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Value	$ 100,000			$ 100,000		$ 100,000
Weighted Average Remaining Maturity (years)		4 years		3 years 6 months
Fair Value	$ (9,404)			$ (9,404)		$ (5,040)
Derivative, variable interest rate	2.88%			2.88%		2.88%

Derivative Financial Instruments - Notional Amounts and Fair Value (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Asset Derivatives
Notional Amount	$ 14,527	$ 56,256
Fair Value	282	910
Derivative Liability [Abstract]
Notional Amount	309,910	840,646
Derivative, fair value	(34,511)	(37,939)
Interest Rate Lock Commitments
Derivative Liability [Abstract]
Derivative, fair value	282	910
Derivatives designated as hedging instruments \| Interest rate swaps
Derivative Liability [Abstract]
Notional Amount	88,200	515,646
Derivatives not designated as hedging instruments \| Interest Rate Lock Commitments
Asset Derivatives
Notional Amount	14,527	56,256
Fair Value	282	910
Derivatives not designated as hedging instruments \| Forward contracts
Derivative Liability [Abstract]
Notional Amount	11,710	115,000
Fair Value	(17)	(153)
Loans \| Derivatives designated as hedging instruments \| Interest rate swaps
Derivative Liability [Abstract]
Notional Amount		427,446
Loans \| Derivatives designated as hedging instruments \| Forward contracts
Derivative Liability [Abstract]
Notional Amount	0	427,446
Fair Value	0	(21,551)
Securities available-for-sale \| Derivatives designated as hedging instruments \| Interest rate swaps
Derivative Liability [Abstract]
Notional Amount	88,200	88,200
Securities available-for-sale \| Derivatives designated as hedging instruments \| Forward contracts
Derivative Liability [Abstract]
Notional Amount	88,200	88,200
Fair Value	(7,097)	(2,806)
Liability \| Derivatives designated as hedging instruments \| Forward contracts
Derivative Liability [Abstract]
Notional Amount	210,000	210,000
Fair Value	$ (27,397)	$ (13,429)

Derivative Financial Instruments - Gain (Loss) Recognized (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Asset Derivatives \| Interest Rate Lock Commitments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net	$ (1,781)	$ 428	$ (628)	$ 820
Forward contracts \| Liability Derivatives
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net	$ 2,281	$ (122)	$ 136	$ (189)

Derivative Financial Instruments - Effect Of Derivatives on Income (Details) - Interest rate swaps - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Loss Recognized in Other Comprehensive Income	$ (509)		$ (13,967)
Amount of Loss Recognized in Other Comprehensive Income		$ (5,892)		$ (9,464)
Loans
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on the condensed consolidated statements of income	(1,221)		(2,445)
Gain (loss) recognized on the condensed consolidated statements of income		(285)		(264)
Securities - taxable
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on the condensed consolidated statements of income	(159)		(250)
Gain (loss) recognized on the condensed consolidated statements of income		(10)		(17)
Securities - non-taxable
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on the condensed consolidated statements of income	(164)		(230)
Gain (loss) recognized on the condensed consolidated statements of income		27		72
Total interest income
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on the condensed consolidated statements of income	(1,544)		(2,925)
Gain (loss) recognized on the condensed consolidated statements of income		(268)		(209)
Deposits
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on the condensed consolidated statements of income	593		899
Gain (loss) recognized on the condensed consolidated statements of income		104		194
Other borrowed funds
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on the condensed consolidated statements of income	589		911
Gain (loss) recognized on the condensed consolidated statements of income		79		113
Total interest expense
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on the condensed consolidated statements of income	1,182		1,810
Gain (loss) recognized on the condensed consolidated statements of income		183		307
Net interest income
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on the condensed consolidated statements of income	$ (2,726)		$ (4,735)
Gain (loss) recognized on the condensed consolidated statements of income		$ (451)		$ (516)

Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance, beginning of period	$ 305,127	$ 294,013	$ 304,913	$ 288,735
Net change in unrealized gain	(2,007)	(2,225)	(9,166)	1,113
Reclassification of net loss realized and included in earnings		458	(41)	458
Accumulated other comprehensive loss before income tax	(21,873)	(15,935)	(23,398)	(14,970)
Income tax provision (benefit)	(735)	(357)	(2,260)	608
Balance, end of period	307,711	296,120	307,711	296,120
Available-For-Sale Securities
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance, beginning of period	(239)	(8,380)	(4,388)	(13,360)
Net change in unrealized gain	(1,498)	3,667	4,801	10,577
Reclassification of net loss realized and included in earnings		458	(41)	458
Accumulated other comprehensive loss before income tax	(1,737)	(4,255)	372	(2,325)
Income tax provision (benefit)	(349)	1,233	1,760	3,163
Balance, end of period	(1,388)	(5,488)	(1,388)	(5,488)
Cash Flow Hedges
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance, beginning of period	(19,627)	(5,788)	(9,803)	(3,181)
Net change in unrealized gain	(509)	(5,892)	(13,967)	(9,464)
Reclassification of net loss realized and included in earnings		0	0	0
Accumulated other comprehensive loss before income tax	(20,136)	(11,680)	(23,770)	(12,645)
Income tax provision (benefit)	(386)	(1,590)	(4,020)	(2,555)
Balance, end of period	(19,750)	(10,090)	(19,750)	(10,090)
Accumulated Other Comprehensive Loss
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance, beginning of period	(19,866)	(14,168)	(14,191)	(16,541)
Balance, end of period	$ (21,138)	$ (15,578)	$ (21,138)	$ (15,578)